Tissue sparing	1
behavioral recovery	17
supraspinal axonal sparing/regeneration	38
sub-acute glial transplantation	88
a model	123
spinal cord contusion Helen R Barbour2	134
Christine D Plant1	174
Alan R Harvey3	194
Giles W Plant1 ,2	213
Abstract Background	232
It	253
olfactory ensheathing glia -LRB- OEG -RRB-	276
olfactory ensheathing glia	276
OEG	304
Schwann cell -LRB- SCs -RRB- transplantation	313
Schwann cell -LRB- SCs -RRB-	313
Schwann cell	313
SCs	327
cellular treatments for spinal cord injury -LRB- SCI -RRB-	366
cellular treatments	366
spinal cord injury -LRB- SCI -RRB-	390
spinal cord injury	390
SCI	410
acute and sub-acute time points	427
this study	463
we	475
DsRED	491
adult OEG and SCs sub-acutely	508
adult OEG and SCs	508
adult OEG	508
SCs	522
14 days	539
a T10 moderate spinal cord contusion injury in the rat	558
a T10 moderate spinal cord contusion injury	558
T10	560
the rat	605
Behaviour	614
open field -LRB- BBB -RRB-	640
open field	640
BBB	652
horizontal ladder walking tests to ascertain improvements in locomotor function	661
horizontal ladder	661
tests	687
improvements	706
locomotor function	722
Fluorogold staining	742
the distal spinal cord	780
the extent of supraspinal and propriospinal axonal sparing/regeneration	816
the extent	816
supraspinal and propriospinal axonal sparing/regeneration	830
4 months post injection time point	891
4 months	891
post injection time point	900
The purpose of this study	927
The purpose	927
this study	942
OEG and SCs cells	975
sub acutely -LRB- 14 days after injury -RRB-	1002
sub acutely	1002
14 days after injury	1015
14 days	1015
injury	1029
i	1045
behavioral outcomes , -LRB- ii -RRB-	1056
behavioral outcomes	1056
ii	1078
sparing/regeneration of propriospinal and supraspinal projections ,	1089
sparing/regeneration of propriospinal	1089
sparing/regeneration	1089
propriospinal	1113
supraspinal projections	1131
iii	1161
tissue loss	1173
Results	1186
OEG and SCs	1195
transplanted rats	1207
significant increased locomotion	1232
injury	1290
the open field tests -LRB- BBB -RRB-	1305
the open field tests	1305
BBB	1327
the ladder walk test	1342
statistically significant differences between treatment and control groups	1376
statistically significant differences	1376
treatment and control groups	1422
a statistically significant increase	1489
the number of supraspinal nuclei	1529
the number	1529
supraspinal nuclei	1543
the distal spinal cord in both OEG and SCs	1578
the distal spinal cord	1578
both OEG and SCs	1604
OEG	1609
SCs	1617
transplanted rats	1621
These	1640
the raphe , reticular and vestibular systems	1655
the raphe	1655
reticular and vestibular systems	1666
Further pairwise multiple comparison tests	1700
a statistically significant increase	1755
raphe	1795
neurons in OEG transplanted rats	1812
neurons	1812
OEG transplanted rats	1823
SCs	1862
transplanted animals	1866
Immunohistochemistry	1888
spinal cord sections short term -LRB- 2 weeks -RRB-	1912
spinal cord sections	1912
short term -LRB- 2 weeks -RRB-	1933
short term	1933
2 weeks	1945
long term -LRB- 4 months -RRB-	1958
long term	1958
4 months	1969
differences	1986
host glial activity	2001
migration and proteoglycan deposits between the two cell types	2022
migration and proteoglycan deposits	2022
the two cell types	2066
Histochemical staining	2086
the volume of tissue remaining at the lesion site	2123
the volume	2123
tissue remaining at the lesion site	2137
tissue remaining	2137
the lesion site	2157
all OEG and SCs treated groups	2190
all OEG and SCs	2190
groups	2214
Significant tissue sparing	2222
both time points following glial SCs transplantation	2265
both time points	2265
glial SCs transplantation	2292
addition	2322
OEG transplants	2332
decreased chondroitin proteoglycan synthesis in the lesion site	2369
decreased chondroitin proteoglycan synthesis	2369
the lesion site	2417
a more CNS tolerant graft	2445
CNS	2452
Conclusions	2472
These results	2485
transplantation of OEG and SCs in a sub-acute phase	2509
transplantation	2509
OEG and SCs	2528
a sub-acute phase	2543
anatomical outcomes	2573
a contusion injury	2599
the spinal cord	2621
the number of spared/regenerated supraspinal fibers	2652
the number	2652
spared/regenerated supraspinal fibers	2666
cavitation	2714
tissue integrity	2739
This	2757
important information	2771
the time window of glial transplantation for the repair of the spinal cord	2796
the time window	2796
glial transplantation for the repair of the spinal cord	2815
glial transplantation	2815
the repair of the spinal cord	2841
the repair	2841
the spinal cord	2855
Background	2873
models of spinal cord injury -LRB- SCI -RRB-	2887
models	2887
spinal cord injury -LRB- SCI -RRB-	2897
spinal cord injury	2897
SCI	2917
transplantation of growth-permissive tissues and cells	2923
transplantation	2923
growth-permissive tissues and cells	2942
trophic support	3008
damaged neurons	3028
the inhibitory milieu of the lesion site	3061
the inhibitory milieu	3061
the lesion site	3086
this	3103
axons	3115
the otherwise impenetrable glial scar or cystic cavity	3137
the otherwise impenetrable glial scar	3137
cystic cavity	3178
Olfactory ensheathing glia -LRB- OEG -RRB-	3193
Olfactory ensheathing glia	3193
OEG	3221
the growth	3237
newly-generated olfactory sensory axons	3251
the olfactory bulb in normal adults -LSB- 1-4 -RSB-	3296
the olfactory bulb	3296
normal adults -LSB- 1-4 -RSB-	3318
normal adults	3318
1-4 -RSB-	3333
olfactory nerve section -LSB- 5,6 -RSB-	3348
olfactory nerve section	3348
5,6 -RSB-	3373
These cells	3379
the potential to facilitate repair after injury	3396
repair	3424
injury	3437
their potential to enhance tissue repair	3449
experimental SCI models -LSB- 7-14 -RSB-	3521
experimental SCI models	3521
7-14 -RSB-	3546
Schwann cell -LRB- SCs -RRB- grafts	3553
Schwann cell	3553
SCs	3567
the ability	3589
axonal regeneration following peripheral and CNS injuries -LSB- 14-18 -RSB-	3612
axonal regeneration	3612
peripheral and CNS injuries -LSB- 14-18 -RSB-	3642
peripheral and CNS injuries	3642
14-18 -RSB-	3671
such	3686
this study	3704
the outcomes achieved using OEG in sub-acute spinal cord injury model	3726
the outcomes	3726
OEG	3754
sub-acute spinal cord injury model	3761
Standard methods for isolating adult rat and human SCs	3797
Standard methods	3797
adult rat and human SCs	3828
adult rat	3828
human SCs	3842
a homogenous population of cells	3889
a homogenous population	3889
cells	3916
stable characteristics -LSB- 19-22 -RSB-	3927
stable characteristics	3927
19-22 -RSB-	3951
methods to both	3968
methods	3968
both	3979
the OEG and transplant	3992
the OEG	4015
the experimental results	4048
considerable morphological plasticity	4086
changing phenotype within hours after changes in culture conditions	4134
changing phenotype	4134
hours after changes in culture conditions	4160
hours	4160
changes in culture conditions	4172
changes	4172
culture conditions	4183
23-26 -RSB-	4203
this	4219
consistent functional and anatomical improvements	4225
olfactory bulb-derived p75-purified OEG	4300
adult inbred rats -LSB- 8-11,13,27 -RSB-	4345
adult inbred rats	4345
8-11,13,27 -RSB-	4364
results with lamina	4377
results	4377
lamina	4390
OEG	4412
28-30 -RSB-	4437
OEG and SCs	4480
immunohistochemistry	4493
an antibody	4520
low affinity nerve growth factor receptor -LRB- p75 -RRB-	4535
low affinity nerve growth factor receptor	4535
p75	4578
this approach	4601
it	4639
transplanted OEG and SCs	4683
endogenous SCs	4713
the spinal cord via dorsal root entry zones	4745
the spinal cord	4745
dorsal root entry zones	4765
blood vessels -LSB- 21,31-33 -RSB-	4792
blood vessels	4792
21,31-33 -RSB-	4807
Detection of p75	4818
Detection	4818
p75	4831
its ligand-binding domain	4867
vivo	4911
endogenous proteases -LSB- 34,35 -RSB-	4932
endogenous proteases	4932
34,35 -RSB-	4954
this reason	4966
lentiviral ex-vivo prelabeling -LSB- 12,26,36 -RSB- of OEG and SCs with DSRED-2	4979
lentiviral ex-vivo prelabeling	4979
12,26,36 -RSB- of OEG and SCs	5011
12,26,36 -RSB-	5011
OEG and SCs	5024
DSRED-2	5041
this study	5066
This	5078
the quantification	5091
surviving	5113
cells	5131
the analysis	5138
their distribution and influence on endogenous spinal cord cells and axons	5154
their distribution and influence	5154
endogenous spinal cord cells and axons	5190
assessment of their impact	5234
assessment	5234
their impact	5248
matrix deposition and the host repair process	5264
matrix deposition	5264
the host repair process	5286
We	5311
transplants of adult OEG or SCs	5332
transplants	5332
adult OEG or SCs	5347
their ability to promote axonal sparing / regeneration -LSB- 4,37 -RSB-	5378
axonal sparing / regeneration -LSB- 4,37 -RSB-	5403
axonal sparing	5403
regeneration -LSB- 4,37	5419
regeneration	5419
4,37	5433
a delayed transplant at 14 days post injury	5448
a delayed transplant	5448
14 days post injury	5472
14 days	5472
anatomical and functional outcomes following a spinal cord contusion	5506
anatomical and functional outcomes	5506
a spinal cord contusion	5551
This experimental study	5576
numerous years of research	5612
numerous years	5612
research	5630
glial types	5649
CNS injuries	5664
the spinal cord	5688
This time point	5705
it	5745
a realistic time window	5759
this type of cellular therapy in a clinical trial	5791
this type	5791
cellular therapy in a clinical trial	5804
cellular therapy	5804
a clinical trial	5824
This time period	5842
consideration	5870
time	5888
sufficient autologous OEGs for transplantation	5923
sufficient autologous OEGs	5923
transplantation	5954
injured patients	5975
stabilization surgery	5993
an optimal time window for best outcomes -LSB- 38 -RSB- ,	6019
an optimal time window	6019
best outcomes -LSB- 38 -RSB- ,	6046
best outcomes	6046
38 -RSB-	6061
ii	6067
experimental data	6071
previous animal studies	6094
delayed transplantation	6132
cell survival , integration	6183
cell survival	6183
integration	6198
immune mediated rejection	6222
8,14,20,38-41 -RSB-	6249
15 days in vivo a significant scar forms that may inhibit cell integration	6281
15 days	6281
a significant scar forms that may inhibit cell integration	6297
a significant scar forms	6297
cell integration	6339
axonal regeneration -LSB- 38	6360
axonal regeneration	6360
38	6381
support of this time point	6389
support	6389
this time point	6400
14 days	6417
the time point	6429
the recent oligodendrocyte precursor and activated macrophage clinical trials	6455
It	6534
the term `` sparing/regeneration ''	6563
relation	6612
the analysis of axonal growth	6624
the analysis	6624
axonal growth	6640
this manuscript	6661
this	6678
a contusion model study -LSB- 8	6721
a contusion model study	6721
8	6746
fluorogold	6755
we	6767
spared and regenerated axons	6803
Methods Animals Adult -LRB- 180-200 g -RRB- female Fischer 344 rats	6834
Methods Animals Adult -LRB- 180-200 g -RRB-	6834
Methods Animals	6834
Adult -LRB- 180-200 g -RRB-	6850
Adult	6850
180-200 g	6857
female Fischer 344 rats	6868
female Fischer	6868
344 rats	6883
Animal Resource Centre	6893
Murdoch	6917
Western Australia	6926
groups of three	6960
groups	6960
three	6970
controlled conditions of temperature and humidity	6982
controlled conditions	6982
temperature and humidity	7007
free access to food and water	7038
free access	7038
food and water	7053
All procedures	7069
the Animal Ethics Committee	7101
The University of Western Australia -LRB- approval number 99/008/E42 -RRB-	7132
The University	7132
Western Australia -LRB- approval number 99/008/E42 -RRB-	7150
Western Australia	7150
approval number 99/008/E42	7169
approval number	7169
99/008/E42	7185
Fourteen days	7198
injury	7218
injection procedures -LSB- 8	7247
injection procedures	7247
8	7269
OEG -LRB- n = 6 short term 2 weeks , and n = 11 long term 4 months -RRB-	7296
OEG	7296
n = 6 short term 2 weeks , and n = 11 long term 4 months	7301
n =	7301
6 short term 2 weeks , and n = 11 long term 4 months	7303
6 short term 2 weeks , and n = 11 long term	7303
2 weeks	7316
11	7331
4 months	7344
SCs -LRB- n = 6 short term 2 weeks and n = 11 long term 4 months -RRB-	7357
SCs	7357
n = 6 short term 2 weeks and n = 11 long term 4 months	7362
n	7362
= 6 short term 2 weeks and n = 11 long term 4 months	7363
= 6 short term 2 weeks	7363
= 6 short term	7363
6	7364
2 weeks	7377
n = 11 long term 4 months	7389
n = 11 long term	7389
n	7389
= 11 long term	7390
11	7391
4 months	7404
the lesion	7419
site controls	7430
an injection	7453
cell culture medium	7469
n = 6 short term 2 weeks and n = 11 long term 4 months	7490
n	7490
= 6 short term 2 weeks and n = 11 long term 4 months	7491
= 6 short term 2 weeks	7491
= 6 short term	7491
6	7492
2 weeks	7505
n = 11 long term 4 months	7517
n = 11 long term	7517
n	7517
= 11 long term	7518
11	7519
4 months	7532
injury alone	7545
n = 6 short term 2 weeks and n = 11 long term 4 months	7559
n	7559
= 6 short term 2 weeks and n = 11 long term 4 months	7560
= 6 short term 2 weeks	7560
= 6 short term	7560
6	7561
2 weeks	7574
n = 11 long term 4 months	7586
n = 11 long term	7586
n	7586
= 11 long term	7587
11	7588
4 months	7601
Six additional rats	7612
2 weeks	7646
contusion	7660
a transplant	7678
the lesion milieu	7703
transplanted cells	7732
Total rats	7779
n = 74	7795
n	7795
74	7797
All rats	7801
a transplant	7820
medium were perfused at 2 weeks or 4 months after transplantation	7840
medium	7840
2 weeks or 4 months	7864
2 weeks	7864
4 months	7875
transplantation	7890
The numbers of animals	7907
The numbers	7907
animals	7922
final numbers analyzed	7935
final numbers	7935
the long term groups	7962
3 animals	7983
the short term groups 6 rats	8005
the short term groups	8005
6 rats	8027
Olfactory ensheathing glia and Schwann cell culture and purification OEG	8035
Olfactory ensheathing glia	8035
Schwann cell culture and purification OEG	8066
the olfactory bulbs of adult female Fischer 344 rats -LSB- 8,13,33 -RSB-	8127
the olfactory bulbs	8127
adult female Fischer 344 rats -LSB- 8,13,33 -RSB-	8150
adult female Fischer 344 rats	8150
8,13,33 -RSB-	8181
brief	8194
the bulbs	8201
the olfactory nerve layer	8231
Tissue	8268
trypsin	8321
0.5 % w/v -LRB- Worthington Biochemical Corporation , Lakewood , NJ -RRB-	8329
0.5 % w/v	8329
Worthington	8339
Biochemical Corporation , Lakewood , NJ	8351
Biochemical Corporation	8351
Lakewood , NJ	8376
Hank 's Balanced Saline Solution -LRB- Sigma -RRB-	8393
Hank 's Balanced Saline Solution	8393
Hank 's	8393
Sigma	8426
60 minutes at 37 °C in a CO2-free incubator	8437
60 minutes	8437
37 °C in a CO2-free incubator	8451
37 °C	8451
a CO2-free incubator	8459
Tissue	8481
centrifugation	8504
1500 rpm	8522
5 minutes	8535
DF10S medium	8561
1:1 DMEM	8575
F-12 - Sigma	8585
F-12	8585
Sigma	8591
10 % -LRB- v/v -RRB- fetal calf serum - Hunter Antisera -RRB-	8599
10 % -LRB- v/v -RRB- fetal calf serum	8599
10 %	8599
v/v	8604
fetal calf serum	8609
Hunter Antisera	8628
Hunter	8628
Antisera	8635
bovine pituitary extract -LRB- 20 μg/mL Gibco -RRB-	8663
bovine pituitary extract	8663
20 μg/mL Gibco	8689
forskolin -LRB- 2 μM Sigma -RRB- , then plated on poly	8709
forskolin -LRB- 2 μM Sigma -RRB-	8709
forskolin	8709
2 μM Sigma	8720
poly	8748
L-lysine-coated culture dishes -LRB- Corning , Acton , MA -RRB- for one week	8754
L-lysine-coated culture dishes -LRB- Corning , Acton , MA -RRB-	8754
L-lysine-coated culture dishes	8754
Corning	8786
Acton	8795
MA	8802
one week	8810
OEG	8820
immunoaffinity	8841
an antibody	8859
the p75 receptor -LRB- 192-IgG -RRB- -LSB- 13,33 -RSB-	8874
the p75 receptor -LRB- 192-IgG -RRB-	8874
the p75 receptor	8874
192-IgG	8892
13,33 -RSB-	8902
SCs	8910
adult female Fischer 344 rats -LSB- 19,33 -RSB-	8933
adult female Fischer 344 rats	8933
19,33 -RSB-	8964
the sciatic nerves	8981
35 mm uncoated tissue culture dishes	9026
D10S medium	9066
DMEM -LRB- Sigma St Louis , MO -RRB- with 10 % fetal calf serum	9092
DMEM -LRB- Sigma St Louis , MO -RRB-	9092
DMEM	9092
Sigma St Louis	9098
MO	9114
10 % fetal calf serum	9123
Hunter Antisera Jesmond , NSW , Australia	9145
Hunter Antisera Jesmond	9145
NSW	9170
Australia	9175
1-2 mm3 pieces	9199
Each week	9215
nerve segments	9226
a new culture dish	9261
fibroblasts that had migrated out of the explants	9296
fibroblasts	9296
the explants	9333
three weeks of fibroblast depletion	9353
three weeks	9353
fibroblast depletion	9368
explants	9390
new dishes	9466
culture	9481
the presence	9492
20 μg/mL Gibco , Carlsbad , CA	9534
20 μg/mL Gibco	9534
Carlsbad , CA	9550
2 μM Sigma	9579
2 μM	9579
Sigma	9584
22 -RSB-	9592
Lentiviral labelling of glia Lentiviral vectors encoding the gene for DSRED-2	9597
Lentiviral labelling	9597
glia Lentiviral vectors encoding the gene for DSRED-2	9621
glia Lentiviral vectors	9621
the gene for DSRED-2	9654
the gene	9654
DSRED-2	9667
methods described by -LSB- 104 -RSB-	9698
methods	9698
-LSB- 104 -RSB-	9719
Cultured OEG or SCs	9726
Cultured OEG	9726
SCs	9742
the vector	9769
a multiplicity of infection of 100 -LSB- 12	9787
a multiplicity	9787
infection of 100 -LSB- 12	9805
infection	9805
100 -LSB- 12	9818
the culture medium	9830
16 hours , followed by 2 washes in culture medium and fresh media for growth	9853
16 hours	9853
2 washes in culture medium and fresh media for growth	9875
2 washes in culture medium	9875
2 washes	9875
culture medium	9887
fresh media for growth	9906
fresh media	9906
growth	9922
Spinal cord injury and post-operative care Anesthesia	9930
Spinal cord injury	9930
post-operative care Anesthesia	9953
5 %	10001
v/v	10005
halothane	10010
60:40 O2	10024
N2O	10033
2-3 %	10057
The skin and muscle layers	10063
the vertebral column	10125
a T10 laminectomy	10151
-LSB- 8 -RSB-	10179
an New York University -LRB- NYU -RRB- impactor	10189
New York University -LRB- NYU -RRB-	10192
New York University	10192
NYU	10213
a moderate contusion injury	10228
a 10 g weight	10280
a 12.5 mm height -LSB- 99,105 -RSB- Gel-Foam	10299
a 12.5 mm height	10299
99,105 -RSB- Gel-Foam	10317
99,105	10317
Gel-Foam	10325
Pharmacia & Upjohn	10335
Kalamazoo	10355
MI	10366
some animals	10399
Animals	10413
clamps	10451
the dorsal processes of T8 and T11/12	10461
the dorsal processes	10461
T8 and T11/12	10485
diaphragm-induced dorso-ventral movement of the spinal column	10514
diaphragm-induced dorso-ventral movement	10514
the spinal column	10558
the injury	10595
the animal	10607
the clamps	10635
the muscles	10650
layers with Vicryl -LRB- Johnson & Johnson , New Brunswick , NJ -RRB-	10673
layers	10673
Vicryl -LRB- Johnson & Johnson , New Brunswick , NJ -RRB-	10685
Vicryl	10685
Johnson & Johnson	10693
New Brunswick	10712
NJ	10727
Skin	10732
Michel suture clips	10753
Fine Science Tools Inc. , North Vancouver , BC , Canada	10774
Fine Science Tools Inc.	10774
North Vancouver	10799
BC	10816
Canada	10820
surgery	10847
each animal	10856
penicillin -LRB- Benacillin intramuscular -RRB-	10886
penicillin	10886
Benacillin	10898
analgesic -LRB- Temgesic buprenorphine sub-cutaneous 0.1 mg/kg -RRB-	10925
analgesic	10925
Temgesic buprenorphine sub-cutaneous 0.1 mg/kg	10936
Temgesic buprenorphine sub-cutaneous	10936
0.1 mg/kg	10973
2-4 mL 0.9 % saline -LRB- sub-cutaneous -RRB-	10988
2-4 mL	10988
0.9 % saline -LRB- sub-cutaneous -RRB-	10995
0.9 % saline	10995
Animal cages	11024
a heating pad for 24 hours	11064
a heating pad	11064
24 hours	11082
maintenance of body temperature	11107
maintenance	11107
body temperature	11122
Antibiotics	11140
alternate days	11170
analgesic twice daily and saline once daily for one	11191
analgesic twice daily	11191
saline once daily for one	11217
saline	11217
one	11239
week	11243
Manual bladder expression	11249
two	11305
three weeks , by which time all animals had recovered bladder tone	11312
three weeks	11312
all animals	11339
bladder tone	11365
Cell transplantation Cells	11379
no more than 2 weeks in vitro -LSB- 8 -RSB-	11430
no more than 2 weeks	11430
-LSB- 8 -RSB-	11460
Fourteen days	11465
adult female rats	11495
anesthetized and the spinal cord exposed as described above	11518
anesthetized and the spinal cord	11518
5 μL	11586
a cell suspension	11594
5 × 105 OEG	11623
5 ×	11623
105 OEG	11627
SCs in culture medium , or medium alone , -LRB- 1:1 DMEM/F -12 Sigma -RRB-	11638
SCs	11638
culture medium , or medium alone , -LRB- 1:1 DMEM/F -12 Sigma -RRB-	11645
culture medium , or medium alone ,	11645
culture medium	11645
medium alone	11664
1:1 DMEM/F -12 Sigma	11679
1:1	11679
DMEM/F -12 Sigma	11683
the center of the lesion over a period of 3 minutes	11718
the center	11718
the lesion over a period of 3 minutes	11732
the lesion	11732
a period of 3 minutes	11748
a period	11748
3 minutes	11760
a 5 μL syringe -LRB- Hamilton , Reno , NV -RRB-	11776
a 5 μL syringe	11776
Hamilton	11792
Reno	11802
NV	11808
a stereotaxic frame	11823
The needle	11844
3 minutes later	11869
cell integration	11898
the injection site	11920
Wounds	11940
post-operative care	11964
Behavioral testing All testing of the BBB and ladder walk	12021
Behavioral testing All testing of the BBB	12021
Behavioral testing	12021
All testing of the BBB	12040
All testing	12040
the BBB	12055
ladder walk	12067
observers blinded to the treatments	12099
observers	12099
the treatments	12120
BBB testing -LSB- 99 -RSB-	12136
BBB testing	12136
99 -RSB-	12149
each animal	12170
the day following contusion	12185
the successful lesion -LRB- a score of 0 -RRB-	12225
the successful lesion	12225
a score of 0	12248
a score	12248
0	12259
The BBB test	12263
day 3 , day 7 and day 14	12292
day 3	12292
day 7	12299
day 14	12309
contusion thereafter every week after cell transplantation	12322
contusion	12322
every week	12343
cell transplantation	12360
3 weeks	12382
animals	12403
BBB results of 10 -- 11	12437
BBB results of 10	12437
BBB results	12437
10	12452
11	12455
A ladder rung walking test modified from -LSB- 106 -RSB-	12459
A ladder	12459
test modified from -LSB- 106 -RSB-	12481
test	12481
-LSB- 106 -RSB-	12500
1 week	12521
injury	12534
every week	12554
4 months	12569
The ladder rung walking test	12579
The ladder	12579
test	12603
6 points -LRB- Table 2 -RRB-	12617
6 points	12617
Table 2	12627
scoring	12640
a greater level of sensitivity	12663
a greater level	12663
sensitivity	12682
the two BBB points	12699
they	12727
The ladder	12748
test	12772
106 -RSB- apparatus	12778
1.5 m in length	12797
1.5 m	12797
length	12806
two clear Perspex sidewalls and a floor	12830
two clear Perspex sidewalls	12830
a floor	12862
removable metal rungs	12875
1 cm	12904
surgery	12925
rats	12934
the ladder to reach their home cage	12966
their home cage	12986
1	13008
week	13010
injury	13021
trials	13029
weekly and video recorded	13051
weekly	13051
video recorded	13062
video	13062
The animals	13078
3 runs per day	13094
3 runs	13094
day	13105
The video camera	13122
the central portion	13165
the ladder , approximately 30 cm in length ,	13188
the ladder	13188
approximately 30 cm in length	13200
approximately 30 cm	13200
length	13223
analysis of approximately 8 steps of each hind limb	13240
analysis	13240
approximately 8 steps of each hind limb	13252
approximately 8 steps	13252
each hind limb	13277
Each hind limb step in each trial	13293
Each hind limb step	13293
each trial	13316
Table	13345
the scores	13354
a single value , per rat , per trial	13387
a single value , per rat ,	13387
a single value	13387
rat	13407
trial	13416
Fluorogold labeling	13423
Ten days	13443
perfusion -LRB- 4 months post-transplantation of cells -RRB-	13461
perfusion	13461
4 months post-transplantation of cells	13472
4 months	13472
post-transplantation of cells	13481
post-transplantation	13481
cells	13505
11 rats from each of the long term	13513
11 rats	13513
each of the long term	13526
each	13526
the long term	13534
4 month	13549
groups	13558
a T12 laminectomy	13609
a stereotaxic frame	13642
Fluorogold -LRB- 1 μL Fluorochrome Inc. , Denver , CO -RRB-	13663
Fluorogold	13663
1 μL Fluorochrome Inc. , Denver , CO	13675
1 μL	13675
Fluorochrome Inc.	13680
Denver , CO	13699
the spinal cord	13729
4 points	13748
0.25 μL each	13758
0.25 μL	13758
each	13766
2 segments	13773
8 mm	13792
the contusion site	13801
All injections	13821
the same individual	13854
comparability	13887
animals	13909
this individual	13917
groups	13962
OEG , SCs or control cells	14003
OEG	14003
SCs	14008
control cells	14015
Muscles	14030
layers and the skin	14054
layers	14054
the skin	14065
Michel	14086
suture clips -LRB- Fine Science Tools Inc. , North Vancouver , BC , Canada -RRB-	14093
suture clips	14093
Fine Science Tools Inc. , North Vancouver , BC , Canada	14107
Fine Science Tools Inc.	14107
North Vancouver	14132
BC	14149
Canada	14153
Animals	14162
the post-operative care regime detailed above	14188
the post-operative care regime	14188
Tissue processing	14235
2 weeks or 4 months	14256
2 weeks	14256
4 months	14267
Schwann cell or OEG transplantation	14282
Schwann cell	14282
OEG transplantation	14298
rats	14319
Nembutal	14358
intraperitoneal sodium pentobarbital Merial Australia	14368
Parramatta	14423
NSW	14435
Australia	14440
approximately 150 mL	14484
heparinized phosphate-buffered saline	14508
Heparin 1 U/mL David Bull Laboratories , Melbourne , VIC , Australia	14547
Heparin 1 U/mL	14547
David Bull Laboratories	14562
Melbourne , VIC , Australia	14587
approximately 150 mL 4 % buffered paraformaldehyde solution	14626
approximately 150 mL	14626
paraformaldehyde solution	14659
The spinal cord and brain	14686
The spinal cord	14686
brain	14706
buffered paraformaldehyde overnight at 4 °C	14755
buffered paraformaldehyde overnight	14755
4 °C	14794
The following day	14799
paraformaldehyde	14818
0.1 M phosphate buffer	14853
tissue sectioning	14886
each spinal cord or brain	14905
each spinal cord	14905
brain	14925
sucrose -LRB- 30 % w/v in phosphate buffer -RRB- overnight and embedded	14947
sucrose -LRB- 30 % w/v in phosphate buffer -RRB-	14947
sucrose	14947
30 % w/v in phosphate buffer	14956
30 % w/v	14956
phosphate buffer	14967
gelatin -LRB- 10 % w/v in phosphate buffer Difco , Franklin Lakes , NJ -RRB-	15011
gelatin	15011
10 % w/v in phosphate buffer Difco	15020
10 % w/v	15020
phosphate buffer Difco	15031
Franklin Lakes , NJ	15055
Franklin Lakes	15055
NJ	15071
The gelatin block	15076
immersion	15107
buffered paraformaldehyde for 2 hours	15120
buffered paraformaldehyde	15120
2 hours	15150
buffered sucrose	15174
solution overnight	15191
Tissue	15211
spinal cord	15233
40 μm brain at 50 μm	15248
40 μm brain	15248
50 μm	15263
a freezing sledge microtome	15276
phosphate buffer	15320
0.05 %	15348
w/v sodium azide	15354
Tissue analysis	15372
Quantification Numbers of animals per group	15390
Quantification Numbers	15390
animals per group	15416
animals	15416
group	15428
8 -- 12 and based on :	15439
8	15439
12 and based on	15441
12	15441
-LRB- i -RRB- a prior power analysis	15458
experimental numbers	15504
animal models of spinal cord injuries	15528
animal models	15528
spinal cord injuries	15545
statistical differences	15600
-LRB- ii -RRB- previous publications from the laboratory	15629
previous publications	15634
the laboratory	15661
All rats	15677
BBB , gridwalk , fluorogold traced , immunohistochemistry , and tissue analysis	15703
BBB , gridwalk , fluorogold traced	15703
BBB	15703
gridwalk	15708
fluorogold traced	15718
fluorogold	15718
immunohistochemistry	15737
tissue analysis	15763
These	15780
the groups	15813
the knowledge of the surgeon or behaviorist	15832
the knowledge	15832
the surgeon or behaviorist	15849
Animals	15877
the naïve cages	15901
post-surgery cages	15936
This number	15969
an independent person	16002
the treatment	16036
every level	16054
the person	16066
the treatment	16092
The perfusions	16107
the same day for all groups	16140
the same day	16140
all groups	16157
the same fixative batch	16173
The immunohistochemistry	16198
each of the groups	16252
each	16252
the groups	16260
differences	16280
staining between days and groups	16295
staining	16295
days and groups	16312
The analysis	16329
a trained viewer who was blinded to the groups	16359
a trained viewer	16359
the groups	16395
Tissue volume estimation One in six sections from each spinal cord	16407
Tissue volume	16407
One	16432
six sections	16439
each spinal cord	16457
gelatin-coated microscope slides	16491
gold chloride solution	16541
myelin followed by cresyl violet for Nissl substance -LSB- 107 -RSB-	16568
myelin	16568
cresyl violet for Nissl substance	16587
cresyl violet	16587
Nissl substance	16605
107 -RSB-	16622
Slides	16628
an ethanol/toluene series	16659
DPX -LRB- Chem Supply , Gillman , Australia -RRB-	16700
DPX	16700
Chem Supply	16705
Gillman	16718
Australia	16727
Sections	16739
a Leica DM RBE microscope	16770
Image Pro Plus -LRB- Media Cybernetics , Silver Spring , MD -RRB-	16824
Image Pro Plus	16824
Image	16824
Pro	16830
Plus	16834
Media Cybernetics	16840
Silver Spring	16859
MD	16874
the tissue area of a 4.5 mm section of spinal cord	16898
the tissue area	16898
a 4.5 mm section of spinal cord	16917
a 4.5 mm section	16917
spinal cord	16937
the lesion center	16954
its midpoint	16975
Tissue cavitation	16989
all animals	17023
an estimate	17043
the effect	17058
the transplanted cells upon the preservation of tissue at the lesion site	17072
the transplanted cells	17072
the preservation of tissue at the lesion site	17100
the preservation	17100
tissue at the lesion site	17120
tissue	17120
the lesion site	17130
the volume of tissue remaining at the injury site	17146
the volume	17146
tissue remaining at the injury site	17160
tissue remaining	17160
the injury site	17180
a similar manner	17212
that described previously -LSB- 8,14,108	17232
that	17232
8,14,108	17259
The combined area of any cysts	17269
The combined area	17269
any cysts	17290
the total tissue area of the section	17335
the total tissue area	17335
the section	17360
a value	17381
the total tissue remaining	17393
the total tissue	17393
Areas showing signs of degeneration	17421
Areas	17421
signs of degeneration	17435
signs	17435
degeneration	17444
microcysts and loss of neuronal profiles	17466
microcysts and loss	17466
neuronal profiles	17489
the values for total tissue remaining to obtain a measure of intact tissue	17529
the values	17529
total tissue remaining to obtain a measure of intact tissue	17544
total tissue	17544
a measure of intact tissue	17577
a measure	17577
intact tissue	17590
The values for the centre four sections of each spinal cord	17605
The values	17605
the centre four sections of each spinal cord	17620
the centre four sections	17620
each spinal cord	17648
a single semi-quantitative value of remaining tissue volume value for each rat	17687
a single semi-quantitative value	17687
remaining tissue volume value for each rat	17723
remaining tissue volume value	17723
each rat	17757
Values from four equivalent sections of an uninjured spinal cord	17767
Values	17767
four equivalent sections of an uninjured spinal cord	17779
four equivalent sections	17779
an uninjured spinal cord	17807
the tissue remaining as a proportion of uninjured spinal cord	17853
the tissue	17853
a proportion of uninjured spinal cord	17877
a proportion	17877
uninjured spinal cord	17893
Immunohistochemistry Series of one in six tissue sections	17916
Immunohistochemistry Series	17916
one	17947
six tissue sections	17954
2 week or 4 month time points	17978
2 week	17978
4 month time points	17988
mouse monoclonal or rabbit polyclonal antibodies	18047
mouse monoclonal	18047
rabbit polyclonal antibodies	18067
Sections	18097
4 °C	18134
primary antibody diluted in phosphate buffer containing 10 % normal goat serum	18141
primary antibody	18141
phosphate buffer	18169
10 % normal goat serum	18197
0.2 % -LRB- v/v -RRB- Triton X-100	18223
0.2 %	18223
v/v	18229
Triton X-100	18234
Mouse monoclonal antibodies used	18248
Mouse monoclonal antibodies	18248
anti-chondroitin sulfate proteoglycans -LRB- CS-56 1:50 Sigma -RRB-	18290
anti-chondroitin sulfate proteoglycans	18290
CS-56 1:50 Sigma	18330
proteoglycan deposition	18360
the lesion site	18387
low affinity nerve growth factor receptor p75	18408
supernatant 192-IgG	18455
OEG and Schwann cells -LRB- both transplanted and endogenous -RRB-	18489
OEG and Schwann cells	18489
transplanted and endogenous	18517
transplanted	18517
endogenous	18534
high neurofilaments RT-97	18568
supernatant Developmental Hybridoma Bank	18595
supernatant Developmental Hybridoma	18595
Bank	18631
spared and regenerated axons	18650
Rabbit polyclonal antibodies were used for	18680
Rabbit	18680
polyclonal antibodies	18687
p75 -LRB- 1:200 Promega , Madison , WI -RRB-	18727
p75	18727
1:200 Promega , Madison , WI	18732
1:200 Promega , Madison	18732
WI	18756
Glial fibrillary acidic protein -LRB- GFAP -RRB-	18761
Glial fibrillary acidic protein	18761
GFAP	18794
1:500 DakoCytomation	18801
Denmark	18823
astrocytes , unmyelinated Schwann cells and olfactory glia , ii -RRB-	18845
astrocytes , unmyelinated Schwann cells and olfactory glia	18845
astrocytes	18845
unmyelinated Schwann cells	18857
olfactory glia	18888
ii	18904
IV	18922
1:200 Rockland Inc. , Gilbertsville , PA	18926
1:200 Rockland Inc.	18926
Gilbertsville	18947
PA	18962
the distribution	18979
basal lamina and blood vessels and iii -RRB- anti-laminin-1	18999
1:200 Sigma	19055
1:200	19055
Sigma	19061
basal lamina and blood vessels	19072
The following day	19104
sections	19123
three times	19144
phosphate buffer	19161
the same solution	19228
primary antibodies	19253
30 minutes at room temperature	19277
30 minutes	19277
room temperature	19291
Sections	19309
three times	19330
phosphate buffer	19347
gelatin-coated glass	19378
microscope slides	19399
air dried and then coverslipped in a glycerol-based mounting medium	19418
air	19418
a glycerol-based mounting medium	19453
Semi-quantitative analysis	19487
proteoglycan , matrix and cell survival	19517
One	19564
6 series of sections at 4 months post transplantation -LRB- and controls -RRB-	19571
6 series	19571
sections at 4 months post transplantation -LRB- and controls -RRB-	19583
sections	19583
4 months post transplantation	19595
Low magnification photomicrographs -LRB- 10 × objective -RRB-	19655
Low magnification photomicrographs	19655
10 × objective	19691
an IX70 Olympus microscope	19723
Pixel fluorescence of immunostaining for CS-56 , laminin and collagen IV	19751
Pixel fluorescence	19751
immunostaining for CS-56 , laminin and collagen IV	19773
immunostaining	19773
CS-56 , laminin and collagen IV	19792
CS-56	19792
laminin	19799
collagen IV	19811
rostral	19839
middle and caudal locations	19848
the contusion	19879
injury sites and the average pixel fluorescence	19894
injury sites	19894
the average pixel fluorescence	19911
background readings of the three areas compared between medium control and OEG	19948
background readings	19948
the three areas compared between medium control and OEG	19971
the three areas	19971
medium control and OEG	20004
SCs groups -LSB- 37,57	20030
SCs groups	20030
37,57	20042
addition	20053
one in 4 series of sections	20063
one	20063
4 series of sections	20070
4 series	20070
sections	20082
the presence of DSRED-2 labeled cells in the 2 week and 4 month survival groups	20109
the presence	20109
DSRED-2 labeled cells in the 2 week and 4 month survival groups	20125
DSRED-2	20125
cells	20141
the 2 week and 4 month survival groups	20150
the 2 week	20150
4 month survival groups	20165
Pixel fluorescence	20190
the 2 survival points	20235
survival of OEG and SCs	20269
survival	20269
OEG and SCs	20281
4 months expressed as a percentage of those present at 2 weeks	20296
4 months	20296
a percentage of those present at 2 weeks	20318
a percentage	20318
those present at 2 weeks	20334
Fluorogold	20360
A 1 in 6 series of brain sections	20394
A 1	20394
6 series of brain sections	20401
6 series	20401
brain sections	20413
gelatin-coated glass microscope slides	20446
a glycerol-based mounting medium	20511
Sections	20545
a Hitachi HV-C20M digital camera	20577
a large tiled image	20613
a fluorescence microscope -LRB- Leica DM RBE -RRB-	20639
a fluorescence microscope	20639
Leica DM RBE	20666
a motorized stage controlled with Image Pro	20685
a motorized stage	20685
Image Pro	20719
Image	20719
Pro	20725
5.1	20735
software -LRB- Media Cybernetics -RRB-	20740
software	20740
Media Cybernetics	20750
The optical dissector method	20770
photograph and count fluorogold-labeled neurons	20811
photograph	20811
count fluorogold-labeled neurons	20826
inaccuracies	20878
double counting	20898
109 -RSB- Photographs	20915
the centre of the z-axis of each section	20946
the centre	20946
the z-axis of each section	20960
the z-axis	20960
each section	20974
Those cell bodies in focus	20988
Those cell bodies	20988
focus	21009
Image	21062
Pro Plus	21068
Pro	21068
Plus	21072
Seven areas were analyzed	21078
Seven areas	21078
the reticular formation	21105
vestibular nucleus	21130
trigeminal and dorsal column nuclei	21150
raphe nucleus	21187
red nucleus	21202
hypothalamus	21215
motor cortex	21232
sparing/regeneration of descending propriospinal neurons	21258
sparing/regeneration	21258
descending propriospinal neurons	21282
the labeled cell bodies	21316
an identical method in the spinal cord region	21359
an identical method	21359
the spinal cord region	21382
the lesion site	21416
Six spinal cord sections -LRB- 1 cm in length -RRB- from each animal	21433
Six spinal cord sections -LRB- 1 cm in length -RRB-	21433
Six spinal cord sections	21433
1 cm in length	21459
1 cm	21459
length	21467
each animal	21480
Statistical analysis	21507
The methods of statistical analysis	21528
The methods	21528
statistical analysis	21543
the animal numbers	21591
this study	21618
Fluorogold labeling of supraspinal projecting nuclei in the brain	21634
Fluorogold labeling	21634
nuclei	21680
the brain	21690
experimental groups	21701
a one-way analysis	21741
variance	21763
ANOVA	21773
the Dunnetts methods of multiple comparisons	21792
the Dunnetts methods	21792
multiple comparisons	21816
a single control group -LRB- injury only -RRB-	21844
a single control group	21844
injury only	21868
the Tukey test	21890
multiple comparison procedures between all experimental and control groups	21909
multiple comparison procedures	21909
all experimental and control groups	21948
Fluorogold analysis of propriospinal projections into the distal spinal cord	21985
Fluorogold analysis	21985
propriospinal projections into the distal spinal cord	22008
propriospinal projections	22008
the distal spinal cord	22039
a one way analysis of variance -LRB- ANOVA -RRB-	22082
a one way analysis	22082
variance -LRB- ANOVA -RRB-	22104
variance	22104
ANOVA	22114
This	22122
the case for the tissue sparing and proteoglycan and cell survival analysis	22136
the case	22136
the tissue sparing and proteoglycan and cell survival analysis	22149
the tissue sparing	22149
proteoglycan and cell survival analysis	22172
the analysis of the BBB scores	22216
the analysis	22216
the BBB scores	22232
groups	22248
the non parametric Kruskal Wallace ANOVA	22275
ranks	22319
This	22326
Dunnetts method of multiple comparisons versus a single control group	22347
Dunnetts method	22347
multiple comparisons versus a single control group	22366
multiple comparisons	22366
a single control group	22394
Results	22419
Table 1 Retrogradely Fluorogold-Labeled Neurons	22427
Control , OEG Transplanted and SC Transplanted groups	22478
Table 2 Scoring scale developed for the ladder rung walking test , modified from	22532
Table	22532
2 Scoring scale	22538
the ladder rung walking test , modified from	22568
the ladder	22568
test , modified from	22592
test	22592
Metz and Whishaw	22613
-LSB- 63 -RSB-	22631
Figure 1 Graphic	22638
the amount	22666
total tissue remaining	22680
intact tissue	22707
the site	22724
the spinal cord contusion injury at day of transplant 2 weeks and 4 months	22736
the spinal cord contusion injury at day of transplant 2 weeks	22736
the spinal cord contusion injury	22736
day of transplant 2 weeks	22772
day	22772
transplant	22779
2 weeks	22790
4 months	22802
Quantification of gold chloride and Nissl	22812
Quantification	22812
gold chloride and Nissl	22830
sagittal sections	22862
the amount of intact tissue and total tissue remaining	22891
the amount	22891
intact tissue and total tissue remaining	22905
intact tissue	22905
total tissue remaining	22923
each of the experimental groups	22953
each	22953
the experimental groups	22961
Image	22991
Pro	22997
-LRB- A -RRB-	23002
Total tissue remaining 2 weeks and 4 months after cell transplantation	23007
Total tissue	23007
2 weeks and 4 months	23030
2 weeks	23030
4 months	23042
cell transplantation	23057
-LRB- B -RRB-	23079
Intact tissue remaining 2 weeks and 4 months after cell transplantation	23084
Intact tissue	23084
2 weeks and 4 months	23108
2 weeks	23108
4 months	23120
cell transplantation	23135
There	23157
a significant increase	23167
p <	23193
p	23193
<	23194
0.05	23195
intact tissue	23204
the OEG and Schwann cell treated groups	23227
medium controls	23284
C , G	23302
C	23302
G	23305
: Appearance of spinal cord lesion site 2 weeks	23307
: Appearance of spinal cord lesion site	23307
Appearance	23309
spinal cord lesion site	23323
2 weeks	23347
injury -LRB- i.e. day of cell transplantation -RRB- -LRB- D -RRB-	23361
injury	23361
i.e. day of cell transplantation	23369
i.e.	23369
day of cell transplantation	23374
day	23374
cell transplantation	23381
D	23404
remaining	23420
at 2 weeks	23430
at 2	23430
weeks	23435
medium injection	23447
-LRB- E -RRB-	23465
Appearance	23469
spinal cord lesion site	23483
2 weeks	23507
OEG transplantation -LRB- 4 weeks after injury -RRB-	23521
OEG transplantation	23521
4 weeks after injury	23542
4 weeks	23542
injury	23556
-LRB- F -RRB-	23565
Appearance	23569
the spinal cord lesion epicenter	23583
2 weeks	23616
Schwann cell transplantation -LRB- 4 weeks after initial injury -RRB-	23630
Schwann cell transplantation	23630
4 weeks after initial injury	23660
4 weeks	23660
initial injury	23674
-LRB- H -RRB-	23691
Appearance of spinal cord lesion site 4 months after medium injection	23696
Appearance	23696
spinal cord lesion site 4 months after medium injection	23710
spinal cord lesion site	23710
4 months	23734
medium injection	23749
-LRB- I -RRB-	23767
the spinal cord tissue	23784
4 months	23807
OEG transplantation	23822
the considerable increased retention of intact tissue	23848
the considerable increased retention	23848
intact tissue	23888
a reduction in cystic volume	23906
a reduction	23906
cystic volume	23921
image -LRB- H -RRB-	23952
image	23952
H	23959
-LRB- J -RRB-	23963
spinal cord at 4 months	23976
spinal cord	23976
4 months	23991
Schwann cells	24026
the 14 day treatment time point	24043
the presence	24081
small microcysts	24097
black arrow	24119
the spinal cord parenchyma	24139
the Schwann cells	24182
Scale bar : 200 μm .	24213
Scale bar	24213
200 μm	24224
Figure 2 Photomicrographs representing lentiviral	24233
Figure 2 Photomicrographs	24233
Figure	24233
2 Photomicrographs	24240
OEG and Schwann cells	24311
A : OEG in vitro labeled with lentiviral DsRed2 .	24334
A : OEG in vitro labeled with lentiviral DsRed2	24334
A : OEG in vitro	24334
OEG in vitro	24337
OEG	24337
vitro	24344
lentiviral DsRed2	24363
B : Schwann cells in vitro labeled with lentiviral DsRed2 .	24382
B	24382
Schwann cells in vitro labeled with lentiviral DsRed2	24385
Schwann cells	24385
lentiviral DsRed2	24421
Scale bar -LRB- A B -RRB- : 50 μm .	24440
Scale bar -LRB- A B -RRB-	24440
Scale bar	24440
A B	24451
50 μm	24457
C D	24464
Localization	24469
transplanted OEG -LRB- C -RRB-	24485
transplanted OEG	24485
C	24503
Schwann cells -LRB- D -RRB-	24510
Schwann cells	24510
D	24525
the spinal cord lesion site 2 weeks after transplantation	24535
the spinal cord lesion site	24535
2 weeks	24563
transplantation	24577
Schwann cells	24594
greater numbers than the OEG	24635
greater numbers	24635
the OEG	24656
OEG	24674
the spinal cord tissue	24705
Schwann cells	24734
a dense aggregate	24758
Scale bar -LRB- C D -RRB- : 100 μm .	24777
Scale bar -LRB- C D -RRB-	24777
Scale bar	24777
C D	24788
100 μm	24794
Figure 3 Glial scar formation at the lesion site	24803
Figure 3 Glial scar formation	24803
Figure 3	24803
Glial scar formation	24812
the lesion site	24836
GFAP and CSPG immunoreactivity	24865
A-D : GFAP in green DsRed2-labeled transplanted cells in red .	24897
A-D	24897
GFAP in green DsRed2-labeled transplanted cells in red	24902
GFAP	24902
green DsRed2-labeled transplanted cells in red	24910
green DsRed2-labeled transplanted cells	24910
red	24953
A-B : Lesion site 2 weeks after transplantation of OEG .	24958
A-B	24958
Lesion site 2 weeks after transplantation of OEG	24963
Lesion site	24963
2 weeks	24975
transplantation of OEG	24989
transplantation	24989
OEG	25008
C-D : Lesion site 2 weeks after transplantation of Schwann cells .	25013
C-D	25013
Lesion site 2 weeks after transplantation of Schwann cells	25018
Lesion site	25018
2 weeks	25030
transplantation of Schwann cells	25044
transplantation	25044
Schwann cells	25063
Dispersal of transplanted cells	25078
Dispersal	25078
transplanted cells	25091
OEG	25125
Schwann cells	25138
Schwann cells	25153
a dense aggregate at the lesion site surrounded by strong GFAP immunoreactivity	25177
a dense aggregate	25177
the lesion site surrounded by strong GFAP immunoreactivity	25198
the lesion site	25198
strong GFAP immunoreactivity	25228
E	25258
Schwann cells	25261
dense proteoglycan network CSPG -LRB- green -RRB-	25293
dense proteoglycan network CSPG	25293
DsRed2-labeled transplanted cells -LRB- red -RRB-	25334
DsRed2-labeled transplanted cells	25334
red	25369
Scale bars : A-D	25375
Scale bars	25375
A-D	25387
100 μm , E : 200 μm	25392
100 μm	25392
E	25400
200 μm	25403
F	25411
Graph	25414
the quantitative fluorescence	25428
mean pixels	25471
GFAP and CSPG	25487
the distal interface of the transplant zone	25504
the distal interface	25504
the transplant zone	25528
n = 10 for each group	25549
n = 10	25549
n	25549
10	25551
each group	25558
OEG	25571
significantly less -LRB- p < 0.05 -RRB- CSPG expression	25579
p < 0.05	25599
p	25599
< 0.05	25600
<	25600
0.05	25601
Schwann cells	25640
Schwann cells	25663
significantly greater -LRB- p < 0.05 -RRB- CSPG expression	25681
p < 0.05	25704
p	25704
< 0.05	25705
<	25705
0.05	25707
medium	25746
controls -LRB- see # -RRB-	25762
controls	25762
Figure 4 Schwann cell , OEG and medium treated spinal cords at 4 months .	25781
Figure 4 Schwann cell	25781
Figure	25781
4 Schwann cell	25788
OEG and medium treated spinal cords at 4 months	25804
OEG and medium	25804
spinal cords	25827
4 months	25843
Photomicrographs	25853
the distribution and immunoreactivity	25880
laminin-1 -LRB- A , B , D-K -RRB- and collagen IV -LRB- C , L-S -RRB-	25922
laminin-1	25922
A , B , D-K	25933
collagen IV	25948
C , L-S	25961
C	25961
L-S	25964
the site of spinal cord contusion lesion	25972
the site	25972
spinal cord contusion lesion	25984
the transplantation of SCs and OEG	26029
the transplantation	26029
SCs and OEG	26052
Areas of strong immunoreactivity for laminin	26065
Areas	26065
strong immunoreactivity for laminin	26074
strong immunoreactivity	26074
laminin	26102
the areas	26134
the transplanted cells -LRB- see arrow in D depicting DsRed-2 OEG -RRB-	26147
the transplanted cells	26147
arrow in D depicting DsRed-2 OEG	26175
arrow	26175
D depicting DsRed-2 OEG	26184
D	26184
DsRed-2 OEG	26196
Laminin immunostaining	26210
the surface of the OEG cells -LRB- see arrows in G -RRB-	26271
the surface	26271
the OEG cells	26286
arrows	26305
G	26315
Laminin	26319
surrounding Schwann cell transplants -LRB- see H -RRB-	26341
surrounding Schwann cell transplants	26341
H	26383
Arrow	26387
the central core of the transplant	26401
the central core	26401
the transplant	26421
Laminin	26437
the region of the Schwann cells	26463
the region	26463
the Schwann cells	26477
I-J	26500
the host spinal cord below the dashed line	26510
the host spinal cord	26510
the dashed line	26537
intensity of staining	26565
intensity	26565
staining	26578
Collagen	26588
IV immunostaining	26597
a central core of staining close to the lesion site	26623
a central core	26623
staining close to the lesion site	26641
staining close	26641
the lesion site	26659
any surviving OEG -LRB- see L -RRB-	26687
any surviving OEG	26687
L	26710
cells	26725
arrows	26736
O	26746
collagen IV	26772
Collagen IV immunostaining	26785
Schwann cell transplanted spinal cords show intense staining surrounding	26815
Schwann cell	26815
transplanted spinal cords	26828
intense staining surrounding	26859
intense staining	26859
the DsRed-2 SC transplant area -LRB- see arrow -RRB-	26899
the DsRed-2 SC transplant area	26899
arrow	26935
higher power	26946
the staining	26959
dashed line	27006
some areas	27023
Scale bars : 100 μm .	27043
Scale bars	27043
100 μm	27055
Scale bar in A	27063
Scale bar	27063
A	27076
C , D , H , L and P. Scale bar	27090
C	27090
D	27093
H	27096
L	27099
P. Scale bar	27105
B	27121
E , F , I , J , M , N , Q and R. Figure	27135
E	27135
F	27138
I	27141
J	27144
M	27147
N	27150
Q	27153
R. Figure	27159
5 Axonal staining	27170
the lesion site of Schwann cell , OEG and medium groups	27191
the lesion site	27191
Schwann cell , OEG and medium groups	27210
Immunoreactivity	27247
RT-97	27268
the site	27277
spinal cord contusion 4 months after medium -LRB- A -RRB- OEG -LRB- B-C -RRB-	27289
spinal cord contusion	27289
4 months	27311
medium -LRB- A -RRB- OEG -LRB- B-C -RRB-	27326
medium -LRB- A -RRB- OEG	27326
A	27334
B-C	27342
Schwann cells -LRB- D-E -RRB- transplantation	27351
Schwann cells	27351
D-E	27366
transplantation	27371
RT97 positive axons	27388
the lesion site in all groups	27428
the lesion site	27428
all groups	27447
number and distribution	27462
Axons in the OEG group -LRB- B -RRB-	27494
Axons in the OEG group	27494
Axons	27494
the OEG group	27503
B	27518
fascicular bundles	27538
rostral	27574
caudal orientation	27585
axons beneath the graft area	27611
axons	27611
the graft area	27625
the ventral white matter	27657
-LRB- C -RRB- for higher power image of -LRB- B -RRB- .	27687
-LRB- C -RRB-	27687
higher power image of -LRB- B -RRB- .	27695
higher power image	27695
B	27718
RT97 staining after Schwann cell transplantation -LRB- see D -RRB- .	27722
RT97 staining	27722
Schwann cell transplantation -LRB- see D -RRB-	27742
Schwann cell transplantation	27742
D	27776
These axons	27780
a close association	27799
DsRed-2 positive cells	27824
a non linear path	27860
Arrows in -LRB- E -RRB-	27879
Arrows in	27879
Arrows	27879
E	27890
DsRed-2	27900
Schwann cells	27916
the transplants	27942
microcysts -LRB- * -RRB-	27970
microcysts	27970
Scale bars : 100 μm .	27986
Scale bars	27986
100 μm	27998
Scale bar in D	28006
Scale bar	28006
D	28019
A and B scale bar in E	28033
A and B scale bar	28033
E	28054
C. Figure	28068
6 Photomicrographs	28079
p75 immunoreactivity of spinal cord sections in the lesion site	28108
p75 immunoreactivity	28108
spinal cord sections in the lesion site	28132
spinal cord sections	28132
the lesion site	28156
SCI	28178
Endogenous p75 positive cells Schwann cells	28183
Endogenous p75 positive cells	28183
Schwann cells	28213
the lesion site 2 weeks -LRB- A -RRB- and 4 months post injury -LRB- B -RRB-	28246
the lesion site 2 weeks -LRB- A -RRB-	28246
the lesion site	28246
2 weeks -LRB- A -RRB-	28262
A	28271
4 months post injury -LRB- B -RRB-	28278
4 months	28278
post injury -LRB- B -RRB-	28287
post injury	28287
B	28300
p75 positive profiles	28304
numbers in OEG -LRB- C-D -RRB- and Schwann cell -LRB- E-F -RRB-	28347
numbers	28347
OEG -LRB- C-D -RRB- and Schwann cell -LRB- E-F -RRB-	28358
OEG	28358
C-D	28363
Schwann cell	28372
E-F	28386
The arrows in C and D	28412
The arrows	28412
C and D	28426
DsRED-2	28444
positive transplanted OEG within the lesion site	28452
positive transplanted OEG	28452
the lesion site	28485
host p75 positive Schwann cells	28516
the Schwann cell transplanted group the p75	28552
the Schwann cell transplanted group	28552
the p75	28588
positive endogenous Schwann cells -LRB- see arrows -RRB-	28596
positive endogenous Schwann cells	28596
arrows	28635
the transplanted DsRed-2	28657
The Schwann cell transplants	28697
the dispersed OEG	28755
C-D	28778
Scale bar in C -LRB- 100 μm -RRB-	28784
Scale bar in C	28784
Scale bar	28784
C	28797
100 μm	28800
A	28820
B. Figure	28826
7 Number	28837
neurons in brain/brainstem nuclei retrogradely labeled with Fluorogold	28849
neurons	28849
brain/brainstem nuclei retrogradely labeled with Fluorogold	28860
brain/brainstem nuclei	28860
Fluorogold	28909
8 mm caudal	28929
the thoracic spinal cord lesion site	28944
OEG transplantation into the contused spinal cord 14 days after injury	28982
OEG transplantation	28982
the contused spinal cord 14 days after injury	29007
the	29007
spinal cord	29020
14 days	29032
injury	29046
significant axonal sparing/regeneration of Raphe -	29062
significant axonal sparing/regeneration	29062
Raphe	29105
Vestibular	29113
Reticulo-spinal axons	29129
Graphs	29152
the mean numbers	29166
total FG-labeled neurons	29186
the brains and brainstems of the four groups -LRB- A -RRB-	29214
the brains and brainstems	29214
the four groups -LRB- A -RRB-	29243
the four groups	29243
A	29260
Mean neuron numbers	29264
the Raphe -LRB- B -RRB-	29287
the Raphe	29287
B	29298
Rubrospinal -LRB- C -RRB-	29302
Hypothalamic -LRB- D -RRB-	29319
Reticular -LRB- E -RRB-	29337
Trigeminal/DC -LRB- F -RRB-	29352
Trigeminal/DC	29352
F	29367
Cortical layer V -LRB- G -RRB-	29371
Cortical layer V	29371
G	29389
Vestibular -LRB- H -RRB-	29396
Vestibular	29396
H	29408
Experimental groups	29412
a one-way analysis	29452
variance -LRB- ANOVA -RRB-	29474
variance	29474
ANOVA	29484
the Dunnett 's method	29504
the Dunnett 's	29504
multiple comparisons versus a single control group -LRB- injury only -RRB-	29528
multiple comparisons versus a single control group	29528
multiple comparisons	29528
a single control group	29556
injury only	29580
the Tukey test	29602
multiple comparison procedures between all experimental and control groups	29621
multiple comparison procedures	29621
all experimental and control groups	29660
Figure 8	29698
Propriospinal neurons rostral to the lesion site	29707
Propriospinal neurons rostral	29707
the lesion site	29740
Fluorogold	29787
caudal -LRB- 8 mm -RRB-	29807
caudal	29807
8 mm	29815
the lesion site -LRB- A -RRB-	29824
the lesion site	29824
A	29841
Significantly higher numbers of propriospinal neurons	29845
Significantly higher numbers	29845
propriospinal neurons	29877
n = 10 , p < 0.05	29900
n = 10 , p <	29900
n	29900
10 , p <	29902
10	29902
0.05	29908
the Schwann cell-transplanted group	29931
#	29968
OEG-transplanted groups	29975
the medium-injected group -LRB- B -RRB-	30015
the medium-injected group	30015
B	30042
Figure 9 Mean BBB scores	30047
4 months	30077
injection of medium	30092
injection	30092
medium	30105
Schwann cells and OEG	30113
Schwann cells	30113
OEG	30131
contusion injury	30151
The red dotted line	30174
the transplant day	30202
A statistically significant increase in BBB scores	30222
A statistically significant increase	30222
BBB scores	30262
the Schwann cell group when compared to contusion only -LRB- # , p < 0.05 -RRB-	30285
the Schwann cell group	30285
# , p < 0.05	30341
# , p <	30341
# , p	30341
<	30345
0.05	30346
A significant increase in BBB scores	30353
A significant increase	30353
BBB scores	30379
the OEG group	30407
injury only -LRB- * , p < 0.05 -RRB-	30446
injury only	30446
* , p < 0.05	30459
* , p <	30459
*	30459
0.05	30464
Figure 10 Ladder walking behavioral testing .	30472
Figure 10 Ladder	30472
behavioral testing	30497
A : representative photo of a rat traversing the horizontal ladder .	30517
: representative photo of a rat traversing the horizontal ladder .	30518
representative photo	30520
a rat traversing the horizontal ladder .	30544
a rat	30544
the horizontal ladder	30561
B	30584
ladder scores	30587
treatment groups	30604
horizontal ladder walking test 6 weeks after cell transplantation date	30624
horizontal ladder walking test	30624
6 weeks	30655
cell transplantation date	30669
C : as for B at 4 months after cell transplantation date .	30696
C	30696
as for B at 4 months after cell transplantation date	30699
B at 4 months	30706
B	30706
4 months	30711
cell transplantation	30726
no stage	30756
statistical differences between groups observed on the horizontal ladder test	30770
statistical differences	30770
groups observed on the horizontal ladder test	30802
groups	30802
the horizontal ladder test	30821
Cell transplantation	30850
improved retention of tissue at the lesion site	30890
improved retention	30890
tissue at the lesion site	30912
tissue	30912
the lesion site	30922
All experimental groups	30938
loss of tissue	30972
loss	30972
tissue	30980
the lesion site following the initial contusion injury -LRB- Figure 1 -RRB-	30990
the lesion site	30990
the initial contusion injury -LRB- Figure 1 -RRB-	31016
the initial contusion injury	31016
Figure 1	31046
Morphological analysis	31057
the total amount of residual tissue	31099
the total amount	31099
residual tissue	31119
this	31136
intact tissue	31150
the remaining graft and other degenerate/regenerate tissue	31176
the remaining graft	31176
other degenerate/regenerate tissue	31200
white or grey matter	31267
The total tissue remaining	31289
degenerate/regenerate tissue	31325
the cellular trabeculae between cysts , lesion site	31358
the cellular trabeculae	31358
cysts , lesion site	31390
cysts	31390
lesion site	31397
cells	31421
Tissue integrity classification	31428
Nissl gold myelin staining	31478
distinction between intact and non-intact tissue containing macrophages	31519
distinction	31519
intact and non-intact tissue containing macrophages	31539
intact and non-intact tissue	31539
macrophages	31579
The extent of the injury/transplant zone	31592
The extent	31592
the injury/transplant zone	31606
the use	31656
GFAP immunostaining	31667
the area of intact spinal cord versus the cyst areas	31701
the area	31701
intact spinal cord versus the cyst areas	31713
intact spinal cord	31713
the cyst areas	31739
the day of transplantation -LRB- i.e. 2 weeks post initial SCI -RRB-	31772
the day	31772
transplantation -LRB- i.e. 2 weeks post initial SCI -RRB-	31783
transplantation	31783
i.e. 2 weeks post	31800
i.e.	31800
2 weeks	31805
initial SCI	31818
the total spinal cord tissue remaining	31832
the total spinal cord tissue	31832
88.4 ± 8.0 %	31875
88.4	31875
8.0 %	31880
uninjured spinal cord	31888
the amount of remaining intact tissue	31914
the amount	31914
remaining intact tissue	31928
55.4 ± 12.8 % -LRB- mean ± s.e.m -RRB-	31956
55.4 ± 12.8 %	31956
55.4	31956
12.8 %	31961
mean ± s.e.m	31968
mean	31968
± s.e.m	31972
Two weeks following cell SCs transplantation	31981
Two weeks	31981
cell SCs transplantation	32001
OEG or SCs	32027
there	32040
no significant differences between groups in the amount of total tissue	32051
no significant differences	32051
groups in the amount of total tissue	32086
groups	32086
the amount of total tissue	32096
the amount	32096
total tissue	32110
p	32124
0.27	32126
72.4 ± 3.7 % > -LRB- n = 6 -RRB- of normal in the medium-injected group	32138
72.4 ±	32138
3.7 %	32143
n = 6	32151
n	32151
= 6	32152
normal in the medium-injected group	32159
normal	32159
the medium-injected group	32169
74.6 ± 9.2 % -LRB- n = 6 -RRB- in the OEG-transplanted group	32196
74.6 ± 9.2 % -LRB- n = 6 -RRB-	32196
74.6 ± 9.2 %	32196
74.6	32196
9.2 %	32201
n	32207
6	32209
the OEG-transplanted group	32215
85.1 ± 2.9 %	32246
85.1	32246
2.9 %	32251
n	32257
6	32259
the SCs-transplanted group	32265
there	32304
no significant differences	32315
p	32343
0.25	32345
groups	32359
intact tissue remaining	32370
4.6 % -LRB- n = 6 -RRB-	32410
4.6 %	32410
n	32416
6	32418
normal in the medium-injected group	32424
normal	32424
the medium-injected group	32434
38.9 ± 7.7 % -LRB- n = 6 -RRB- in the OEG-transplanted group	32461
38.9 ± 7.7 % -LRB- n = 6 -RRB-	32461
38.9 ± 7.7 %	32461
38.9	32461
7.7 %	32466
n	32472
6	32474
the OEG-transplanted group	32480
41.6 ± 2.3 % -LRB- n = 6 -RRB- in the SCs-transplanted group	32511
41.6 ± 2.3 % -LRB- n = 6 -RRB-	32511
41.6 ± 2.3 %	32511
41.6	32511
2.3 %	32516
n	32522
6	32524
the SCs-transplanted group	32530
It	32558
the 4 month time point	32575
tissue in the transplanted groups	32609
tissue	32609
the transplanted groups	32619
controls	32686
p = 0.028	32696
p	32696
= 0.028	32697
Total tissue	32706
6.2 % -LRB- n = 11 -RRB-	32728
6.2 %	32728
n	32734
11	32736
uninjured spinal cord tissue in the medium-injected group	32743
uninjured spinal cord tissue	32743
the medium-injected group	32775
63.1 ± 3.7 % -LRB- n = 11 -RRB- in the OEGtransplanted group	32802
63.1 ± 3.7 % -LRB- n = 11 -RRB-	32802
63.1 ± 3.7 %	32802
63.1	32802
3.7 %	32807
n	32813
11	32815
the OEGtransplanted group	32822
64.1 ± 5.7 % -LRB- n = 11 -RRB- in the SCstransplanted group	32852
64.1 ± 5.7 % -LRB- n = 11 -RRB-	32852
64.1 ± 5.7 %	32852
64.1	32852
5.7 %	32857
n	32863
11	32865
the SCstransplanted group	32872
A significant difference -LRB- p = 0.028 -RRB-	32899
A significant difference	32899
p	32925
0.028	32927
groups	32956
4 months	32966
the amount	32978
intact tissue remaining	32992
26.0 ± 3.9 % -LRB- n = 11 -RRB-	33027
26.0 ± 3.9 %	33027
26.0	33027
3.9 %	33032
n	33038
11	33040
normal in the medium-injected group , 39.5 ± 4.1 % -LRB- n = 11 -RRB-	33047
normal in the medium-injected group , 39.5 ± 4.1 %	33047
normal in the medium-injected group , 39.5 ±	33047
normal	33047
the medium-injected group , 39.5	33057
the medium-injected group	33057
39.5	33084
n	33095
11	33097
the OEG-transplanted group , and 35.1 ±	33104
the OEG-transplanted group	33104
35.1 ±	33136
the SCs-transplanted group -LRB- Figure 1A , B -RRB-	33149
the SCs-transplanted group	33149
Figure 1A , B	33177
Figure 1A	33177
B	33188
Nissl staining/gold chloride staining Spinal cord sections	33192
Nissl staining	33267
good preservation of spinal tissue	33289
good preservation	33289
spinal tissue	33310
Cysts that were present	33325
Cysts	33325
Figure 1D , E and F	33376
Figure 1D	33376
E	33386
F	33392
number	33411
no difference in tissue survival	33439
no difference	33439
tissue survival	33456
any of the control or transplanted groups -LRB- OEG or SCs -RRB-	33485
any	33485
the control or transplanted groups -LRB- OEG or SCs -RRB-	33492
the control	33492
transplanted groups -LRB- OEG or SCs -RRB-	33507
transplanted groups	33507
OEG or SCs	33528
Nissl gold myelin staining at 4 months	33541
Nissl gold myelin staining	33541
4 months	33571
a reduction	33587
tissue loss , particularly the reduction	33602
tissue loss	33602
the reduction	33628
cyst volume and sparing of white and grey matter within the lesion zone	33645
cyst volume and sparing	33645
white and grey matter within the lesion zone	33672
white and grey matter	33672
the lesion zone	33701
Figure 1H , I and J	33722
Figure 1H	33722
I	33732
J	33738
The presence of round microcysts	33742
The presence	33742
round microcysts	33758
the spinal cords of SCs treated rats	33793
the spinal cords	33793
SCs treated rats	33813
SCs	33813
rats	33825
2 week	33851
4 month spinal cords	33862
4 month	33862
spinal cords	33870
neither OEG transplanted rats or control -LRB- medium injected -RRB-	33884
neither OEG	33884
transplanted rats or control -LRB- medium injected -RRB-	33896
transplanted rats or control	33896
medium injected	33926
medium	33926
rats	33943
these cysts	33955
Transgene expression	33968
cell dispersal and survival	33990
transplanted Schwann cells	34021
OEG	34052
Approximately 92 % of OEG and 99 % of SCs	34056
Approximately 92 % of OEG	34056
Approximately 92 %	34056
OEG	34077
99 % of SCs	34085
99 %	34085
SCs	34092
a total of all Hoechst 33342 labeled cells	34122
a total	34122
all Hoechst 33342 labeled cells	34133
all Hoechst 33342	34133
cells	34159
Figure 2A and B	34167
OEG or SCs	34185
self	34232
lentiviral-DSRED-2 vectors	34250
This vector	34278
non-toxic -LRB- data not shown -RRB-	34306
non-toxic	34306
data not shown	34317
data	34317
visualization of cytoplasmic spread	34345
visualization	34345
cytoplasmic spread	34362
cellular morphology for up to 4 months post-transplantation into the CNS	34385
cellular morphology	34385
up to 4 months post-transplantation into the CNS	34409
up to 4 months	34409
the CNS	34450
DSRED-2 's stability and capacity to track cells	34459
DSRED-2 's stability and capacity	34459
DSRED-2 's	34459
track cells	34495
GFP -LSB- 12,26,36,42 -RSB-	34565
GFP	34565
12,26,36,42 -RSB-	34570
DSRED-2 labeled	34584
DSRED-2	34584
no additional immunological response	34607
the GFP transgene which may occur with LacZ	34669
the GFP transgene	34669
LacZ	34708
43 -RSB- or human placental alkaline phosphatase	34714
43 -RSB-	34714
human placental alkaline phosphatase	34721
44 -RSB-	34759
Figures 2C and D	34764
Figures 2C	34764
D	34779
representative spinal cord	34786
sagittal sections with OEG and SCs grafts 2 weeks	34813
sagittal sections	34813
OEG and SCs grafts	34836
2 weeks	34855
cell transplantation	34873
Lentiviral-DSRED-2 labeled OEG	34895
Lentiviral-DSRED-2	34895
OEG	34922
all but one of the animals	34942
all but one	34942
the animals	34957
lentiviral-DSRED-2 labeled SCs	34977
lentiviral-DSRED-2	34977
SCs	35004
all animals	35024
2 weeks after transplantation to the injured spinal cord	35040
2 weeks	35040
transplantation to the injured spinal cord	35054
transplantation	35054
the injured spinal cord	35073
DSRED-2 fluorescence pixel intensity for surviving transplanted OEG	35098
DSRED-2 fluorescence pixel intensity	35098
transplanted OEG	35149
70 ± 29	35170
70	35170
29	35173
the rostral aspects of the transplant/lesion zone	35179
the rostral aspects	35179
the transplant/lesion zone	35202
91	35237
± 37	35239
SCs	35247
the center of the lesion 86 ± 35 for OEG	35255
the center of the lesion 86 ± 35	35255
the center	35255
the lesion 86	35269
35	35283
OEG	35290
100 ± 41 for SCs	35298
100 ± 41	35298
SCs	35309
the DSRED-2 fluorescence pixel intensity	35321
the caudal edge of the transplant/lesion	35365
the caudal edge	35365
the transplant/lesion	35384
83 ± 34	35410
83	35410
34	35413
OEG and 79 ± 32	35420
OEG	35420
79 ± 32	35428
79	35428
32	35431
SCs	35438
rats at 2 weeks -LRB- n = 6 per group -RRB- analyzed	35446
rats	35446
2 weeks -LRB- n = 6 per group -RRB- analyzed	35454
2 weeks -LRB- n = 6 per group -RRB-	35454
n = 6 per group	35463
n = 6	35463
n	35463
6	35465
group	35471
transplanted OEG	35499
some cases	35523
5 mm	35550
the center of the injection site , the furthest distance measured	35560
the center	35560
the injection site , the furthest distance measured	35574
the injection site	35574
the furthest distance measured	35594
the furthest distance	35594
contrast , DSRED-2	35629
contrast	35629
DSRED-2	35639
positive transplanted SCs	35647
the site of injection	35698
the site	35698
injection	35710
more than 0.6 mm	35735
the injection site	35757
2 weeks post transplantation	35780
2 weeks	35780
the surviving OEG	35809
the lesion site and adjacent spinal cord tissue	35853
the lesion site	35853
adjacent spinal cord tissue	35873
the rostrocaudal axis of the spinal cord	35925
the rostrocaudal axis	35925
the spinal cord	35950
SCs	35967
an alignment	35997
the graft area	36041
the intact host CNS tissue surrounding the lesion site	36082
the intact host CNS tissue	36082
the lesion site	36121
Four months	36138
OEG transplantation	36156
DSRED-2 positive OEG	36177
7	36215
11 animals -LRB- 64 % -RRB-	36224
11 animals	36224
64 %	36236
DSRED-2 positive SCs	36249
11	36287
11 animals -LRB- 100 % -RRB-	36297
11 animals	36297
100 %	36309
Measurements of DSRED	36316
Measurements	36316
DSRED	36332
2 fluorescence pixel intensity	36339
OEG	36377
the rostral part of the lesion	36384
the rostral part	36384
the lesion	36404
22 ± 9 and SCs 34 ± 14	36418
22 ± 9	36418
22 ±	36418
9	36421
SCs 34 ± 14	36427
SCs 34	36427
14	36434
the center of the lesion the values were 21 ± 9 for OEG and 29 ± 12 for SCs	36441
the center	36441
the lesion the values were 21 ± 9 for OEG and 29 ± 12 for SCs	36455
the lesion	36455
the values	36466
21 ± 9	36482
21	36482
9	36485
OEG and 29 ± 12	36491
OEG	36491
29 ± 12	36499
29	36499
12	36502
SCs	36509
DSRED-2 pixel fluorescence	36514
19 ± 8	36557
19	36557
8	36560
OEG at the caudal part of the lesion and 28 ± 12 for SCs	36566
OEG	36566
the caudal part of the lesion and 28 ± 12	36573
the caudal part of the lesion	36573
the caudal part	36573
the lesion	36592
28 ± 12	36607
28	36607
12	36610
SCs	36617
the DSRED-2 fluorescence	36640
the levels of OEG present within the spinal cord	36666
the levels	36666
OEG present within the spinal cord	36680
OEG	36680
the spinal cord	36699
the rostral-caudal axis of the lesion	36740
the rostral-caudal axis	36740
the lesion	36767
74 % at 4 months from the value seen at 2 weeks post transplantation	36781
74 %	36781
4 months from the value seen at 2 weeks post transplantation	36788
4 months	36788
the value seen at 2 weeks post transplantation	36802
the value	36802
2 weeks post transplantation	36820
2 weeks	36820
the same time DSRED-2 fluorescence pixel values	36853
SCs reduced from 2 weeks and 4 months	36905
SCs	36905
2 weeks and 4 months	36922
2 weeks	36922
4 months	36934
fluorescence levels	36952
OEG levels -LRB- p < 0.05 -RRB-	37003
OEG levels	37003
p < 0.05	37015
p	37015
< 0.05	37016
<	37016
0.05	37017
Additional file 1 : Table S1	37028
file 1	37039
Table S1	37047
Table	37047
S1	37053
Scar formation	37058
CS56 synthesis and gliosis Deposition	37074
proteoglycan	37115
transplanted OEG	37170
SCs	37188
control medium	37197
spinal cords	37221
immunofluorescence section staining with antibodies to GFAP and CS56	37237
immunofluorescence section staining	37237
antibodies to GFAP and CS56	37278
antibodies	37278
GFAP and CS56	37292
chondroitin sulphate proteoglycans	37311
The extent of staining	37348
The extent	37348
staining	37362
the lesion site in a rostro-caudal direction	37391
the lesion site	37391
a rostro-caudal direction	37410
2 weeks post transplantation	37443
2 weeks	37443
OEG spinal cords	37473
a moderate change	37497
GFAP staining	37518
SCs and medium treated spinal cords -LRB- n = 6 -LRB- Figure 3A , C -RRB-	37549
SCs and medium	37549
spinal cords -LRB- n = 6 -LRB- Figure 3A , C -RRB-	37572
spinal cords -LRB- n = 6	37572
spinal cords	37572
n = 6	37586
n	37586
6	37588
Figure 3A , C	37591
Figure 3A	37591
C	37601
this	37620
the caudal aspect of the transplant zone -LRB- Figure 3B , D -RRB-	37638
the caudal aspect	37638
the transplant zone -LRB- Figure 3B , D -RRB-	37659
the transplant zone	37659
Figure 3B , D	37680
Figure 3B	37680
D	37690
4 months following OEG , SCs and medium injections	37697
4 months	37697
OEG , SCs and medium injections	37716
OEG	37716
SCs	37721
medium injections	37729
GFAP immunofluorescence staining -LRB- analyzed by pixel intensity -RRB-	37748
GFAP immunofluorescence staining	37748
pixel intensity	37794
a trend	37820
a lower degree of GFAP immunofluorescence	37836
a lower degree	37836
GFAP immunofluorescence	37854
the injury zone	37881
The OEG	37898
transplanted group	37906
a reduction of 27 % in GFAP immunofluorescence	37932
a reduction	37932
27 % in GFAP immunofluorescence	37947
27 %	37947
GFAP immunofluorescence	37954
the SCs	37995
transplanted group and a 23 % reduction	38003
transplanted group	38003
a 23 % reduction	38026
GFAP immunofluorescence when	38045
GFAP immunofluorescence	38045
the medium-injected group	38086
this difference	38122
p < 0.05	38173
p	38173
< 0.05	38174
<	38174
0.05	38175
Integration of transplanted cells with host astrocytes	38182
Integration	38182
transplanted cells with host astrocytes	38197
transplanted cells	38197
host astrocytes	38221
the OEG transplant groups but infrequent for the SCs transplant animals	38254
OEG transplant groups	38258
OEG	38258
transplant groups	38262
the SCs	38299
CS56 proteoglycan staining	38327
the OEG , SCs and medium groups in the 4 month post transplant spinal cords	38374
the OEG , SCs and medium groups in the 4 month post transplant	38374
the OEG , SCs and medium groups	38374
the 4 month post transplant	38408
n	38450
11	38452
Immunofluorescence staining	38457
CS56	38489
the SCs	38497
transplanted group -LRB- Figure 3E -RRB-	38505
transplanted group	38505
Figure 3E	38525
medium	38567
control sections -LRB- p < 0.001 -RRB- -LRB- Figure 3F -RRB-	38583
control sections -LRB- p < 0.001 -RRB-	38583
control sections	38583
p < 0.001	38601
p	38601
< 0.001	38602
<	38602
0.001	38603
Figure 3F	38611
the CS56 immunofluorescence	38626
the SCs group	38669
the OEG transplanted group -LRB- p < 0.01 -RRB- -LRB- Figure 3F -RRB-	38695
the OEG transplanted group -LRB- p < 0.01 -RRB-	38695
the OEG transplanted group	38695
p < 0.01	38723
p	38723
< 0.01	38724
<	38724
0.01	38725
Figure 3F	38732
CS56 immunofluorescence in the OEG group	38744
CS56 immunofluorescence	38744
the OEG group	38771
the levels seen in the medium injected controls	38822
the levels	38822
the medium injected controls	38841
the medium	38841
controls	38861
Extracellular matrix deposition within the lesion site	38871
Extracellular matrix deposition	38871
the lesion site	38910
4 months post injury	38929
the grey and white matter bordering the lesion site	38951
the grey and white matter	38951
the lesion site	38987
numerous blood vessels	39013
the walls	39037
laminin-1 staining -LRB- Figure 4A,B,D-K -RRB-	39076
laminin-1 staining	39076
Figure 4A,B,D-K	39096
The dura mater	39114
laminin-1	39161
all analyzed spinal cords	39174
all	39174
spinal cords	39187
addition to the meningeal and vascular-associated laminin-1	39204
addition	39204
the meningeal and vascular-associated laminin-1	39216
the meningeal	39216
vascular-associated laminin-1	39234
the graft sites of OEG and SCs grafts	39265
the graft sites	39265
OEG and SCs grafts	39284
laminin-1	39318
the medium injected control group	39341
the medium	39341
control group	39361
the laminin-1-stained area	39376
both the OEG and SCs	39430
the OEG	39435
SCs	39447
transplanted groups	39451
these differences	39476
p = 0.15	39530
p	39530
= 0.15	39531
higher magnification	39542
it	39564
areas strongly immunoreactive for laminin-1	39585
areas	39585
laminin-1	39619
the DSRED-2	39645
positive cells	39657
the SCs	39680
transplanted group -LRB- see Figure 4I , J , K vs. E , F , G -RRB-	39688
transplanted group	39688
Figure 4I , J , K vs. E , F , G	39712
Figure 4I	39712
J	39722
K vs. E	39724
F	39732
G	39734
the areas of strong laminin-1 immunoreactivity in OEG	39750
the areas	39750
strong laminin-1 immunoreactivity in OEG	39763
strong laminin-1 immunoreactivity	39763
OEG	39800
spinal cords	39812
the location of surviving DSRED-2 positive transplanted cells	39850
the location	39850
surviving DSRED-2 positive transplanted cells	39866
another source or cell type such as endothelial cells for the laminin-1	39924
another source or cell type	39924
endothelial cells for the laminin-1	39960
endothelial cells	39960
the laminin-1	39982
Laminin-1-positive structures around bundles of axons in both the OEG and SCs	39997
Laminin-1-positive structures	39997
bundles of axons in both the OEG and SCs	40034
bundles	40034
axons in both the OEG and SCs	40045
axons	40045
both the OEG and SCs	40054
the OEG	40059
SCs	40071
transplanted groups	40075
The profile of immunoreactivity for collagen IV -LRB- Figure 4C and L-S -RRB-	40110
The profile of immunoreactivity for collagen IV	40110
The profile	40110
immunoreactivity for collagen IV	40125
immunoreactivity	40125
collagen IV	40146
Figure 4C and L-S	40159
Figure 4C	40159
L-S	40173
that observed for laminin-1	40193
that	40193
laminin-1	40211
Structures resembling blood vessels	40222
Structures	40222
blood vessels	40244
the site	40278
the spinal cord lesion in the OEG transplanted group -LRB- Figure 4L -RRB-	40290
the spinal cord lesion	40290
the OEG transplanted group -LRB- Figure 4L -RRB-	40316
the OEG transplanted group	40316
Figure 4L	40344
the graft site of the OEG	40362
the graft site	40362
the OEG	40380
transplanted group	40388
more collagen IV immunofluorescence	40417
that of the other groups	40458
that	40458
the other groups	40466
Figure 4L and P vs. C	40484
Figure 4L and P	40484
C	40504
measurement using pixel intensity	40508
measurement	40508
pixel intensity	40526
the collagen IV immunofluorescence	40551
each group to be statistically similar -LRB- p = 0.10 -RRB-	40590
p = 0.10	40630
p	40630
= 0.10	40631
laminin-1	40647
higher magnification	40661
collagen IV	40683
high quantities in regions of the SCs grafts	40712
high quantities	40712
regions of the SCs grafts	40731
regions	40731
the SCs grafts	40742
the OEG transplanted group high amounts of collagen IV	40769
the OEG	40769
transplanted group high amounts	40777
collagen IV	40812
DSRED-2 negative cells in the vicinity of the DSRED-2	40851
DSRED-2 negative cells	40851
the vicinity of the DSRED-2	40877
the vicinity	40877
the DSRED-2	40893
positive cells	40905
Figure 4O , S	40921
Figure 4O	40921
S	40931
endogenous SCs invading from the periphery or host endothelial cells	40962
endogenous SCs	40962
the periphery or host endothelial cells	40991
the periphery	40991
host endothelial cells	41008
Axonal profiles	41032
lesion site Immunohistochemistry with the neurofilament-specific antibody RT-97	41055
lesion site Immunohistochemistry	41055
the neurofilament-specific antibody RT-97	41093
the presence	41156
medium and high neurofilament-containing axons	41172
the lesion site of all transplanted groups and controls	41233
the lesion site	41233
all transplanted groups and controls	41252
Figure 5	41290
the lesion epicenter of all groups	41304
the lesion epicenter	41304
all groups	41328
continuous white matter tracts of spared axons	41340
continuous white matter tracts	41340
spared axons	41374
the ventral edges of each section -LRB- Figure 5A , B , and D -RRB-	41404
the ventral edges	41404
each section -LRB- Figure 5A , B , and D -RRB-	41425
each section	41425
Figure 5A , B , and D	41439
Figure 5A	41439
B	41449
D	41456
Dorsal white matter tracts	41460
an improved state of preservation	41495
an improved state	41495
preservation	41516
OEG and SCs transplants	41535
addition	41563
RT97 + axons	41573
RT97	41573
axons	41579
the lesion site in all transplanted	41601
the lesion site	41601
all transplanted	41620
control groups with RT97 + axons being co-extensive with DSRED-2 OEG and SCs	41641
control groups	41641
RT97 + axons being co-extensive with DSRED-2 OEG and SCs	41661
RT97 + axons	41661
DSRED-2 OEG and SCs	41697
Figure 5E	41718
Axons entering SCs graft areas or putative graft areas	41730
Axons	41730
SCs graft areas or putative graft areas	41745
SCs graft areas	41745
putative graft areas	41764
rostral-caudal directionality	41817
the random internal organization of the graft -LRB- Figure 5E -RRB-	41872
the random internal organization	41872
the graft -LRB- Figure 5E -RRB-	41908
the graft	41908
Figure 5E	41919
this nonlinear pathway for axons	41939
this nonlinear pathway	41939
axons	41966
the OEG	41988
transplanted spinal cords -LRB- Figure 5C -RRB-	41996
transplanted spinal cords	41996
Figure 5C	42023
Evidence for infiltration of endogenous Schwann cells	42035
Evidence	42035
infiltration	42048
endogenous Schwann cells	42064
the spinal cord	42094
several	42113
the OEG or SCs transplanted animals , the lesion site	42124
the OEG or SCs	42124
transplanted animals , the lesion site	42139
transplanted animals	42139
the lesion site	42161
numerous fascicles of cells	42187
numerous fascicles	42187
cells	42209
glial-like spindle-shaped morphology	42220
these cells	42258
p75	42288
DSRED-2	42309
Sections from the medium-injected group	42318
Sections	42318
the medium-injected group	42332
p75-positive cells	42373
2 weeks	42400
4 months	42412
transplant day	42427
Figure 6A , B	42443
Figure 6A	42443
B	42453
The p75-positive cells	42457
the OEG -LRB- Figure 6C and D -RRB-	42483
the OEG	42483
Figure 6C and D	42492
Figure 6C	42492
D	42506
SCs -LRB- Figure 6E , F -RRB- transplant groups	42513
SCs	42513
Figure 6E , F	42518
Figure 6E	42518
F	42528
transplant groups	42531
donor cells that were not expressing the DSRED-2 transgene	42563
donor cells	42563
the DSRED-2 transgene	42600
It	42623
SCs	42648
the spinal cord from blood vessels	42670
the spinal cord	42670
blood vessels	42691
the spinal cord	42712
the dorsal roots -LSB- 45 -RSB-	42735
the dorsal roots	42735
45 -RSB-	42753
The latter	42758
the method using lentiviral vectors encoding transgene such as GFP	42793
the method	42793
lentiviral vectors	42810
transgene such as GFP	42838
transgene	42838
GFP	42856
long term expression -LSB- 12	42898
long term expression	42898
12	42920
these p75-positive cells	42928
the medium-injected groups	42975
Numbers	43003
retrogradely	43014
descending axons	43035
glial transplantation Retrograde labeling with Fluorogold	43065
glial transplantation Retrograde labeling	43065
Fluorogold	43112
extension	43144
spared/regenerated descending supraspinal axons	43157
8 mm	43214
the most caudal edge of the contusion site	43226
the most caudal edge	43226
the contusion site	43250
Mean ± standard errors of numbers of descending Fluorogold-labeled cells	43270
Mean ± standard errors	43270
Mean	43270
standard errors	43275
numbers of descending Fluorogold-labeled cells	43294
numbers	43294
descending Fluorogold-labeled cells	43305
There	43356
statistically significant differences	43367
p < 0.05	43406
p	43406
< 0.05	43407
<	43407
0.05	43408
the total brain counts	43422
the OEG transplanted group -LRB- 3019 ± 216 -RRB-	43448
the OEG transplanted group	43448
3019 ± 216	43476
3019 ±	43476
216	43481
also the SCs transplanted group -LRB- 2767 ± 411 -RRB-	43490
also the SCs	43490
transplanted group -LRB- 2767 ± 411 -RRB-	43503
transplanted group	43503
2767 ± 411	43523
2767 ±	43523
411	43528
the control injury	43550
only group -LRB- 1204 ± 331 -RRB-	43569
only group	43569
1204 ± 331	43581
1204 ±	43581
331	43586
Statistical differences -LRB- p < 0.05 -RRB-	43592
Statistical differences	43592
p < 0.05	43617
p	43617
< 0.05	43618
<	43618
0.05	43619
a number of separate brain regions projecting distally through the injury zone	43638
a number	43638
separate brain regions projecting distally through the injury zone	43650
separate brain regions	43650
the injury zone	43701
OEG transplanted rats	43718
OEG	43718
rats	43735
statistically significant differences	43747
the Raphe	43788
neurons -LRB- 562 ± 43 -RRB- compared to controls -LRB- 184 ± 62	43809
neurons -LRB- 562 ± 43 -RRB- compared to	43809
neurons -LRB- 562 ± 43 -RRB-	43809
neurons	43809
562 ± 43	43818
562 ±	43818
43	43822
controls -LRB- 184 ± 62	43838
controls	43838
184 ± 62	43848
184	43848
62	43852
Numbers	43857
Fluorogold neurons	43868
the Raphe	43890
SCs	43904
rats -LRB- 296 ± 50 -RRB-	43921
rats	43921
296 ± 50	43927
296	43927
50	43931
significant differences	43948
injuries	43997
Rubrospinal Fluorogold numbers in the OEG and SCs grafted groups	44012
Rubrospinal Fluorogold numbers	44012
the OEG and SCs grafted groups	44046
the OEG and SCs	44046
groups	44070
243 ± 34 and 244 ± 50 respectively	44091
243 ±	44091
34 and 244 ± 50 respectively	44095
34 and 244 ± 50	44095
34 and 244	44095
50	44106
the control injury only group -LRB- 115 ± 42 -RRB-	44174
the control injury	44174
only group -LRB- 115 ± 42 -RRB-	44193
only group	44193
115 ± 42	44205
115	44205
42	44209
The numbers of Fluorogold labeled neurons in the hypothalamus	44214
The numbers	44214
Fluorogold labeled neurons in the hypothalamus	44229
Fluorogold	44229
neurons in the hypothalamus	44248
neurons	44248
the hypothalamus	44259
both the OEG and SCs groups -LRB- 135 ± 16 and 116 ± 23 respectively -RRB-	44305
the OEG	44310
SCs groups -LRB- 135 ± 16 and 116 ± 23 respectively -RRB-	44322
SCs groups	44322
135 ± 16 and 116 ± 23	44334
135 ± 16	44334
135	44334
16	44338
116 ± 23	44345
116	44345
23	44349
to controls -LRB- 60 ± 15	44380
controls -LRB- 60 ± 15	44383
controls	44383
60 ± 15	44393
60	44393
15	44396
Fluorogold	44401
neurons	44420
the reticular formation in control injury	44431
the reticular formation	44431
control injury	44458
rats	44478
632 ± 165 , as compared to 1590 ± 100 for OEG treated rats and 1635 ± 23	44492
632 ±	44492
165 , as compared to 1590 ± 100 for OEG treated rats and 1635	44496
165	44496
1590 ±	44516
100 for OEG treated rats and 1635	44521
100	44521
OEG treated rats and 1635	44529
OEG	44529
rats and 1635	44541
rats	44541
1635	44550
23	44555
SCs grafted animals -LRB- Table 1 and Figure 7 -RRB-	44562
SCs	44562
animals -LRB- Table 1 and Figure 7 -RRB-	44574
animals	44574
Table 1 and Figure 7	44583
Table 1	44583
Figure 7	44595
Fluorogold numbers in the trigeminal/DC	44606
Fluorogold numbers	44606
the trigeminal/DC	44628
all groups -LRB- Table 1 and Figure 7 -RRB-	44696
all groups	44696
Table 1 and Figure 7	44708
Table 1	44708
Figure 7	44720
This	44731
the case	44745
corticospinal layer V neurons	44758
axons	44794
the distal spinal cord -LRB- 8 mm -RRB-	44828
the distal spinal cord	44828
8 mm	44852
fluorogold injection site -LRB- Figure 7 -RRB-	44858
fluorogold injection site	44858
Figure 7	44885
neurons labeled in the vestibular system	44905
neurons	44905
the vestibular system	44924
significantly increased	44951
the OEG and SCs transplanted rats -LRB- 373 ± 65 and 360 ± 51 respectively -RRB-	44978
the OEG	44978
SCs transplanted rats -LRB- 373 ± 65 and 360 ± 51 respectively -RRB-	44990
SCs	44990
transplanted rats -LRB- 373 ± 65 and 360 ± 51 respectively -RRB-	44994
transplanted rats	44994
373 ± 65 and 360 ± 51	45013
373 ± 65	45013
373	45013
65	45017
360 ± 51	45024
360	45024
51	45028
injury only rats -LRB- 117 ± 27 -RRB-	45070
injury	45070
only rats -LRB- 117 ± 27 -RRB-	45077
only rats	45077
117 ± 27	45088
117	45088
27	45092
Schwann and OEG cell grafts	45097
Schwann	45097
OEG cell grafts	45109
the number	45134
spared/regenerated propriospinal neurons	45148
Fluorogold propriospinal neurons	45189
spinal cord segments rostral to the lesion/transplantation site	45240
spinal cord segments	45240
the lesion/transplantation site	45272
Figure 8A	45322
Propriospinal neurons that had reached the caudal injected Fluorogold	45334
Propriospinal neurons	45334
the caudal injected Fluorogold	45373
the caudal	45373
Fluorogold	45393
8 mm caudal from the caudal borders of the injury site	45405
8 mm caudal	45405
the caudal borders of the injury site	45422
the caudal borders	45422
the injury site	45444
6 ±	45470
3	45472
the medium injected group 38 ± 26 in the OEG transplanted group and 131	45477
the medium	45477
group 38	45497
26	45506
the OEG transplanted group and 131	45512
the OEG transplanted group	45512
131	45543
59	45547
the SCs	45553
transplanted group -LRB- see Figure 8B -RRB-	45561
transplanted group	45561
Figure 8B	45585
Figure 8	45608
there	45617
a significant difference between the medium injected and OEG transplanted groups	45627
a significant difference between the medium injected	45627
a significant difference	45627
the medium injected	45660
the medium	45660
OEG transplanted groups	45684
a significantly larger number of labeled propriospinal neurons	45713
a significantly larger number	45713
labeled propriospinal neurons	45746
the SCs group	45792
the medium injected group -LRB- p < 0.03 -RRB-	45821
the medium	45821
group -LRB- p < 0.03 -RRB-	45841
group	45841
p < 0.03	45848
p	45848
< 0.03	45849
<	45849
0.03	45850
There	45857
no statistically significant difference	45867
the OEG and SCs transplanted groups	45915
the OEG	45915
SCs	45927
Functional recovery	45952
open field behavioral testing -LRB- BBB -RRB- and Ladder	45973
open field behavioral testing -LRB- BBB -RRB-	45973
open field behavioral testing	45973
BBB	46004
Ladder	46013
testing	46025
two weeks after injury and again at two weeks after transplantation	46036
two weeks	46036
injury	46052
two weeks after transplantation	46072
two weeks	46072
transplantation	46088
rats in all groups	46105
rats	46105
all groups	46113
bladder function	46137
field	46160
behavioral scoring	46166
no statistically significant changes in the BBB scores	46195
no statistically significant changes	46195
the BBB scores	46235
all groups	46253
transplantation -LRB- Figure 9 -RRB-	46271
transplantation	46271
Figure 9	46288
One week following transplantation of OEG or SCs	46299
One week	46299
transplantation of OEG or SCs	46318
transplantation	46318
OEG or SCs	46337
i.e. 21 days post injury	46349
i.e. 21 days post	46349
i.e.	46349
21 days	46354
injury	46367
these scores	46375
control scores , with all groups	46411
control scores	46411
all groups	46432
scoring 10 -- 11	46443
10 -- 11	46451
2 weeks after treatment with cells or medium	46461
2 weeks	46461
treatment with cells or medium	46475
treatment	46475
cells or medium	46490
control injury	46507
rats	46527
a mean of 11	46539
a mean	46539
11	46549
medium injected	46553
medium	46553
10	46576
OEG	46580
12	46591
SCs	46598
11 -LRB- Figure 9 -RRB-	46609
11	46609
Figure 9	46613
Three weeks following injection of cells , the mean BBB scores for OEG	46624
Three weeks	46624
injection of cells , the mean BBB scores for OEG	46646
injection	46646
cells , the mean BBB scores for OEG	46659
cells	46659
the mean BBB scores for OEG	46666
the mean BBB scores	46666
OEG	46690
rats	46703
13	46713
SCs	46717
12	46728
medium injected	46732
medium	46732
10	46755
injury	46762
11	46781
Theses scores	46785
all the following time points until day 133 and 144	46819
all the following time points	46819
day 133 and 144	46855
OEG	46876
a mean of 14	46887
a mean	46887
14	46897
SCs	46901
13	46912
medium injected	46916
medium	46916
11 and 10	46939
injury	46954
11 and 11	46973
Figure 9	47001
one	47018
week of testing on the BBB	47022
week	47022
testing on the BBB	47030
testing	47030
the BBB	47041
the rats	47055
the ladder walk -LRB- see Figure 10A -RRB-	47083
the ladder walk	47083
Figure 10A	47104
6 weeks or 4 months after treatment	47120
6 weeks	47120
4 months after treatment	47131
4 months	47131
treatment	47146
most rats	47157
between 3.5 and 5.5	47174
Table 2 -RRB- out of 6 on the horizontal ladder walking test -LRB- Figure 10B-C	47199
Table 2 -RRB- out of 6 on the horizontal ladder walking	47199
Table 2 -RRB- out of 6	47199
Table	47199
2 -RRB- out of 6	47205
out	47208
6	47215
the horizontal ladder walking	47220
the horizontal ladder	47220
test -LRB- Figure 10B-C	47250
test	47250
Figure 10B-C	47256
Figure	47256
10B-C	47263
no significant differences observed between groups	47276
no significant differences	47276
groups	47320
Discussion We have shown the capacity of purified	47329
Discussion	47329
We	47340
the capacity of purified	47354
the capacity	47354
primary OEG and SCs	47380
primary OEG	47380
SCs	47396
behavioral recovery , increase numbers of supraspinal axons	47411
behavioral recovery	47411
increase numbers of supraspinal axons	47432
increase numbers	47432
supraspinal axons	47452
increase tissue	47475
two weeks	47517
a moderate spinal cord contusion injury	47533
A lentiviral vector encoding DSRED-2	47574
OEG and SCs	47633
this study	47650
it	47661
both cell types	47723
4 months	47745
transplantation	47772
Viable transplanted OEG and SCs	47789
Viable transplanted OEG	47789
SCs	47817
similar numbers	47835
2 weeks	47854
4 months	47873
the OEG numbers	47882
the number of SCs remaining	47913
the number	47913
SCs remaining	47927
SCs	47927
Histochemical tissue analysis	47942
a significant reduction	47979
tissue loss in both the OEG and SCs groups	48006
tissue loss	48006
both the OEG and SCs groups	48021
the OEG	48026
SCs groups	48038
4 months	48049
dorsal white matter tracts	48089
the transplant groups	48151
non-cellular transplanted controls -LRB- medium -RRB-	48181
non-cellular transplanted controls	48181
medium	48217
Analysis of DSRED-2 labeled glia in the spinal cords	48226
Analysis	48226
DSRED-2 labeled glia in the spinal cords	48238
DSRED-2	48238
glia in the spinal cords	48254
glia	48254
the spinal cords	48262
a migration/dispersal difference between the two cell types	48286
a migration/dispersal difference	48286
the two cell types	48327
OEG	48347
a rostro-caudal direction	48383
greater integration of OEG with host astrocytes	48414
greater integration	48414
OEG with host astrocytes	48437
OEG	48437
host astrocytes	48446
the tight interwoven grafts in the SCs transplanted rats	48491
interwoven grafts in the SCs	48501
interwoven grafts	48501
the SCs	48522
OEG transplanted rats	48549
significantly lower levels of CS56 immunofluorescence	48581
significantly lower levels	48581
CS56 immunofluorescence	48611
the lesion/transplant site when	48653
the lesion/transplant site	48653
the SCs group	48697
Matrix deposition	48712
OEG and SCs groups	48750
laminin and collagen IV immunofluorescence	48774
laminin	48774
collagen IV immunofluorescence	48786
a closer co-existence of these matrix molecules	48824
a closer co-existence	48824
these matrix molecules	48849
SCs	48875
OEG	48887
Axonal staining using neurofilament antibodies	48892
Axonal staining	48892
neurofilament antibodies	48914
tighter bundles of axons within the SCs transplant zone	48946
tighter bundles	48946
axons within the SCs transplant zone	48965
axons	48965
the SCs transplant zone	48978
OEG zones	49010
field behavioral testing -LRB- BBB -RRB-	49026
field behavioral testing	49026
BBB	49052
significant differences	49064
the transplanted groups and the controls up to 4 months	49096
the transplanted groups	49096
the controls up to 4 months	49124
the controls	49124
up to 4 months	49137
transplantation	49158
BBB scores	49175
the OEG group	49214
injury	49248
medium and SCs	49256
rats	49280
Additional behavioral testing using the ladder walk however	49286
Additional behavioral testing	49286
the ladder walk	49322
any significant differences between experimental and control groups	49360
any significant differences	49360
experimental and control groups	49396
8 mm	49459
the injury/transplantation site	49474
significant differences between control groups and OEG and SCs	49515
significant differences between control groups	49515
significant differences	49515
control groups	49547
OEG and SCs	49566
OEG	49566
SCs	49574
transplanted groups in supraspinal projecting axon populations	49578
transplanted groups	49578
supraspinal projecting axon populations	49601
supraspinal	49601
axon populations	49624
This	49642
strong evidence	49656
a sub-acute transplant of SCs or OEG	49677
a sub-acute transplant	49677
SCs or OEG	49703
an environment	49722
promotion	49746
sparing/regeneration of supraspinal axonal projections to the spinal cord	49759
sparing/regeneration	49759
supraspinal axonal projections to the spinal cord	49783
supraspinal axonal projections	49783
the spinal cord	49817
SCs and OEG	49848
their interaction with host spinal cord cells and matrix production	49870
their interaction with host spinal cord cells	49870
their interaction	49870
host spinal cord cells	49893
matrix production	49920
Evidence of statistically significant tissue-protective effects of OEG	49939
Evidence	49939
statistically significant tissue-protective effects of OEG	49951
statistically significant tissue-protective effects	49951
OEG	50006
4 months	50023
transplantation	50038
2 weeks	50058
tissue loss	50088
The tissue-protective effects of transplanted OEG or SCs	50121
The tissue-protective effects	50121
transplanted OEG or SCs	50154
the secretion	50189
factors	50206
BDNF , NGF , GDNF and NT4/5 -LSB- 13,46-48 -RSB- or matrix	50237
BDNF	50237
NGF , GDNF and NT4/5	50243
13,46-48 -RSB-	50264
matrix	50277
laminin-1	50285
collagen IV	50296
N-Cadherin	50332
49-51 -RSB-	50355
These mechanisms	50363
protection combined with tissue-rebuilding or new cell birth -LSB- 52 -RSB- ,	50383
protection combined with tissue-rebuilding or new cell birth	50383
protection	50383
tissue-rebuilding or new cell birth	50408
tissue-rebuilding	50408
new cell birth	50429
anatomical functional outcomes	50493
Proliferation of donor OEG	50525
Proliferation	50525
donor OEG	50542
the labeling method employed in this study	50571
the labeling method	50571
this study	50603
all daughter cells	50630
the number of labeled cells at 4 months in the lesion site	50669
the number	50669
labeled cells at 4 months in the lesion site	50683
labeled cells	50683
4 months in the lesion site	50700
4 months	50700
the lesion site	50712
2 weeks	50760
The fewer numbers of detectable OEG	50769
The fewer numbers	50769
detectable OEG	50790
movement	50814
the site	50833
injury -LRB- measurement area -RRB-	50845
injury	50845
measurement area	50853
death -LRB- via apoptotic or anoikis mechanisms -RRB- -LSB- 42,44	50875
death -LRB- via apoptotic or anoikis mechanisms -RRB-	50875
death	50875
apoptotic or anoikis mechanisms	50886
42,44	50920
a small number of animals	50931
a small number	50931
animals	50949
OEG	50958
several millimeters	50976
the injection site	51001
earlier studies	51040
OEG migration	51071
distances of 9 mm	51088
distances	51088
9 mm	51101
the injection site -LSB- 9,53,54 -RSB-	51111
the injection site	51111
9,53,54 -RSB-	51131
contrast to the OEG	51144
contrast	51144
the OEG	51156
SCs	51165
the immediate lesion area	51201
a distance of 1.5 mm	51250
a distance	51250
1.5 mm	51264
A similar lack of dispersal	51272
A similar lack	51272
dispersal	51290
peripheral nerve grafts inserted into the adult CNS -LSB- 55,56 -RSB-	51325
peripheral nerve grafts	51325
the adult CNS -LSB- 55,56 -RSB-	51363
the adult CNS	51363
55,56 -RSB-	51378
This	51386
interactions with host astrocytes	51408
interactions	51408
host astrocytes	51426
other endogenous non-neuronal cells -LSB- 57 -RSB-	51446
other endogenous non-neuronal cells	51446
57 -RSB-	51483
The observed difference	51488
the amount of intact tissue between the OEG and SCs transplanted groups	51515
the amount	51515
intact tissue between the OEG and SCs transplanted groups	51529
tissue between the OEG and SCs	51536
tissue	51536
the OEG and SCs	51551
the OEG	51551
SCs	51563
chemotropic effects	51597
the OEG -LSB- 58 -RSB- ,	51620
the OEG	51620
58 -RSB-	51629
the chemotropic effects	51645
glia	51680
development -LSB- 59	51692
development	51692
59	51705
increased infiltration of various cells into the lesion site	51724
increased infiltration	51724
various cells into the lesion site	51750
various cells	51750
the lesion site	51769
OEG	51786
a different inflammatory response	51821
the secretion	51858
chemokines	51875
CX3CL1	51894
60 -RSB-	51902
a known ligand	51916
the receptor CX3CR1 found on microglia and dendritic cells -LSB- 60,61 -RSB-	51935
the receptor CX3CR1	51935
microglia and dendritic cells	51964
microglia	51964
dendritic cells	51978
60,61 -RSB-	51995
the amount of tissue preservation/removal	52014
the amount	52014
tissue preservation/removal	52028
OEG	52057
death and subsequent phagocytosis	52100
death	52100
subsequent phagocytosis	52110
macrophages than SCs	52137
macrophages	52137
SCs	52154
OEG	52159
different factors	52184
unique antigenic profiles	52211
the ones	52248
them	52284
immune attack -LSB- 62 -RSB-	52309
immune attack	52309
62 -RSB-	52324
OEG and SCs transplants	52329
the properties	52358
proliferation or differentiation	52395
spinal cord progenitor cells/stem cells -LSB- 52,63 -RSB-	52431
spinal cord progenitor cells/stem cells	52431
52,63 -RSB-	52472
Glial transplants	52480
these stem cells , like fibroblasts -LSB- 64 -RSB- ,	52534
these stem cells	52534
fibroblasts -LSB- 64 -RSB-	52557
fibroblasts	52557
64 -RSB-	52570
neurons or myelinating glia	52580
neurons	52580
myelinating glia	52591
64-67 -RSB-	52609
our study	52620
we	52630
the direct OEG or SCs myelination potential or host myelination	52649
the direct OEG	52649
SCs myelination potential or host myelination	52667
SCs	52667
myelination potential or host myelination	52671
the lesion site	52720
Both cell types	52737
the capacity	52758
their effectiveness and mechanisms involved -LSB- 75 , Plant et al. ,	52798
their effectiveness and mechanisms	52798
75 , Plant et al. ,	52843
75	52843
Plant et al.	52847
Plant	52847
et al.	52853
unpublished observations	52862
The proliferation of endogenous cells	52889
The proliferation	52889
endogenous cells	52910
SCI -LSB- 45 -RSB-	52941
SCI -LSB-	52941
These cells	52951
progenitor cells	52975
endothelial	52993
pericytes stimulated by factors such as epidermal growth factor	53009
pericytes	53009
factors such as epidermal growth factor	53033
factors	53033
epidermal growth factor	53049
fibroblast growth factor-2	53080
68-70 -RSB-	53108
Proliferation	53116
OEG and SCs	53169
similar levels of FGF-2	53202
similar levels	53202
FGF-2	53220
71 -RSB-	53227
Two recent findings	53232
new cells	53267
a role in SCI	53282
a role	53282
SCI	53292
New evidence from Goritz and colleagues -LSB- 72 -RSB-	53297
New evidence from Goritz	53297
New evidence	53297
Goritz	53315
colleagues -LSB- 72 -RSB-	53326
colleagues	53326
72 -RSB-	53338
pericytes	53361
a role	53376
the spinal cord injury response	53386
these cells	53427
sites of injury	53459
sites	53459
injury	53468
OEG and SCs in our model	53476
OEG and SCs	53476
our model	53491
the number of these cells in the lesion site	53528
the number	53528
these cells in the lesion site	53542
these cells	53542
the lesion site	53557
a reparative outcome	53589
addition	53614
evidence by Decimo and colleagues -LSB- 73 -RSB-	53624
evidence by Decimo	53624
evidence	53624
Decimo	53636
colleagues -LSB- 73 -RSB-	53647
colleagues	53647
73 -RSB-	53659
new adult stem cell	53669
precursor cells	53690
the meninges	53727
SCI	53749
the injury site	53766
a target	53798
glial cell differentiation or activation	53811
glial cell differentiation	53811
activation	53841
this study	53856
we	53867
evidence	53878
following spinal cord contusion injury	53892
endogenous repair processes	53932
SCs migration	53970
Proliferation	53998
ependymal cells	54015
the walls of the central canal	54034
the walls	54034
the central canal	54047
adjacent intact parts of spinal cord -LSB- 45,52,65,74,75 -RSB-	54074
adjacent intact parts	54074
spinal cord -LSB- 45,52,65,74,75 -RSB-	54099
spinal cord	54099
45,52,65,74,75 -RSB-	54112
one route	54131
Ependymal cells	54142
the lesion site	54192
new blood vessels , astrocytes and fibroblasts	54219
This	54266
the cellular trabeculae and scar tissue	54307
our lesion cysts	54359
45,75,76 -RSB-	54377
Host SCs from the dorsal roots or blood vessels	54388
Host SCs	54388
the dorsal roots or blood vessels	54402
the lesion site	54453
our model	54472
large numbers of p75-positive	54492
large numbers	54492
p75-positive	54509
DSRED-2 negative cells	54523
all groups , as has previously been observed in the rat -LSB- 14,45,55,77,78	54549
all groups	54549
the rat -LSB- 14,45,55,77,78	54596
the rat	54596
14,45,55,77,78	54605
human -LSB- 79 -RSB- with the majority from the dorsal roots -LSB- 32 -RSB-	54625
human -LSB- 79 -RSB-	54625
the majority	54641
the dorsal roots	54659
32 -RSB-	54677
a previous study from our laboratory -LSB- 57 -RSB-	54685
a previous study	54685
our laboratory -LSB- 57 -RSB-	54707
our laboratory	54707
57 -RSB-	54723
we	54728
molecules -LRB- including neurotrophins -RRB-	54746
molecules	54746
neurotrophins	54767
Schwann cells promote the reactivity of astrocytes	54794
Schwann cells	54794
the reactivity of astrocytes	54816
the reactivity	54816
astrocytes	54834
SCs	54859
astrocytes	54873
CS56 staining	54929
This	54944
a dense glial scar	54955
the lesion	54981
the entry of axons	55005
the entry	55005
axons	55018
other host non-neuronal cells -LSB- 57 -RSB-	55032
other host non-neuronal cells	55032
57 -RSB-	55063
this study	55071
we	55082
sub-acute 14 day glial transplants	55100
OEG	55136
significantly lower CS56 expression and slightly higher collagen	55161
significantly lower CS56 expression	55161
slightly higher collagen	55201
IV expression in the lesion and graft site compared to SCs	55226
IV expression	55226
the lesion and graft site compared to SCs	55243
the lesion and graft site	55243
SCs	55281
OEG	55292
astrocytes	55331
-LSB- 49,80 -RSB-	55351
their release of extracellular matrix and cell adhesion molecules	55360
their release	55360
extracellular matrix and cell adhesion molecules	55377
their modulation of these factors	55430
their modulation	55430
these factors	55450
the observed axonal infiltration into the glial scar -LSB- 81 -RSB-	55485
the observed axonal infiltration	55485
the glial scar -LSB- 81 -RSB-	55523
the glial scar	55523
81 -RSB-	55539
Molecules such as Fibulin-3 and its ability to bind TIMP-3	55544
Molecules	55544
Fibulin-3 and its ability to bind TIMP-3	55562
Fibulin-3	55562
its ability to bind TIMP-3	55576
TIMP-3	55596
a part in the different interaction	55617
a part	55617
the different interaction	55627
host glia -LSB- 26 -RSB-	55658
host glia	55658
26 -RSB-	55669
OEG isolated from the olfactory bulb	55674
OEG	55674
the olfactory bulb	55692
high levels of this protein when	55716
high levels	55716
this protein when	55731
this protein	55731
SCs -LSB- 26 -RSB-	55761
SCs	55761
26 -RSB-	55766
One recent report	55771
an important role of MMP 's	55808
an important role	55808
MMP 's	55829
cell migration and modulation of the ECM -LSB- 82 -RSB-	55838
cell migration and modulation	55838
the ECM -LSB- 82 -RSB-	55871
both OEG and SCs	55891
both OEG	55891
SCs	55904
a greater quantity of extracellular matrix molecules in the lesion site	55939
a greater quantity	55939
extracellular matrix molecules in the lesion site	55961
extracellular matrix molecules	55961
the lesion site	55995
the effect of medium injection	56023
the effect	56023
medium injection	56037
their profiles	56061
The laminin	56086
a complementary and nonoverlapping pattern to DSRED-2 labeled SCs and OEG	56113
a complementary and nonoverlapping pattern	56113
DSRED-2 labeled SCs and OEG	56159
DSRED-2	56159
SCs and OEG	56175
SCs	56188
basement membrane	56212
OEG	56237
these molecules	56266
the quantity seen in SCs grafted animals	56293
the quantity	56293
SCs grafted animals	56314
SCs	56314
animals	56326
they	56343
other cells	56365
extracellular matrix such as astrocytes or endothelial cells	56388
extracellular matrix	56388
astrocytes or endothelial cells	56417
astrocytes	56417
endothelial cells	56431
This	56450
the role	56479
the OEG play	56488
the olfactory system	56504
OEG form channels	56532
axonal degeneration in the olfactory bulb for axons	56580
axonal degeneration	56580
the olfactory bulb for axons	56603
the olfactory bulb	56603
axons	56626
areas of the olfactory bulb	56669
areas	56669
the olfactory bulb	56678
83,84 -RSB-	56698
One mechanism for OEG reparative outcomes in the CNS	56706
One mechanism	56706
OEG reparative outcomes in the CNS	56724
OEG reparative outcomes	56724
the CNS	56751
their close	56762
fibroblasts/meningeal cells	56794
48,81 -RSB- and ability	56827
48,81 -RSB-	56827
ability	56838
these cells -LSB- 9,85 -RSB-	56863
these cells	56863
9,85 -RSB-	56876
OEGs	56883
a very close relationship with fibroblasts in the olfactory system	56893
a very close relationship	56893
fibroblasts in the olfactory system	56924
fibroblasts	56924
the olfactory system	56939
SCs in the peripheral nerve	56967
SCs	56967
the peripheral nerve	56974
their role	57000
SCs	57033
myelinate axons	57056
fibroblasts and their associated matrix -LSB- 86 -RSB-	57075
fibroblasts	57075
their associated matrix -LSB- 86 -RSB-	57091
their associated matrix	57091
86 -RSB-	57116
OEG	57129
an axonal replacement/regenerating system	57145
myelination -LSB- 87 -RSB-	57195
myelination -LSB-	57195
addition	57216
they	57225
a role in fascicle-forming arrangements	57262
a role	57262
fascicle-forming arrangements	57272
fibroblasts -LSB- 88-90 -RSB-	57310
fibroblasts	57310
88-90 -RSB-	57323
Olfactory glia and Schwann cells	57331
regeneration	57389
sub	57405
treated SCI	57415
Our results	57427
transplantation of OEG or SCs	57449
transplantation	57449
OEG or SCs	57468
2 weeks	57482
contusion	57496
significant axonal sparing	57518
regeneration	57546
those	57573
transplants carried out 7 days after a contusion injury -LSB- 33 -RSB-	57587
transplants	57587
7 days	57611
a contusion injury -LSB- 33 -RSB-	57624
a contusion injury	57624
33 -RSB-	57644
Significant increases in regenerated propriospinal fibers	57649
Significant increases	57649
regenerated propriospinal fibers	57674
graft groups	57733
numbers in SCs treated animals	57751
numbers	57751
SCs treated animals	57762
SCs	57762
animals	57774
OEG transplantation	57819
This	57840
a more potent , local secretion of factors	57855
a more potent , local secretion	57855
factors	57889
SCs compared to OEG	57900
SCs	57900
OEG	57916
no study	57932
these differences	57966
this study	57988
an OEG or SCs transplantation following a contusion injury	58000
an OEG or SCs transplantation	58000
a contusion injury	58040
an increased amount of intact tissue at the lesion site	58079
an increased amount	58079
intact tissue at the lesion site	58102
intact tissue	58102
the lesion site	58119
Immunohistochemistry for neurofilament-positive axons	58136
Immunohistochemistry	58136
neurofilament-positive axons	58161
strongly immunoreactive profiles	58197
the lesion site	58233
both OEG and SCs	58253
both OEG	58253
SCs	58266
transplanted groups after a 14 day delay of transplantation	58270
transplanted groups	58270
a 14 day delay of transplantation	58296
a 14 day delay	58296
transplantation	58314
Neurofilament positive axons in the SCs group	58331
Neurofilament positive axons	58331
the SCs group	58363
those seen in the OEG group	58411
those	58411
the OEG group	58425
This	58440
the interaction with host astrocytes	58467
the interaction	58467
host astrocytes	58488
the even distribution of the cells	58521
the even distribution	58521
the cells	58546
the formation of a clear cellular boundary -LSB- 91 -RSB-	58560
the formation	58560
a clear cellular boundary -LSB- 91 -RSB-	58577
a clear cellular boundary	58577
91 -RSB-	58604
Retrograde tracing using Fluorogold	58609
Retrograde	58609
Fluorogold	58634
statistically significant increased numbers for supraspinal tracts	58654
statistically significant increased numbers	58654
supraspinal tracts	58702
OEG or SCs transplantation	58727
OEG	58727
SCs transplantation	58734
Supraspinal spinal tracts such as reticular , vestibular and hypothalamic	58755
Supraspinal spinal tracts	58755
reticular , vestibular and hypothalamic	58789
reticular	58789
transplant groups	58867
It	58886
these supraspinal fibers	58910
8 mm	58954
the injury site	58969
so possible differences	58990
fiber numbers between the transplanted cell groups at the lesion site	59017
fiber numbers	59017
the transplanted cell groups at the lesion site	59039
the transplanted cell groups	59039
the lesion site	59071
itself	59087
the other spinal tracts	59123
the raphe tract	59148
a far more robust fashion in the OEG group	59177
a far more robust fashion	59177
the OEG group	59206
This	59221
increased responsiveness	59237
BDNF from the OEG directly	59265
BDNF	59265
the OEG directly	59275
the OEG	59275
the interaction	59298
activated microglia	59319
BDNF	59366
ATP activation	59377
the P2X4 receptor -LSB- 92 -RSB-	59400
the P2X4 receptor	59400
92 -RSB-	59419
OEG	59424
SCs in their levels of fractalkine secretion	59438
SCs	59438
their levels of fractalkine secretion	59445
their levels	59445
fractalkine secretion	59461
this	59488
microglia	59506
different neurotrophic profiles	59550
that initiated by SCs that do not secrete this protein at the same level	59585
that	59585
SCs that do not secrete this protein at the same level	59603
SCs	59603
this protein	59627
the same level	59643
An important consideration	59659
the time of cell delivery	59718
the time	59718
cell delivery	59730
the stage	59748
cellular differentiation of transplanted glia after a period of time in vivo	59761
cellular differentiation	59761
transplanted glia after a period of time in vivo	59789
transplanted glia	59789
a period of time in vivo	59813
a period	59813
time in vivo	59825
time	59825
vivo	59833
SCs	59839
myelin	59867
cells	59882
their regenerative/autocrine secretory products	59916
93-95	59965
OEG stay	59980
an undifferentiated -LSB- p75-positive -RRB- non-myelin	59992
state for a longer periods -LRB- Plant -- unpublished observations -RRB-	60046
state	60046
a longer periods -LRB- Plant -- unpublished observations -RRB-	60056
a longer periods	60056
Plant -- unpublished observations	60074
Plant	60074
unpublished observations	60082
all -LSB- 33 -RSB-	60132
Functional recovery	60142
sub acute transplantation	60180
OEG and SCs	60209
Significant behavioral differences	60221
the control injury	60278
medium injected rats	60301
both OEG and SCs grafted groups	60327
both OEG and SCs	60327
groups	60352
Improvements	60360
studies similar to that undertaken here	60405
studies	60405
that undertaken here	60424
that	60424
compensatory effects	60462
reflex-based segmental cord systems -LSB- 96 -RSB-	60500
reflex-based segmental cord systems	60500
96 -RSB-	60537
OEG transplantation into a completely transected spinal cord	60542
OEG transplantation	60542
a completely transected spinal cord	60567
improved hindlimb function -LSB- 9,10,97	60616
improved hindlimb function	60616
9,10,97	60644
One possibility that could increase locomotion	60667
locomotion	60703
increased noradrenergic and serotonergic varicosities	60717
the motor associated cholinergic neurons -LSB- 98 -RSB-	60780
the motor	60780
cholinergic neurons -LSB- 98 -RSB-	60801
cholinergic neurons	60801
98 -RSB-	60822
OEG treated rats	60827
OEG	60827
rats	60839
significant numbers	60851
raphe projecting axons reaching at least 8 mm distal from the injury site	60874
raphe	60874
axons	60891
at least 8 mm distal from the injury site	60906
at least 8 mm	60906
the injury site	60932
these	60952
such a behavioral response	60974
This	61002
the SCs	61032
rats which may use an alternate but effective pathway of locomotion	61048
rats	61048
an alternate but effective pathway of locomotion	61067
an alternate but effective pathway	61067
locomotion	61105
SCs	61117
recovery	61129
a graft relay system	61170
regeneration of propriospinal axons regeneration	61209
regeneration	61209
propriospinal axons regeneration	61225
our results	61269
Only small numbers of spared fibers -LRB- < 5 % -RRB-	61287
Only small numbers	61287
spared fibers -LRB- < 5 % -RRB-	61309
spared fibers	61309
< 5 %	61324
<	61324
5 %	61325
compensatory return of function via segmental circuits -LSB- 99 -RSB-	61356
compensatory return	61356
function via segmental circuits -LSB- 99 -RSB-	61379
function	61379
segmental circuits -LSB- 99 -RSB-	61392
segmental circuits	61392
99 -RSB-	61412
Phasic behavioral recovery in the SCs group	61417
Phasic behavioral recovery	61417
the SCs group	61447
particular 49 days	61465
the end of the experiment	61490
the end	61490
the experiment	61501
phasic secretion	61531
neurotrophins	61551
the same level via the transplantation of OEG	61595
the same level	61595
the transplantation of OEG	61614
the transplantation	61614
OEG	61637
Conclusions Glial cells transplanted at 14 days post injury	61642
Conclusions Glial cells	61642
Conclusions	61642
Glial cells	61654
14 days post injury	61682
14 days	61682
a less accommodating lesion site	61717
1 week	61768
injury	61781
a reduced glial survival	61807
particular for OEG than seen in earlier transplant studies	61835
particular	61835
OEG than seen in earlier transplant studies	61850
OEG	61850
earlier transplant studies	61867
14 days post SCI	61898
14 days	61898
proteoglycan deposition at the lesion site	61915
proteoglycan deposition	61915
the lesion site	61942
-LSB- 100,101	61991
the OEG transplanted groups	62032
a positive milieu	62070
the sparing/regeneration	62092
supraspinal axons -LRB- serotonergic positive fibers -RRB-	62120
supraspinal axons	62120
serotonergic positive fibers	62139
This evidence	62170
our use	62206
fluorogold	62217
immunohistochemistry for 5-HT	62262
immunohistochemistry	62262
5-HT	62287
98 -RSB- -LRB- which labels serotonergic axons innervating the spinal cord -RRB-	62293
98 -RSB-	62293
serotonergic axons innervating the spinal cord	62311
serotonergic axons	62311
the spinal cord	62342
Supplementation of glial transplants with neurotrophins	62360
Supplementation	62360
glial transplants with neurotrophins	62379
glial transplants	62379
neurotrophins	62402
cell survivability	62428
13 -RSB-	62448
combination	62459
removal of the glial scar by the use of chondroitinase	62476
removal	62476
the glial scar by the use of chondroitinase	62487
the glial scar	62487
the use of chondroitinase	62505
the use	62505
chondroitinase	62516
axonal regeneration	62557
this 14 day delayed glial transplant model -LSB- 102,103 -RSB-	62580
this 14 day	62580
glial transplant model -LSB- 102,103 -RSB-	62600
glial transplant model	62600
102,103 -RSB-	62624
the delay between injury and treatment	62642
the delay	62642
injury and treatment	62660
a strong bearing	62690
the experimental outcome but also the success of the glial type	62710
the experimental outcome	62710
the success of the glial type	62744
the success	62744
the glial type	62759
tissue and behavioral outcomes	62785
the lesion site	62824
sparing/regeneration of axonal populations	62852
sparing/regeneration	62852
axonal populations	62876
the present study	62915
it	62933
a 14 day delay in glial transplantation	62954
a 14 day delay	62954
glial transplantation	62972
a contusive spinal cord injury	63062
the mechanisms of repair of the two glial types	63097
the mechanisms	63097
repair of the two glial types	63115
repair	63115
the two glial types	63125
We	63160
two time points -LRB- 2 weeks and 4 months -RRB-	63177
two time points	63177
2 weeks and 4 months	63194
2 weeks	63194
4 months	63206
multiple behavioral and anatomical analysis	63222
an indication of efficacy	63293
an indication	63293
efficacy	63310
Further physiological , behavioral and anatomical correlative studies	63320
these glial cells at 14 days post injury time point	63395
glial cells at 14 days	63401
glial cells	63401
14 days	63416
valuable evidence of cell potential and reproducibility	63461
valuable evidence	63461
cell potential and reproducibility	63482
future CNS repair applications	63521
Additional file Additional file 1 : Table S1 .	63554
Additional file Additional file 1	63554
Additional file Additional file	63554
1	63586
Table S1	63589
Table	63589
S1	63595
DSRED-2 Fluorescence	63599
OEG Transplanted and SC Transplanted groups	63630
Abbreviations OEG	63675
Abbreviations	63675
OEG	63689
Olfactory ensheathing glia ; SCs	63694
Olfactory ensheathing glia	63694
SCs	63722
Schwann cells ; BBB	63727
Schwann cells	63727
BBB	63742
Basso , Beattie and Bresnahan ; ANOVA	63747
Basso , Beattie and Bresnahan	63747
ANOVA	63777
One way analysis	63784
variance	63804
SCI	63814
Spinal cord injury	63819
GFP	63839
Green fluorescent protein	63844
GFAP	63871
Glial fibrillary acidic protein	63877
BDNF	63910
Brain	63916
neurotrophic factor	63930
NGF : Nerve growth factor	63951
NGF	63951
Nerve growth factor	63956
GDNF	63977
Glial	63983
neurotrophic factor ; NT4/5 : Neurotrophin 4/5	63997
neurotrophic factor	63997
NT4/5 : Neurotrophin 4/5	64018
NT4/5	64018
Neurotrophin 4/5	64025
DMEM	64043
Dulbecco 's	64049
eagle 's medium	64069
eagle 's	64069
NYU : New York University	64085
NYU	64085
New York University	64090
Competing interests	64111
The authors	64131
they	64156
no competing interests	64166
Authors ' contributions HB	64190
Authors '	64190
the acquisition of data , analysis and interpretation	64231
the acquisition	64231
data , analysis and interpretation	64250
CDP	64285
the analysis of data	64304
the analysis	64304
data	64320
manuscript	64338
intellectual content	64366
ARH	64388
the analysis of data	64407
the analysis	64407
data	64423
manuscript and intellectual content	64441
manuscript	64441
intellectual content	64456
GWP	64478
the study and design , acquisition of data , analysis	64495
the study and design	64495
acquisition of data , analysis	64517
acquisition	64517
data , analysis	64532
data	64532
analysis	64538
the manuscript	64559
All authors	64575
the manuscript	64610
Acknowledgements	64626
We	64643
Seok Voon Lee	64672
technical contributions	64690
We	64715
William Hendriks and Joost Verhaagen	64734
their help with lentiviral vector design and production	64775
their help	64775
lentiviral vector design and production	64791
GWP 's laboratory	64832
GWP 's	64832
the National Health and Medical Research Council -LRB- RD Wright Fellowship N °	64866
the National Health	64866
Medical Research Council -LRB- RD Wright Fellowship N °	64890
303265 -RRB-	64941
Eileen Bond	64950
Australian Rotary Health Research Fund	64963
Australian	64963
Rotary Health Research Fund	64974
Spinal Cure Australia	65003
Spinal Cure	65003
Australia	65015
Stanford University	65026
James Doty Neurosurgery Fund , and Hearst Neuroscience Fund	65047
James Doty Neurosurgery Fund	65047
Hearst Neuroscience Fund	65081
Author details 1Department	65107
Neurosurgery	65137
Stanford Partnership for Spinal Cord Injury and Repair	65151
Stanford Partnership	65151
Spinal Cord Injury and Repair	65176
Spinal Cord Injury	65176
Repair	65199
Stanford University	65207
Lorry I Lokey Stem Cell Research Building	65228
Lorry I Lokey Stem	65228
Cell Research Building	65247
265 Campus Drive	65271
Stanford	65289
CA 94305	65299
USA	65309
2Eileen Bond	65314
Spinal Research Center , University of Western Australia , Perth , Australia	65327
Spinal Research Center , University	65327
Western Australia , Perth , Australia	65365
Western Australia	65365
Perth , Australia	65384
3School	65402
Anatomy Physiology and Human Biology	65413
Anatomy Physiology	65413
Human Biology	65436
University of Western Australia	65451
University	65451
Western Australia	65465
Perth	65484
Australia	65491
19 February 2013 Accepted : 18 September 2013 Published	65512
19 February 2013 Accepted : 18 September 2013	65512
19 February 2013 Accepted	65512
19 February 2013	65512
Accepted	65529
18 September 2013	65539
18	65539
September 2013	65542
27 September 2013 References 1	65568
27 September 2013 References	65568
1	65597
Doucette R : PNS-CNS transitional zone of the first cranial nerve .	65600
Doucette R	65600
PNS-CNS transitional zone of the first cranial nerve	65612
PNS-CNS transitional zone	65612
the first cranial nerve	65641
J Comp Neurol 1991 , 312 -LRB- 3 -RRB-	65666
J Comp	65666
Neurol 1991 , 312 -LRB- 3 -RRB-	65673
Neurol 1991 , 312	65673
3	65690
451 -- 466	65693
451	65693
466	65697
Ramer LM , Richter MW , Roskams AJ , Tetzlaff W , Ramer MS	65705
Ramer LM	65705
Richter MW	65715
Roskams AJ	65727
Tetzlaff W	65739
Ramer MS	65751
Peripherallyderived olfactory ensheathing cells	65761
primary afferent regeneration following dorsal root injury	65824
primary afferent regeneration	65824
dorsal root injury	65864
Glia 2004 , 47 -LRB- 2 -RRB- : 189 -- 206 .	65884
Glia 2004 , 47 -LRB- 2 -RRB-	65884
Glia 2004	65884
47 -LRB- 2 -RRB-	65895
47	65895
2	65898
189 -- 206	65901
Richter MW , Roskams AJ	65913
Richter MW	65913
Roskams AJ	65925
Olfactory ensheathing cell transplantation	65937
spinal cord injury : Hype or hope	65990
spinal cord injury	65990
Hype or hope	66010
Hype	66010
Exp Neurol 2008 , 209 -LRB- 2 -RRB- : 353 -- 367 .	66024
Exp Neurol 2008 , 209 -LRB- 2 -RRB-	66024
Exp Neurol 2008 , 209	66024
2	66045
353 -- 367	66048
Ruitenberg MJ , Vukovic J , Sarich J , Busfield SJ , Plant GW	66060
Ruitenberg MJ	66060
Vukovic J	66075
Sarich J	66086
Busfield SJ	66096
Plant GW	66109
Olfactory ensheathing cells	66119
characteristics genetic engineering and therapeutic potential	66148
characteristics	66148
genetic engineering and therapeutic potential	66164
J Neurotrauma 2006 , 23 -LRB- 3 -- 4 -RRB- : 468 -- 478 .	66211
J Neurotrauma 2006 , 23 -LRB- 3 -- 4 -RRB-	66211
J Neurotrauma 2006 , 23	66211
3 -- 4	66234
3	66234
4	66236
468 -- 478	66239
5	66248
Graziadei PP , Monti Graziadei GA	66251
Graziadei PP	66251
Monti Graziadei GA	66265
Neurogenesis and neuron regeneration in the olfactory system of mammals III	66285
Neurogenesis	66285
neuron regeneration in the olfactory system of mammals III	66302
neuron regeneration in the olfactory system of mammals	66302
neuron regeneration	66302
the olfactory system of mammals	66325
the olfactory system	66325
mammals	66349
III	66357
Deafferentation and reinnervation	66362
the olfactory bulb following section of the fila olfactoria in rat	66399
the olfactory bulb	66399
section of the fila olfactoria in rat	66428
section	66428
the fila olfactoria in rat	66439
the fila olfactoria	66439
rat	66462
J Neurocytol 1980 , 9 -LRB- 2 -RRB- : 145 -- 162 .	66467
J Neurocytol 1980 , 9 -LRB- 2 -RRB-	66467
J Neurocytol 1980 , 9	66467
2	66488
145 -- 162	66491
6	66500
Monti Graziadei GA , Karlan MS , Bernstein JJ , Graziadei PP	66503
Monti Graziadei GA	66503
Karlan MS	66523
Bernstein JJ	66534
Graziadei PP	66548
Reinnervation	66562
the olfactory bulb	66579
section of the olfactory nerve in monkey -LRB- Saimiri sciureus -RRB-	66604
section	66604
the olfactory nerve in monkey -LRB- Saimiri sciureus -RRB-	66615
the olfactory nerve	66615
monkey -LRB- Saimiri sciureus -RRB-	66638
monkey	66638
Saimiri sciureus	66646
Brain Res 1980 , 189 -LRB- 2 -RRB-	66665
Brain	66665
Res 1980 , 189 -LRB- 2 -RRB-	66671
Res 1980 , 189	66671
2	66685
343 -- 354	66688
343	66688
354	66692
7	66697
Li Y	66700
Field PM	66706
Raisman G	66716
Repair	66727
adult rat corticospinal tract by transplants of olfactory ensheathing cells	66737
adult rat corticospinal tract	66737
transplants of olfactory ensheathing cells	66770
transplants	66770
olfactory ensheathing cells	66785
Science 1997 , 277 -LRB- 5334 -RRB- : 2000 -- 2002 .	66814
Science 1997 , 277 -LRB- 5334 -RRB-	66814
Science 1997 , 277	66814
5334	66832
2000 -- 2002	66838
8	66849
Plant GW	66852
Christensen CL	66862
Oudega M	66878
Bunge MB : Delayed transplantation of olfactory ensheathing glia	66888
Bunge MB	66888
Delayed transplantation of olfactory ensheathing glia	66898
Delayed transplantation	66898
olfactory ensheathing glia	66925
sparing/regeneration of supraspinal axons in the contused adult rat spinal cord	66961
sparing/regeneration	66961
supraspinal axons in the contused adult rat spinal cord	66985
supraspinal axons	66985
the contused adult rat spinal cord	67006
J Neurotrauma 2003 , 20 -LRB- 1 -RRB- : 1 -- 16 .	67042
J Neurotrauma 2003 , 20 -LRB- 1 -RRB-	67042
J Neurotrauma 2003 , 20	67042
1	67065
1 -- 16	67068
9	67074
Ramon-Cueto A , Plant GW , Avila J , Bunge MB	67077
Ramon-Cueto A	67077
Plant GW	67092
Avila J	67102
Bunge MB	67111
Long-distance axonal regeneration in the transected adult rat spinal cord	67121
Long-distance axonal regeneration	67121
the transected adult rat spinal cord	67158
olfactory ensheathing glia transplants	67210
J Neurosci 1998 , 18 -LRB- 10 -RRB- : 3803 -- 3815 .	67250
J Neurosci 1998 , 18 -LRB- 10 -RRB-	67250
J Neurosci 1998 , 18	67250
10	67270
3803 -- 3815	67274
10	67285
Ramon-Cueto A , Cordero MI , Santos-Benito FF , Avila J	67289
Ramon-Cueto A	67289
Cordero MI	67304
Santos-Benito FF	67316
Avila J	67334
Functional recovery of paraplegic rats	67343
Functional recovery	67343
paraplegic rats	67366
motor axon regeneration in their spinal cords by olfactory ensheathing glia	67386
motor axon regeneration	67386
their spinal cords by olfactory ensheathing glia	67413
their spinal cords	67413
olfactory ensheathing glia	67435
Neuron 2000 , 25 -LRB- 2 -RRB- : 425 -- 435 .	67463
Neuron 2000 , 25 -LRB- 2 -RRB-	67463
Neuron 2000	67463
25 -LRB- 2 -RRB-	67476
25	67476
2	67479
425 -- 435	67482
11	67491
Ruitenberg MJ , Levison DB , Lee SV , Verhaagen J , Harvey AR , Plant GW	67495
Ruitenberg MJ	67495
Levison DB	67510
Lee SV	67522
Verhaagen J	67530
Harvey AR	67543
Plant GW	67554
NT-3 expression from engineered olfactory ensheathing glia	67564
NT-3 expression	67564
engineered olfactory ensheathing glia	67585
spinal sparing and regeneration	67632
Brain 2005 , 128 -LRB- Pt 4 -RRB- : 839 -- 853 .	67665
Brain 2005 , 128 -LRB- Pt 4 -RRB-	67665
Brain 2005	67665
128 -LRB- Pt 4 -RRB-	67677
128	67677
Pt 4	67681
839 -- 853	67687
12	67696
Ruitenberg MJ	67700
Plant GW	67715
Christensen CL	67725
Blits B	67741
Niclou SP	67750
Harvey AR	67761
Boer GJ	67772
Verhaagen J	67781
Viral vector-mediated gene expression	67794
olfactory ensheathing glia implants in the lesioned rat spinal cord	67835
olfactory ensheathing glia implants	67835
the lesioned rat spinal cord	67874
Gene Ther 2002 , 9 -LRB- 2 -RRB- : 135 -- 146 .	67904
Gene Ther 2002 , 9 -LRB- 2 -RRB-	67904
Gene Ther 2002 , 9	67904
2	67922
135 -- 146	67925
13	67934
Ruitenberg MJ	67938
Plant GW	67953
Hamers FP	67963
Wortel J	67974
Blits B	67984
Dijkhuizen PA	67993
Gispen WH	68008
Boer GJ	68019
Verhaagen J	68028
Ex vivo	68041
adenoviral vector-mediated neurotrophin gene transfer	68049
olfactory ensheathing glia	68106
effects	68134
rubrospinal tract regeneration lesion size and functional recovery	68145
implantation in the injured rat spinal cord	68218
implantation	68218
the injured rat spinal cord	68234
J Neurosci 2003 , 23 -LRB- 18 -RRB- : 7045 -- 7058 .	68263
J Neurosci 2003 , 23 -LRB- 18 -RRB-	68263
J Neurosci 2003 , 23	68263
18	68283
7045 -- 7058	68287
14	68298
Takami T , Oudega M , Bates ML , Wood PM , Kleitman N , Bunge MB : Schwann cell	68302
Takami T	68302
Oudega M	68312
Bates ML	68322
Wood PM	68332
Kleitman N	68341
Bunge MB : Schwann cell	68353
Bunge MB	68353
Schwann cell	68363
olfactory ensheathing glia transplants	68384
hindlimb locomotor performance	68431
the moderately contused adult rat thoracic spinal cord	68465
adult rat	68489
J Neurosci 2002 , 22 -LRB- 15 -RRB- : 6670 -- 6681 .	68521
J Neurosci 2002 , 22 -LRB- 15 -RRB-	68521
J Neurosci 2002 , 22	68521
15	68541
6670 -- 6681	68545
15	68556
Guest JD , Rao A , Olson L , Bunge MB , Bunge RP	68560
Guest JD	68560
Rao A	68570
Olson L	68577
Bunge MB	68586
Bunge RP	68596
The ability	68606
human Schwann cell grafts	68621
regeneration	68658
the transected nude rat spinal cord	68674
Exp Neurol 1997 , 148 -LRB- 2 -RRB- : 502 -- 522 .	68711
Exp Neurol 1997 , 148 -LRB- 2 -RRB-	68711
Exp Neurol 1997 , 148	68711
2	68732
502 -- 522	68735
16	68744
Imaizumi T , Lankford KL , Burton WV , Fodor WL , Kocsis JD	68748
Imaizumi T	68748
Lankford KL	68760
Burton WV	68773
Fodor WL	68784
Kocsis JD	68794
Xenotransplantation of transgenic pig olfactory ensheathing cells	68805
Xenotransplantation	68805
transgenic pig olfactory ensheathing cells	68828
axonal regeneration in rat spinal cord	68880
axonal regeneration	68880
rat spinal cord	68903
Nature Biotech 2000 , 18 -LRB- 9 -RRB- : 949 -- 953 .	68920
Nature Biotech 2000 , 18 -LRB- 9 -RRB-	68920
Nature Biotech 2000 , 18	68920
9	68944
949 -- 953	68947
17	68956
Xu XM , Chen A , Guenard V , Kleitman N , Bunge MB	68960
Xu XM	68960
Chen A	68967
Guenard V	68975
Kleitman N	68986
Bunge MB	68998
Bridging Schwann cell transplants	69008
axonal regeneration	69050
both the rostral and caudal stumps	69075
the rostral	69080
caudal stumps	69096
transected adult rat spinal cord	69113
J Neurocytol 1997 , 26 -LRB- 1 -RRB- : 1 -- 16 .	69147
J Neurocytol 1997 , 26 -LRB- 1 -RRB-	69147
J Neurocytol 1997 , 26	69147
1	69169
1 -- 16	69172
18	69178
Xu XM , Guenard V , Kleitman N , Bunge MB	69182
Xu XM	69182
Guenard V	69189
Kleitman N	69200
Bunge MB	69212
Axonal regeneration	69222
Schwann cell-seeded guidance channels	69247
transected adult rat spinal cord	69298
J Comp Neurol 1995 , 351 -LRB- 1 -RRB-	69332
J Comp	69332
Neurol 1995 , 351 -LRB- 1 -RRB-	69339
Neurol 1995 , 351	69339
1	69356
145 -- 160	69359
145	69359
160	69363
19	69368
Morrissey TK , Kleitman N , Bunge RP	69372
Morrissey TK	69372
Kleitman N	69386
Bunge RP	69398
Isolation and functional characterization	69408
Schwann cells derived from adult peripheral nerve	69453
Schwann cells	69453
adult peripheral nerve	69480
J Neurosci 1991 , 11 -LRB- 8 -RRB- : 2433 -- 2442 .	69504
J Neurosci 1991 , 11 -LRB- 8 -RRB-	69504
J Neurosci 1991 , 11	69504
8	69524
2433 -- 2442	69527
20	69538
Pearse DD , Barakat DJ : Cellular repair strategies for spinal cord injury .	69542
Pearse DD , Barakat DJ	69542
Pearse DD	69542
Barakat DJ	69553
Cellular repair strategies for spinal cord injury	69565
Cellular repair strategies	69565
spinal cord injury	69596
Expert Op Biol Ther 2006 , 6 -LRB- 7 -RRB-	69616
Expert Op	69616
Biol Ther 2006 , 6 -LRB- 7 -RRB-	69626
Biol Ther 2006 , 6	69626
7	69644
639 -- 652	69647
639	69647
652	69651
21	69656
Pearse DD	69660
Sanchez AR	69671
Pereira FC	69683
Andrade CM	69695
Puzis R	69707
Pressman Y	69716
Golden K	69728
Kitay BM	69738
Blits B	69748
Wood PM	69757
Bunge MB	69766
Transplantation of Schwann cells	69776
Transplantation	69776
Schwann cells	69795
olfactory ensheathing glia	69816
spinal cord : Survival migration axon association	69861
spinal cord	69861
Survival migration axon association	69874
Glia 2007 , 55 -LRB- 9 -RRB- : 976 -- 1000 .	69935
Glia 2007 , 55 -LRB- 9 -RRB-	69935
Glia 2007	69935
55 -LRB- 9 -RRB-	69946
55	69946
9	69949
976 -- 1000	69952
22	69962
Plant GW Ramon-Cueto A , Bunge MB	69966
Plant GW Ramon-Cueto A	69966
Bunge MB	69990
Transplantation	70000
Schwann cell	70019
Schwann cells	70035
glia	70065
regeneration	70081
adult spinal cord	70097
Axonal Regeneration in the Central Nervous System	70119
Axonal Regeneration	70119
the Central Nervous System	70142
Ingoglia N , Murray M. New York and Basel	70180
Marcel Dekker Inc	70222
2001a	70241
529	70247
561	70251
23	70256
Harvey AR , Plant GW	70260
Harvey AR	70260
Plant GW	70271
Olfactory ensheathing glia and spinal cord injury	70281
Olfactory ensheathing glia	70281
spinal cord injury	70312
basic mechanisms to transplantation	70332
basic mechanisms	70332
transplantation	70352
Fut Neurol 2006 , 1 -LRB- 4 -RRB- : 453 -- 463 .	70369
Fut Neurol 2006 , 1 -LRB- 4 -RRB-	70369
Fut Neurol 2006 , 1	70369
4	70388
453 -- 463	70391
24	70400
van den	70404
Pol AN , Santarelli JG	70412
Pol AN	70412
Santarelli JG	70420
Olfactory ensheathing cells	70435
Olfactory ensheathing	70435
cells	70457
time lapse imaging of cellular interactions	70464
time lapse imaging	70464
cellular interactions	70486
axonal support rapid morphologic shifts and mitosis	70508
axonal support rapid morphologic shifts	70508
mitosis	70552
J Comp Neurol 2003 , 458 -LRB- 2 -RRB-	70561
J Comp	70561
Neurol 2003 , 458 -LRB- 2 -RRB-	70568
Neurol 2003 , 458	70568
2	70585
175 -- 194	70588
175	70588
194	70592
25	70597
Vincent AJ , West AK , Chuah MI	70601
Vincent AJ	70601
West AK	70613
Chuah MI	70622
Morphological plasticity of olfactory ensheathing cells	70632
Morphological plasticity	70632
olfactory ensheathing cells	70660
cAMP and endothelin-1	70704
Glia 2003 , 41 -LRB- 4 -RRB- : 393 -- 403 .	70727
Glia 2003 , 41 -LRB- 4 -RRB-	70727
Glia 2003	70727
41 -LRB- 4 -RRB-	70738
41	70738
4	70741
393 -- 403	70744
26	70753
Vukovic J	70757
Ruitenberg MJ	70768
Roet K	70783
Franssen E	70791
Arulpragasam A	70803
Sasaki T	70819
Verhaagen J	70829
Harvey AR	70842
Busfield SJ	70853
Plant GW	70866
The glycoprotein fibulin-3	70876
morphology and motility of olfactory ensheathing cells	70913
morphology and motility	70913
olfactory ensheathing cells	70940
Glia 2009 , 57 -LRB- 4 -RRB- : 424 -- 443 .	70978
Glia 2009 , 57 -LRB- 4 -RRB-	70978
Glia 2009	70978
57 -LRB- 4 -RRB-	70989
57	70989
4	70992
424 -- 443	70995
27	71004
Ramon-Cueto A	71008
Perez J	71023
Nieto-Sampedro M : In vitro enfolding of olfactory neurites by p75 NGF receptor	71032
Nieto-Sampedro M	71032
In vitro enfolding of olfactory neurites by p75 NGF receptor	71050
In vitro enfolding	71050
olfactory neurites by p75 NGF receptor	71072
olfactory neurites	71072
p75 NGF receptor	71094
positive ensheathing cells from adult rat olfactory bulb	71111
positive ensheathing cells	71111
adult rat olfactory bulb	71143
Eur J Neurosci 1993 , 5 -LRB- 9 -RRB-	71169
Eur J	71169
Neurosci 1993 , 5 -LRB- 9 -RRB-	71175
Neurosci 1993 , 5	71175
9	71192
1172 -- 1180	71195
1172	71195
1180	71200
28	71206
Lu J , Feron F , Ho SM , Mackay-Sim A , Waite PM	71210
Lu J	71210
Feron F	71216
Ho SM	71225
Mackay-Sim A	71232
Waite PM	71246
Transplantation of nasal olfactory tissue	71256
Transplantation	71256
nasal olfactory tissue	71275
partial recovery in paraplegic adult rats	71307
partial recovery	71307
paraplegic adult rats	71327
Brain Res 2001 , 889 -LRB- 1 -- 2 -RRB-	71350
Brain	71350
Res 2001 , 889 -LRB- 1 -- 2 -RRB-	71356
Res 2001 , 889	71356
1 -- 2	71370
1	71370
2	71372
344 -- 357	71375
344	71375
357	71379
29	71384
Lu P , Yang H , Culbertson M , Graham L , Roskams J , Tuszynski MH	71388
Lu P	71388
Yang H	71394
Culbertson M	71402
Graham L	71416
Roskams J	71426
Tuszynski MH	71437
Olfactory Ensheathing Cells	71451
Not Exhibit Unique Migratory	71482
Not Exhibit	71482
Axonal Growth - Promoting Properties after Spinal Cord Injury	71514
Axonal Growth	71514
Promoting Properties after Spinal Cord Injury	71529
Promoting Properties	71529
Spinal Cord Injury	71556
J Neurosci 2006 , 26:11120 -- 11130 .	71576
J Neurosci 2006 , 26:11120	71576
11130	71602
30	71609
Richter MW , Fletcher PA , Liu J , Tetzlaff W , Roskams AJ	71613
Richter MW	71613
Fletcher PA	71625
Liu J	71638
Tetzlaff W	71645
Roskams AJ	71657
Lamina propria and olfactory bulb ensheathing cells	71669
Lamina propria	71669
olfactory bulb ensheathing cells	71688
differential integration and migration	71729
differential axon sprouting in the lesioned spinal cord	71780
differential axon	71780
the lesioned spinal cord	71811
J Neurosci 2005 , 25 -LRB- 46 -RRB- : 10700 -- 10711 .	71837
J Neurosci 2005 , 25 -LRB- 46 -RRB-	71837
J Neurosci 2005 , 25	71837
46	71857
10700 -- 10711	71861
31	71874
Boyd JG , Lee J , Skihar V , Doucette R , Kawaja MD	71878
Boyd JG	71878
Lee J	71887
Skihar V	71894
Doucette R	71904
Kawaja MD	71916
LacZ-expressing olfactory ensheathing cells	71927
not associate with myelinated axons after implantation	71974
not associate	71974
myelinated axons after implantation	71993
myelinated axons	71993
implantation	72016
the compressed spinal cord	72034
Proc Natl Acad Sci U S A 2004 , 101 -LRB- 7 -RRB-	72062
Proc Natl Acad Sci U S	72062
A 2004 , 101 -LRB- 7 -RRB-	72085
A 2004 , 101	72085
7	72097
2162 -- 2166	72100
2162	72100
2166	72105
32	72111
Nagoshi N	72115
Shibata S	72126
Hamanoue M	72137
Mabuchi Y	72149
Matsuzaki Y	72160
Toyama Y	72173
Nakamura M	72183
Okano H	72195
Schwann cell plasticity	72204
spinal cord injury shown by neural crest lineage tracing	72234
spinal cord injury	72234
neural crest lineage tracing	72262
neural crest lineage	72262
Glia 2011 , 59 -LRB- 5 -RRB- : 771 -- 784 .	72292
Glia 2011 , 59 -LRB- 5 -RRB-	72292
Glia 2011	72292
59 -LRB- 5 -RRB-	72303
59	72303
5	72306
771 -- 784	72309
33	72318
Plant GW , Currier PF , Cuervo EP , Bates ML , Pressman Y , Bunge MB , Wood PM	72322
Plant GW	72322
Currier PF	72332
Cuervo EP	72344
Bates ML	72355
Pressman Y	72365
Bunge MB	72377
Wood PM	72387
adult ensheathing glia	72405
myelinate axons	72436
culture	72458
conditions that enable Schwann cells to form myelin	72466
Schwann cells	72489
J Neurosci 2002 , 22 -LRB- 14 -RRB- : 6083 -- 6091 .	72519
J Neurosci 2002 , 22 -LRB- 14 -RRB-	72519
J Neurosci 2002 , 22	72519
14	72539
6083 -- 6091	72543
34	72554
DiStefano PS , Johnson EM Jr	72558
DiStefano PS	72558
Johnson EM Jr	72572
Identification of a truncated form of the nerve growth factor receptor	72587
Identification	72587
a truncated form of the nerve growth factor receptor	72605
form of the nerve growth factor	72617
form	72617
the nerve growth factor	72625
Proc Natl Acad Sci U S A 1988 , 85 -LRB- 1 -RRB-	72659
Proc Natl Acad Sci U S	72659
A 1988 , 85 -LRB- 1 -RRB-	72682
A 1988 , 85	72682
1	72693
270 -- 274	72696
270	72696
274	72700
35	72705
Zupan AA , Johnson EM Jr	72709
Zupan AA	72709
Johnson EM Jr	72719
Evidence	72734
endocytosis-dependent proteolysis	72747
the generation	72784
soluble truncated nerve growth factor receptors by A875 human melanoma cells	72802
soluble	72802
nerve growth factor receptors	72820
A875 human melanoma cells	72853
J Biol Chem 1991 , 266 -LRB- 23 -RRB-	72880
J Biol	72880
Chem 1991 , 266 -LRB- 23 -RRB-	72887
Chem 1991 , 266	72887
23	72902
15384 -- 15390	72906
15384	72906
15390	72912
36	72919
Hu	72923
Y	72926
Leaver SG	72929
Plant GW	72940
Hendriks WT	72950
Niclou SP	72963
Verhaagen J	72974
Harvey AR	72987
Cui Q	72998
Lentiviral-mediated transfer	73005
CNTF	73037
schwann cells	73045
reconstructed peripheral nerve grafts	73066
adult retinal ganglion	73113
cell survival and axonal regeneration	73136
cell survival	73136
axonal regeneration	73154
Mol Ther 2005 , 11 -LRB- 6 -RRB- : 906 -- 915 .	73175
Mol Ther 2005 , 11 -LRB- 6 -RRB-	73175
Mol Ther 2005 , 11	73175
6	73193
906 -- 915	73196
37	73205
Leaver SG , Harvey AR , Plant GW	73209
Leaver SG	73209
Harvey AR	73220
Plant GW	73231
Adult olfactory ensheathing glia	73241
the long-distance growth of adult retinal ganglion cell neurites	73282
the long-distance growth	73282
adult retinal ganglion cell neurites	73310
Glia 2006 , 53 -LRB- 5 -RRB- : 467 -- 476 .	73357
Glia 2006 , 53 -LRB- 5 -RRB-	73357
Glia 2006	73357
53 -LRB- 5 -RRB-	73368
53	73368
5	73371
467 -- 476	73374
38	73383
Schwartz M , Yoles E	73387
Schwartz M	73387
Yoles E	73399
Immune-based therapy for spinal cord repair	73408
Immune-based therapy	73408
spinal cord repair	73433
autologous macrophages and beyond	73453
autologous macrophages	73453
beyond	73480
J Neurotrauma 2006 , 23 -LRB- 3 -- 4 -RRB- : 360 -- 370 .	73488
J Neurotrauma 2006 , 23	73488
3 -- 4	73511
3	73511
4	73513
360 -- 370	73516
360	73516
370	73520
39	73525
Cummings BJ	73529
Uchida N	73542
Tamaki SJ	73552
Salazar DL	73563
Hooshmand M	73575
Summers R	73588
Gage FH	73599
Anderson AJ	73608
Human neural stem cells	73621
locomotor recovery in spinal cord-injured mice	73671
locomotor recovery	73671
spinal cord-injured mice	73693
Proc Natl Acad Sci U S A 2005 , 102 -LRB- 39 -RRB-	73719
Proc Natl Acad Sci U S	73719
A 2005 , 102 -LRB- 39 -RRB-	73742
A 2005 , 102	73742
39	73754
14069 -- 14074	73758
14069	73758
14074	73764
40	73771
Iwanami A	73775
Kaneko S	73786
Nakamura M	73796
Kanemura Y	73808
Mori H	73820
Kobayashi S	73828
Yamasaki M	73841
Momoshima S	73853
Ishii H	73866
Ando K	73875
Tanioka Y	73883
Tamaoki N	73894
Nomura T	73905
Toyama Y	73915
Okano H	73925
Transplantation of human neural stem cells for spinal cord injury in primates	73934
Transplantation	73934
human neural stem cells for spinal cord injury in primates	73953
human neural stem cells	73953
spinal cord injury in primates	73981
spinal cord injury	73981
primates	74003
J Neurosci Res 2005 , 80 -LRB- 2 -RRB-	74013
J Neurosci	74013
Res 2005 , 80 -LRB- 2 -RRB-	74024
Res 2005 , 80	74024
2	74037
182 -- 190	74040
182	74040
190	74044
41	74049
Koshizuka	74053
S	74063
Okada S	74066
Okawa A	74075
Koda M	74084
Murasawa M	74092
Hashimoto M	74104
Kamada T	74117
Yoshinaga K	74127
Murakami M	74140
Moriya H	74152
Yamazaki M	74162
hematopoietic stem cells	74187
bone marrow	74217
neural lineage cells	74248
functional recovery	74281
spinal cord injury in mice	74307
spinal cord injury	74307
mice	74329
J Neuropath and Exp Neurol 2004 , 63 -LRB- 1 -RRB- : 64 -- 72 .	74335
J Neuropath and Exp Neurol 2004 , 63 -LRB- 1 -RRB-	74335
J Neuropath and Exp Neurol 2004 , 63	74335
J Neuropath	74335
Exp Neurol 2004 , 63	74351
1	74371
64 -- 72	74374
42	74381
Barakat DJ	74385
Gaglani SM	74397
Neravetla SR	74409
Sanchez AR	74423
Andrade CM	74435
Pressman Y	74447
Puzis R	74459
Garg MS	74468
Bunge MB	74477
Pearse DD	74487
Survival	74498
integration	74508
axon growth support	74525
glia transplanted into the chronically contused spinal cord	74548
glia	74548
the chronically contused spinal cord	74571
Cell Transplant 2005 , 14 -LRB- 4 -RRB-	74609
Cell Transplant	74609
2005 , 14 -LRB- 4 -RRB-	74625
2005 , 14	74625
2005	74625
14	74631
4	74634
225 -- 240	74637
225	74637
240	74641
43	74646
Sasaki M	74650
Lankford KL	74660
Zemedkun M , Kocsis JD : Identified olfactory ensheathing cells	74673
Zemedkun M , Kocsis JD :	74673
Zemedkun M	74673
Kocsis JD	74685
olfactory ensheathing cells	74707
the transected dorsal funiculus bridge the lesion and form myelin	74753
the	74753
dorsal funiculus bridge the lesion and form	74768
dorsal funiculus bridge	74768
the lesion and form	74792
J Neurosci 2004 , 24 -LRB- 39 -RRB- : 8485 -- 8493 .	74820
J Neurosci 2004 , 24 -LRB- 39 -RRB-	74820
J Neurosci 2004 , 24	74820
39	74840
8485 -- 8493	74844
44	74855
Hill CE	74859
Moon LD	74868
Wood PM , Bunge MB : Labeled Schwann cell transplantation	74877
Wood PM , Bunge MB :	74877
Wood PM	74877
Bunge MB	74886
Schwann cell transplantation	74904
cell loss , host Schwann cell replacement	74934
cell loss	74934
host Schwann cell replacement	74945
host	74945
Schwann cell replacement	74950
strategies to enhance survival	74980
survival	75002
Glia 2006 , 53 -LRB- 3 -RRB- : 338 -- 343 .	75012
Glia 2006 , 53 -LRB- 3 -RRB-	75012
Glia 2006	75012
53 -LRB- 3 -RRB-	75023
53	75023
3	75026
338 -- 343	75029
45	75038
Beattie MS	75042
Bresnahan JC	75054
Komon J	75068
Tovar CA	75077
Van Meter M	75087
Anderson DK	75100
Faden AI	75113
Hsu CY	75123
Noble LJ	75131
Salzman S	75141
Young W	75152
Endogenous repair after spinal cord contusion injuries in the rat	75161
Endogenous repair	75161
spinal cord contusion injuries in the rat	75185
spinal cord contusion injuries	75185
the rat	75219
Exp Neurol 1997 , 148 -LRB- 2 -RRB- : 453 -- 463 .	75228
Exp Neurol 1997 , 148 -LRB- 2 -RRB-	75228
Exp Neurol 1997 , 148	75228
2	75249
453 -- 463	75252
46	75261
Boruch AV	75265
Conners JJ	75276
Pipitone M	75288
Deadwyler G	75300
Storer PD	75313
Devries GH	75324
Jones KJ	75336
Neurotrophic and migratory properties of an olfactory ensheathing cell line	75346
Neurotrophic	75346
migratory properties of an olfactory ensheathing cell line	75363
migratory properties	75363
an olfactory ensheathing cell line	75387
Glia 2001 , 33 -LRB- 3 -RRB- : 225 -- 229 .	75423
Glia 2001 , 33 -LRB- 3 -RRB-	75423
Glia 2001	75423
33 -LRB- 3 -RRB-	75434
33	75434
3	75437
225 -- 229	75440
47	75449
Cao L	75453
Liu L	75460
Chen ZY	75467
Wang LM	75476
Ye JL	75485
Ye	75485
JL	75488
Qiu HY	75492
Lu CL	75500
He C	75507
He	75507
C	75510
Olfactory ensheathing cells	75513
GDNF	75573
spinal cord repair	75589
Brain 2004 , 127 -LRB- 3 -RRB- : 535 -- 549 .	75609
Brain 2004 , 127 -LRB- 3 -RRB-	75609
Brain 2004	75609
127 -LRB- 3 -RRB-	75621
127	75621
3	75625
535 -- 549	75628
48	75637
Woodhall E , West AK , Chuah MI : Cultured olfactory ensheathing cells	75641
Woodhall E	75641
West AK , Chuah MI : Cultured olfactory ensheathing cells	75653
West AK , Chuah MI :	75653
West AK	75653
Chuah MI	75662
olfactory ensheathing cells	75681
nerve growth	75717
factor brain-derived neurotrophic factor glia cell	75730
line-derived neurotrophic factor and their receptors	75781
line-derived neurotrophic factor	75781
their receptors	75818
Brain Res Mol Brain Res 2001 , 88 -LRB- 1 -- 2 -RRB-	75835
Brain Res Mol	75835
Brain Res 2001 , 88 -LRB- 1 -- 2 -RRB-	75849
Brain Res 2001 , 88	75849
1 -- 2	75868
1	75868
2	75870
203 -- 213	75873
203	75873
213	75877
49	75882
Fairless R , Frame MC , Barnett SC	75886
Fairless R	75886
Frame MC	75898
Barnett SC	75908
N-cadherin	75920
Schwann cell and olfactory ensheathing cell adhesion and migration responses	75957
Schwann cell	75957
olfactory ensheathing cell adhesion and migration responses	75974
contact with astrocytes	76039
contact	76039
astrocytes	76052
Mol Cell Neurosci 2005 , 28 -LRB- 2 -RRB-	76064
Mol Cell	76064
Neurosci 2005 , 28 -LRB- 2 -RRB-	76073
Neurosci 2005 , 28	76073
2	76091
253 -- 263	76094
253	76094
263	76098
50	76103
Grimpe B , Dong S , Doller C , Temple K , Malouf AT , Silver J	76107
Grimpe B	76107
Dong S	76117
Doller C	76125
Temple K	76135
Malouf AT	76145
Silver J	76156
The critical role of basement membrane-independent laminin gamma 1 chain	76166
role of basement	76179
role	76179
basement	76187
axon regeneration in the CNS	76246
axon regeneration	76246
the CNS	76267
J Neurosci 2002 , 22 -LRB- 8 -RRB- : 3144 -- 3160 .	76276
J Neurosci 2002 , 22 -LRB- 8 -RRB-	76276
J Neurosci 2002 , 22	76276
8	76296
3144 -- 3160	76299
51	76310
Tom VJ , Doller CM , Malouf AT , Silver J	76314
Tom VJ	76314
Doller CM	76322
Malouf AT	76333
Silver J	76344
Astrocyte-associated fibronectin	76354
axonal regeneration in adult white matter	76403
axonal regeneration	76403
adult white matter	76426
J Neurosci 2004 , 24 -LRB- 42 -RRB- : 9282 -- 9290 .	76446
J Neurosci 2004 , 24 -LRB- 42 -RRB-	76446
J Neurosci 2004 , 24	76446
42	76466
9282 -- 9290	76470
52	76481
Horky LL , Galimi F , Gage FH , Horner PJ : Fate of endogenous stem	76485
Horky LL	76485
Galimi F	76495
Gage FH	76505
Horner PJ : Fate of endogenous stem	76514
Horner PJ	76514
Fate of endogenous stem	76525
Fate	76525
endogenous stem	76533
progenitor cells	76550
spinal cord injury	76577
J Comp Neurol 2006 , 498 -LRB- 4 -RRB-	76597
J Comp	76597
Neurol 2006 , 498 -LRB- 4 -RRB-	76604
Neurol 2006 , 498	76604
4	76621
525 -- 538	76624
525	76624
538	76628
53	76633
Lee IH	76637
Bulte JW	76645
Schweinhardt P	76655
Douglas T	76671
Trifunovski A	76682
Hofstetter C	76697
Olson L	76711
Spenger C	76720
In vivo magnetic resonance	76731
tracking of olfactory ensheathing glia	76758
tracking	76758
olfactory ensheathing glia	76770
the rat spinal cord	76810
Exp Neurol 2004 , 187 -LRB- 2 -RRB- : 509 -- 516 .	76831
Exp Neurol 2004 , 187 -LRB- 2 -RRB-	76831
Exp Neurol 2004 , 187	76831
2	76852
509 -- 516	76855
54	76864
Ramon-Cueto A	76868
Nieto-Sampedro M	76883
Regeneration into the spinal cord of transected dorsal root axons	76901
Regeneration	76901
the spinal cord of transected dorsal root axons	76919
the spinal cord	76919
transected dorsal root axons	76938
glia transplants	76994
Exp Neurol 1994 , 127 -LRB- 2 -RRB- : 232 -- 244 .	77012
Exp Neurol 1994 , 127 -LRB- 2 -RRB-	77012
Exp Neurol 1994 , 127	77012
2	77033
232 -- 244	77036
55	77045
Duncan ID , Aguayo AJ , Bunge RP , Wood PM	77049
Duncan ID	77049
Aguayo AJ	77060
Bunge RP	77071
Wood PM	77081
Transplantation	77090
rat Schwann cells grown in tissue culture into the mouse spinal cord	77109
rat Schwann cells	77109
tissue culture	77136
the mouse spinal cord	77156
J Neurol Sci 1981 , 49 -LRB- 2 -RRB-	77179
J Neurol	77179
Sci 1981 , 49 -LRB- 2 -RRB-	77188
Sci 1981 , 49	77188
2	77201
241 -- 252	77204
241	77204
252	77208
56	77213
Symons NA , Danielsen N , Harvey AR	77217
Symons NA	77217
Danielsen N	77228
Harvey AR	77241
Migration	77252
cells	77265
peripheral nerve isografts in the peripheral and central nervous systems	77287
peripheral nerve isografts	77287
the peripheral and central nervous systems	77317
the adult mouse	77363
Eur J Neurosci 2001 , 14 -LRB- 3 -RRB-	77380
Eur J	77380
Neurosci 2001 , 14 -LRB- 3 -RRB-	77386
Neurosci 2001 , 14	77386
3	77404
522 -- 532	77407
522	77407
532	77411
57	77416
Plant GW , Bates ML , Bunge MB	77420
Plant GW	77420
Bates ML	77430
Bunge MB	77440
Inhibitory proteoglycan immunoreactivity	77450
the caudal than the rostral Schwann cell graft-transected spinal cord interface	77504
the rostral Schwann cell	77520
Mol Cell Neurosci 2001 , 17 -LRB- 3 -RRB-	77585
Mol Cell	77585
Neurosci 2001 , 17 -LRB- 3 -RRB-	77594
Neurosci 2001 , 17	77594
3	77612
471 -- 487	77615
471	77615
487	77619
58	77624
Doucette R	77628
Glial cells	77640
the nerve fiber layer of the main olfactory bulb of embryonic and adult mammals	77655
the nerve fiber layer	77655
the main olfactory bulb of embryonic and adult mammals	77680
the main olfactory bulb	77680
embryonic and adult mammals	77707
Microsc Res Tech 1993 , 24 -LRB- 2 -RRB-	77736
Microsc Res	77736
Tech 1993 , 24 -LRB- 2 -RRB-	77748
Tech 1993 , 24	77748
2	77762
113 -- 130	77765
113	77765
130	77769
59	77774
Lemke G : Glial control of neuronal development .	77778
Lemke G	77778
Glial control of neuronal development	77787
Glial control	77787
neuronal development	77804
Ann Rev Neurosci 2001 , 24:87 -- 105 .	77826
Ann Rev Neurosci 2001 , 24:87	77826
Ann Rev	77826
Neurosci 2001 , 24:87	77834
105	77855
60	77860
Ruitenberg MJ	77864
Vukovic J	77879
Blomster L	77890
Hall JM	77902
Jung S	77911
Filgueira L	77919
McMenamin PG	77932
Plant GW	77946
CX3CL1/fractalkine	77956
branching and migration	77985
monocyte-derived cells in the mouse olfactory epithelium	78012
monocyte-derived cells	78012
the mouse olfactory epithelium	78038
J Neuroimmunol 2008 , 205 -LRB- 1 -- 2 -RRB- : 80 -- 85 .	78070
J Neuroimmunol 2008 , 205 -LRB- 1 -- 2 -RRB-	78070
J Neuroimmunol 2008 , 205	78070
1 -- 2	78095
1	78095
2	78097
80 -- 85	78100
61	78107
Chinnery HR , Ruitenberg MJ , Plant GW , Pearlman E , Jung S , McMenamin PG	78111
Chinnery HR	78111
Ruitenberg MJ	78124
Plant GW	78139
Pearlman E	78149
Jung S	78161
McMenamin PG	78169
The chemokine receptor CX3CR1	78183
homing of MHC class II-positive cells	78222
homing	78222
MHC class II-positive cells	78232
the normal mouse corneal epithelium	78263
Ophthalmol Vis Sci 2007 , 48 -LRB- 4 -RRB- : 1568 -- 1574	78307
Ophthalmol Vis Sci 2007 , 48 -LRB- 4 -RRB-	78307
Ophthalmol Vis	78307
Sci 2007 , 48 -LRB- 4 -RRB-	78322
Sci 2007 , 48	78322
4	78335
1568 -- 1574	78338
62	78349
Roet KC , Bossers K , Franssen EH , Ruitenberg MJ , Verhaagen J	78353
Roet KC	78353
Bossers K	78362
Franssen EH	78373
Ruitenberg MJ	78386
Verhaagen J	78401
A metaanalysis	78414
microarray-based gene expression studies	78432
olfactory bulbderived olfactory ensheathing cells	78476
Exp Neurol 2011 , 229 -LRB- 1 -RRB- : 10 -- 45 .	78527
Exp Neurol 2011 , 229 -LRB- 1 -RRB-	78527
Exp Neurol 2011 , 229	78527
1	78548
10 -- 45	78551
63	78558
Shihabuddin LS , Ray J , Gage FH	78562
Shihabuddin LS	78562
Ray J	78578
Gage FH	78585
FGF-2	78594
progenitors found in the adult mammalian spinal cord	78625
progenitors	78625
the adult mammalian spinal cord	78646
Exp Neurol 1997 , 148 -LRB- 2 -RRB- : 577 -- 586 .	78679
Exp Neurol 1997 , 148 -LRB- 2 -RRB-	78679
Exp Neurol 1997 , 148	78679
2	78700
577 -- 586	78703
64	78712
McTigue DM , Horner PJ , Stokes BT , Gage FH	78716
McTigue DM	78716
Horner PJ	78728
Stokes BT	78739
Gage FH	78750
Neurotrophin-3 and brainderived neurotrophic factor	78759
Neurotrophin-3	78759
brainderived neurotrophic factor	78778
oligodendrocyte proliferation and myelination	78818
regenerating axons in the contused adult rat spinal cord	78867
regenerating axons	78867
the contused adult rat spinal cord	78889
J Neurosci 1998 , 18 -LRB- 14 -RRB- : 5354 -- 5365 .	78925
J Neurosci 1998 , 18 -LRB- 14 -RRB-	78925
J Neurosci 1998 , 18	78925
14	78945
5354 -- 5365	78949
65	78960
Horner PJ	78964
Power AE	78975
Kempermann G	78985
Kuhn HG	78999
Palmer TD	79008
Winkler J	79019
Thal LJ	79030
Gage FH	79039
Proliferation and differentiation	79048
progenitor cells throughout the intact adult rat spinal cord	79085
progenitor cells	79085
the intact adult rat spinal cord	79113
J Neurosci 2000 , 20 -LRB- 6 -RRB- : 2218 -- 2228 .	79147
J Neurosci 2000 , 20 -LRB- 6 -RRB-	79147
J Neurosci 2000 , 20	79147
6	79167
2218 -- 2228	79170
66	79181
Lytle JM , Wrathall JR	79185
Lytle JM	79185
Wrathall JR	79195
Glial cell loss proliferation and replacement in the contused murine spinal cord	79208
Glial cell loss proliferation and replacement	79208
the contused murine spinal cord	79257
Eur J Neurosci 2007 , 25 -LRB- 6 -RRB-	79290
Eur J	79290
Neurosci 2007 , 25 -LRB- 6 -RRB-	79296
Neurosci 2007 , 25	79296
6	79314
1711 -- 1724	79317
1711	79317
1724	79322
67	79328
Yang H	79332
Lu P	79340
McKay HM	79346
Bernot T	79356
Keirstead H	79366
Steward O	79379
Gage FH	79390
Edgerton VR	79399
Tuszynski MH	79412
Endogenous neurogenesis	79426
oligodendrocytes and astrocytes	79459
primate spinal cord injury	79497
J Neurosci 2006 , 26 -LRB- 8 -RRB- : 2157 -- 2166 .	79525
J Neurosci 2006 , 26 -LRB- 8 -RRB-	79525
J Neurosci 2006 , 26	79525
8	79545
2157 -- 2166	79548
68	79559
Adrian EK Jr : Cell division in injured spinal cord .	79563
Adrian EK Jr	79563
Cell division in injured spinal cord	79577
Cell division	79577
injured spinal cord	79594
J Anat 1968 , 123 -LRB- 3 -RRB- : 501 -- 520 .	79618
J	79618
Anat 1968 , 123 -LRB- 3 -RRB- : 501 -- 520 .	79620
Anat 1968 , 123 -LRB- 3 -RRB-	79620
Anat 1968 , 123	79620
3	79635
501 -- 520 .	79638
501	79638
520	79642
69	79647
Adrian EK Jr , Williams MG , George FC	79651
Adrian EK Jr	79651
Williams MG	79665
George FC	79678
Fine structure	79689
reactive cells	79707
injured nervous tissue labeled with 3H-thymidine injected before injury	79725
injured nervous tissue	79725
3H-thymidine injected before injury	79761
3H-thymidine	79761
injury	79790
J Comp Neurol 1978 , 180 -LRB- 4 -RRB-	79798
J Comp	79798
Neurol 1978 , 180 -LRB- 4 -RRB-	79805
Neurol 1978 , 180	79805
4	79822
815 -- 839	79825
815	79825
839	79829
70	79834
Kojima A , Tator CH	79838
Kojima A	79838
Tator CH	79848
Intrathecal administration of epidermal growth factor	79858
Intrathecal administration	79858
epidermal growth factor	79888
fibroblast growth factor 2	79916
fibroblast growth factor	79916
2	79941
ependymal proliferation and functional recovery	79952
proliferation	79962
spinal cord injury in adult rats	80006
spinal cord injury	80006
adult rats	80028
J Neurotrauma 2002 , 19 -LRB- 2 -RRB- : 223 -- 238 .	80040
J Neurotrauma 2002 , 19 -LRB- 2 -RRB-	80040
J Neurotrauma 2002 , 19	80040
2	80063
223 -- 238	80066
71	80075
Santos-Silva A	80079
Fairless R	80095
Frame MC	80107
Montague P	80117
Smith GM	80129
Toft A	80139
Riddell JS	80147
Barnett SC	80159
FGF/heparin	80171
Schwann cell	80208
olfactory ensheathing cell interactions with astrocytes : a role in astrocytosis	80225
olfactory ensheathing cell interactions with astrocytes	80225
olfactory ensheathing cell interactions	80225
astrocytes	80270
a role in astrocytosis	80282
a role	80282
astrocytosis	80292
J Neurosci 2007 , 27 -LRB- 27 -RRB- : 7154 -- 7167 .	80306
J Neurosci 2007 , 27 -LRB- 27 -RRB-	80306
J Neurosci 2007 , 27	80306
27	80326
7154 -- 7167	80330
72	80341
Goritz C , Dias DO , Tomilin N , Barbacid M , Shupliakov O , Frisen J	80345
Goritz C	80345
Dias DO	80355
Tomilin N	80364
Barbacid M	80375
Shupliakov O	80387
Frisen J	80401
A pericyte origin of spinal cord scar tissue	80411
A pericyte origin	80411
spinal cord scar tissue	80432
Science 2011 , 333 -LRB- 6039 -RRB- : 238 -- 242 .	80457
Science 2011 , 333 -LRB- 6039 -RRB-	80457
Science 2011 , 333	80457
6039	80475
238 -- 242	80481
73	80490
Decimo I	80494
Bifari F	80504
Rodriguez FJ	80514
Malpeli G	80528
Dolci S	80539
Lavarini V	80548
Pretto S	80560
Vasquez S	80570
Sciancalepore M	80581
Montalbano A	80598
Berton V	80612
Krampera M	80622
Fumagalli G	80634
Nestin	80647
doublecortin-positive cells	80659
adult spinal cord meninges	80697
injury-induced parenchymal reaction	80743
Stem Cells 2011 , 29 -LRB- 12 -RRB-	80780
Stem Cells	80780
2011 , 29 -LRB- 12 -RRB-	80791
2011 , 29	80791
2011	80791
29	80797
12	80800
2062 -- 2076	80804
2062	80804
2076	80809
74	80815
Barnabe-Heider F	80819
Gorit C	80837
Sabelstrom H	80846
Takebayashi H	80860
Pfrieger FW	80875
Meletis K	80888
Frisen J	80899
Origin of new glial cells in intact and injured adult spinal cord	80909
Origin	80909
new glial cells in intact and injured adult spinal cord	80919
new glial cells	80919
intact and injured adult spinal cord	80938
Cell Stem Cell 2010 , 7 -LRB- 4 -RRB-	80976
Cell Stem Cell	80976
2010 , 7 -LRB- 4 -RRB-	80991
2010 , 7	80991
2010	80991
7	80997
4	80999
470 -- 482	81002
470	81002
482	81006
75	81011
Meletis K	81015
Barnabe-Heider F	81026
Carlen M	81044
Evergren E	81054
Tomilin N	81066
Shupliakov O	81077
Frisen J	81091
Spinal cord injury	81101
multilineage differentiation of ependymal cells	81128
multilineage differentiation	81128
ependymal cells	81160
PLoS Biol 2008 , 6 -LRB- 7 -RRB- : e182 .	81177
PLoS Biol 2008 , 6 -LRB- 7 -RRB-	81177
PLoS Biol 2008 , 6	81177
7	81195
e182	81198
76	81204
Casella GT , Marcillo A , Bunge MB , Wood PM	81208
Casella GT	81208
Marcillo A	81220
Bunge MB	81232
Wood PM	81242
New vascular tissue	81251
neural parenchyma and vessels	81288
a contusion injury	81331
the rat spinal cord	81353
Exp Neurol 2002 , 173 -LRB- 1 -RRB- : 63 -- 76 .	81374
Exp Neurol 2002 , 173 -LRB- 1 -RRB-	81374
Exp Neurol 2002 , 173	81374
1	81395
63 -- 76	81398
77	81405
Brook GA	81409
Plate D	81419
Franzen R	81428
Martin D	81439
Moonen G	81449
Schoenen J	81459
Schmitt AB	81471
Noth J	81483
Nacimiento W	81491
Spontaneous	81505
axonal regeneration	81543
the Schwann cell framework	81582
the lesion site following spinal cord compression injury of the rat	81616
the lesion site	81616
spinal cord compression injury of the rat	81642
spinal cord compression injury	81642
the rat	81676
J Neurosci Res 1998 , 53 -LRB- 1 -RRB-	81685
J Neurosci	81685
Res 1998 , 53 -LRB- 1 -RRB-	81696
Res 1998 , 53	81696
1	81709
51 -- 65	81712
51	81712
65	81715
78	81719
Hill CE , Beattie MS , Bresnahan JC	81723
Hill CE	81723
Beattie MS	81732
Bresnahan JC	81744
Degeneration	81758
identified descending supraspinal axons	81788
contusive spinal cord injury in the rat	81834
contusive spinal cord injury	81834
the rat	81866
Exp Neurol 2001 , 171 -LRB- 1 -RRB- : 153 -- 169 .	81875
Exp Neurol 2001 , 171 -LRB- 1 -RRB-	81875
Exp Neurol 2001 , 171	81875
1	81896
153 -- 169	81899
79	81908
O'Brien DF , Farrell M , Fraher JP , Bolger C	81912
O'Brien DF	81912
Farrell M	81924
Fraher JP	81935
Bolger C	81946
Schwann cell invasion of the conus medullaris	81956
Schwann cell invasion	81956
the conus medullaris	81981
case report	82003
case	82003
report	82008
Eur Spine J 2003 , 12 -LRB- 3 -RRB-	82016
Eur Spine	82016
J 2003 , 12 -LRB- 3 -RRB-	82026
J 2003 , 12	82026
3	82037
328 -- 331	82040
328	82040
331	82044
80	82049
Lakatos A , Barnett SC , Franklin RJ	82053
Lakatos A	82053
Barnett SC	82064
Franklin RJ	82076
Olfactory ensheathing cells	82089
less host astrocyte response and chondroitin sulphate proteoglycan expression	82124
less host astrocyte response	82124
chondroitin sulphate proteoglycan expression	82157
Schwann cells following transplantation into adult CNS white matter	82207
Schwann cells	82207
transplantation into adult CNS white matter	82231
transplantation	82231
adult CNS white matter	82252
adult CNS	82252
white matter	82262
Exp Neurol 2003 , 184 -LRB- 1 -RRB- : 237 -- 246 .	82276
Exp Neurol 2003 , 184 -LRB- 1 -RRB-	82276
Exp Neurol 2003 , 184	82276
1	82297
237 -- 246	82300
81	82309
Ramon-Cueto A , Avila J : Olfactory ensheathing glia : properties and function .	82313
Ramon-Cueto A , Avila J	82313
Ramon-Cueto A	82313
Avila J	82328
Olfactory ensheathing glia : properties and function	82337
Olfactory ensheathing glia	82337
properties and function	82365
properties	82365
function	82380
Brain Res Bull 1998 , 46 -LRB- 3 -RRB-	82390
Brain	82390
Res Bull 1998 , 46 -LRB- 3 -RRB-	82396
Res Bull 1998 , 46	82396
3	82414
175 -- 187	82417
175	82417
187	82421
82	82426
Gueye Y	82430
Ferhat L	82439
Sbai O	82449
Bianco J	82457
Ould-Yahoui A	82467
Bernard A	82482
Charrat E	82493
Chauvin JP	82504
Risso JJ	82516
Feron F	82526
Rivera S	82535
Khrestchatisky M	82545
Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing	82563
Trafficking and secretion	82563
matrix metalloproteinase-2 in olfactory ensheathing	82592
matrix metalloproteinase-2	82592
olfactory ensheathing	82622
glial cells	82644
A role in cell migration	82657
A role	82657
cell migration	82667
Glia 2011 , 59 -LRB- 5 -RRB- : 750 -- 770 .	82683
Glia 2011 , 59 -LRB- 5 -RRB-	82683
Glia 2011	82683
59 -LRB- 5 -RRB-	82694
59	82694
5	82697
750 -- 770	82700
83	82709
Li Y , Li D , Raisman G	82713
Li Y	82713
Li D	82719
Raisman G	82725
Interaction of olfactory ensheathing cells with astrocytes	82736
Interaction	82736
olfactory ensheathing cells with astrocytes	82751
olfactory ensheathing cells	82751
astrocytes	82784
the key to repair of tract injuries in the spinal cord	82802
the key	82802
repair of tract injuries in the spinal cord	82813
repair	82813
tract injuries in the spinal cord	82823
tract injuries	82823
the spinal cord	82841
the ` pathway hypothesis '	82858
J Neurocytol 2005 , 34 -LRB- 3 -- 5 -RRB- : 343 -- 351 .	82884
J Neurocytol 2005 , 34 -LRB- 3 -- 5 -RRB-	82884
J Neurocytol 2005 , 34	82884
3 -- 5	82906
3	82906
5	82908
343 -- 351	82911
84	82920
Tisay KT , Key B : The extracellular matrix	82924
Tisay KT	82924
Key B : The extracellular matrix	82934
Key B	82934
The extracellular matrix	82941
olfactory neurite outgrowth on ensheathing cells	82976
olfactory neurite outgrowth	82976
ensheathing cells	83007
J Neurosci 1999 , 19 -LRB- 22 -RRB- : 9890 -- 9899 .	83026
J Neurosci 1999 , 19 -LRB- 22 -RRB-	83026
J Neurosci 1999 , 19	83026
22	83046
9890 -- 9899	83050
85	83061
Franssen EH , Roet KC , de Bree FM , Verhaagen J	83065
Franssen EH	83065
Roet KC	83078
de Bree FM , Verhaagen J	83087
de	83087
Bree FM , Verhaagen J	83090
Bree FM	83090
Verhaagen J	83099
Olfactory ensheathing glia and Schwann cells	83112
a distinct interaction behavior	83165
meningeal cells	83202
J Neurosci Res 2009 , 87:1556 -- 1564 .	83219
J Neurosci Res 2009 , 87:1556	83219
J Neurosci	83219
Res 2009 , 87:1556	83230
1564	83248
86	83254
Obremski VJ , Johnson MI , Bunge MB	83258
Obremski VJ	83258
Johnson MI	83271
Bunge MB	83283
Fibroblasts	83293
Schwann cell basal lamina deposition	83322
Schwann cell	83322
basal lamina deposition	83335
ensheathment of unmyelinated sympathetic neurites in culture	83363
ensheathment	83363
unmyelinated sympathetic neurites in culture	83379
unmyelinated sympathetic neurites	83379
culture	83416
J Neurocytol 1993 , 22 -LRB- 2 -RRB- : 102 -- 117 .	83425
J Neurocytol 1993 , 22 -LRB- 2 -RRB-	83425
J Neurocytol 1993 , 22	83425
2	83447
102 -- 117	83450
87	83459
Ibanez C , Ito D , Zawadzka M , Jeffery ND , Franklin RJ	83463
Ibanez C	83463
Ito D	83473
Zawadzka M	83480
Jeffery ND	83492
Franklin RJ	83504
Calponin	83517
fibroblasts and meningeal cells	83542
olfactory ensheathing cells in the adult peripheral olfactory system	83582
olfactory ensheathing cells	83582
the adult peripheral olfactory system	83613
Glia 2007 , 55 -LRB- 2 -RRB- : 144 -- 151 .	83652
Glia 2007 , 55 -LRB- 2 -RRB-	83652
Glia 2007	83652
55 -LRB- 2 -RRB-	83663
55	83663
2	83666
144 -- 151	83669
88	83678
Barnett SC	83682
Alexander CL	83694
Iwashita Y	83708
Gilson JM	83720
Crowther J	83731
Clark L	83743
Dunn LT	83752
Papanastassiou V	83761
Kennedy PG	83779
Franklin RJ	83791
Identification	83804
a human olfactory ensheathing cell	83822
transplant-mediated remyelination of demyelinated CNS axons	83873
transplant-mediated remyelination	83873
CNS axons	83923
Brain 2000 , 123 -LRB- 8 -RRB- : 1581 -- 1588 .	83934
Brain 2000 , 123 -LRB- 8 -RRB-	83934
Brain 2000	83934
123 -LRB- 8 -RRB-	83946
123	83946
8	83950
1581 -- 1588	83953
89	83964
Boyd JG , Jahed A , McDonald TG , Krol KM , Van Eyk JE , Doucette R , Kawaja MD	83968
Boyd JG	83968
Jahed A	83977
McDonald TG	83986
Krol KM	83999
Van Eyk JE	84008
Doucette R	84020
Kawaja MD	84032
Proteomic evaluation	84043
olfactory ensheathing cells but not Schwann cells	84077
olfactory ensheathing cells	84077
Schwann cells	84113
Schwann	84113
cells	84121
calponin	84135
Glia 2006 , 53 -LRB- 4 -RRB- : 434 -- 440 .	84145
Glia 2006 , 53 -LRB- 4 -RRB-	84145
Glia 2006	84145
53 -LRB- 4 -RRB-	84156
53	84156
4	84159
434 -- 440	84162
90	84171
Li Y , Field PM , Raisman G	84175
Li Y	84175
Field PM	84181
Raisman G	84191
Regeneration	84202
adult rat corticospinal axons	84218
transplanted olfactory ensheathing cells	84259
transplanted olfactory ensheathing	84259
cells	84294
J Neurosci 1998 , 18 -LRB- 24 -RRB- : 10514 -- 10524 .	84301
J Neurosci 1998 , 18 -LRB- 24 -RRB-	84301
J Neurosci 1998 , 18	84301
24	84321
10514 -- 10524	84325
91	84338
Lakatos A , Franklin RJ , Barnett SC	84342
Lakatos A	84342
Franklin RJ	84353
Barnett SC	84366
Olfactory ensheathing cells and Schwann cells	84378
their	84434
interactions	84449
astrocytes	84467
Glia 2000 , 32 -LRB- 3 -RRB- : 214 -- 225 .	84479
Glia 2000 , 32 -LRB- 3 -RRB-	84479
Glia 2000	84479
32 -LRB- 3 -RRB-	84490
32	84490
3	84493
214 -- 225	84496
92	84505
Trang T , Beggs S , Wan X , Salter MW	84509
Trang T	84509
Beggs S	84518
Wan X	84527
Salter MW	84534
P2X4-receptor-mediated synthesis and release	84545
brain-derived neurotrophic factor in microglia	84593
brain-derived neurotrophic factor	84593
microglia	84630
calcium and p38-mitogen-activated protein kinase activation	84656
calcium	84656
p38-mitogen-activated protein kinase activation	84668
J Neurosci 2009 , 29 -LRB- 11 -RRB- : 3518 -- 3528 .	84717
J Neurosci 2009 , 29 -LRB- 11 -RRB-	84717
J Neurosci 2009 , 29	84717
11	84737
3518 -- 3528	84741
93	84752
Heumann R	84756
Lindholm D	84767
Bandtlow C	84779
Meyer M	84791
Radeke M	84800
Misko TP J	84810
Shooter E	84822
Thoenen H	84833
Differential regulation	84844
mRNA	84871
nerve growth factor and its receptor	84885
nerve growth factor	84885
its receptor	84909
rat sciatic nerve	84925
development , degeneration , and regeneration : role of macrophages	84950
development , degeneration , and regeneration	84950
role of macrophages	84995
role	84995
macrophages	85003
Proc Natl Acad Sci U S A 1987 , 84 -LRB- 23 -RRB-	85016
Proc Natl Acad Sci U S	85016
A 1987 , 84 -LRB- 23 -RRB-	85039
A 1987 , 84	85039
23	85050
8735 -- 8739	85054
8735	85054
8739	85059
94	85065
Meier C , Parmantier E , Brennan A , Mirsky R , Jessen KR	85069
Meier C	85069
Parmantier E	85078
Brennan A	85092
Mirsky R	85103
Jessen KR	85113
Developing Schwann cells	85124
the ability	85157
axons	85188
an autocrine circuit	85210
insulin-like growth factor neurotrophin-3 and platelet-derived growth factor-BB	85241
insulin-like growth factor neurotrophin-3	85241
platelet-derived growth factor-BB	85287
J Neurosci 1999 , 19 -LRB- 10 -RRB- : 3847 -- 3859 .	85322
J Neurosci 1999 , 19 -LRB- 10 -RRB-	85322
J Neurosci 1999 , 19	85322
10	85342
3847 -- 3859	85346
95	85357
Dowsing BJ , Morrison WA , Nicola NA , Starkey GP , Bucci T , Kilpatrick TJ	85361
Dowsing BJ	85361
Morrison WA	85373
Nicola NA	85386
Starkey GP	85397
Bucci T	85409
Kilpatrick TJ	85418
Leukemia inhibitory factor	85433
an autocrine survival factor for Schwann cells	85463
an autocrine survival factor	85463
Schwann cells	85496
J Neurochem 1999 , 73 -LRB- 1 -RRB- : 96 -- 104 .	85511
J Neurochem 1999 , 73 -LRB- 1 -RRB-	85511
J Neurochem 1999 , 73	85511
1	85532
96 -- 104	85535
96	85543
Edgerton VR , Roy RR : Paralysis recovery in humans and model systems .	85547
Edgerton VR , Roy RR	85547
Edgerton VR	85547
Roy RR	85560
Paralysis recovery in humans and model systems	85568
Paralysis recovery	85568
humans and model systems	85590
Curr Opin Neurobiol 2002 , 12 -LRB- 6 -RRB-	85616
Curr Opin	85616
Neurobiol 2002 , 12 -LRB- 6 -RRB-	85626
Neurobiol 2002 , 12	85626
6	85645
658 -- 667	85648
658	85648
667	85652
97	85657
Kubasak MD	85661
Jindrich DL	85673
Zhong H	85686
Takeoka A	85695
McFarland KC	85706
Munoz-Quiles C	85720
Roy RR	85736
Edgerton VR	85744
Ramon-Cueto A , Phelps PE	85757
Ramon-Cueto A	85757
Phelps PE	85772
OEG implantation	85783
step training	85804
hindlimb-stepping ability in adult spinal transected rats	85826
hindlimb-stepping ability	85826
adult spinal transected rats	85855
Brain 2008 , 131 -LRB- Pt 1 -RRB- : 264 -- 276 .	85885
Brain 2008 , 131 -LRB- Pt 1 -RRB-	85885
Brain 2008	85885
131 -LRB- Pt 1 -RRB-	85897
131	85897
Pt 1	85901
264 -- 276	85907
98	85916
Takeoka A , Kubasak MD , Zhong H , Roy RR , Phelps PE	85920
Takeoka A	85920
Kubasak MD	85931
Zhong H	85943
Roy RR	85952
Phelps PE	85960
Serotonergic innervation	85971
the caudal spinal stump in rats after complete spinal transection	85999
the caudal spinal stump	85999
rats after complete spinal transection	86026
rats	86026
complete spinal transection	86037
effect of olfactory ensheathing glia	86066
effect	86066
olfactory ensheathing glia	86076
J Comp Neurol 2009 , 515 -LRB- 6 -RRB-	86104
J Comp	86104
Neurol 2009 , 515 -LRB- 6 -RRB-	86111
Neurol 2009 , 515	86111
6	86128
664 -- 676	86131
664	86131
676	86135
99	86140
Basso DM , Beattie MS , Bresnahan JC :	86144
Basso DM	86144
Beattie MS , Bresnahan JC :	86154
Beattie MS	86154
Bresnahan JC	86166
histological and locomotor outcomes	86187
spinal cord contusion using the NYU weight-drop device versus transection	86229
spinal cord contusion	86229
the NYU weight-drop device versus transection	86257
the NYU weight-drop device	86257
transection	86291
Exp Neurol 1996 , 139 -LRB- 2 -RRB- : 244 -- 256 .	86304
Exp Neurol 1996 , 139 -LRB- 2 -RRB-	86304
Exp Neurol 1996 , 139	86304
2	86325
244 -- 256	86328
100	86337
Fitch MT , Doller C , Combs CK , Landreth GE , Silver J	86342
Fitch MT	86342
Doller C	86352
Combs CK	86362
Landreth GE	86372
Silver J	86385
Cellular and molecular mechanisms of glial scarring and progressive cavitation	86395
Cellular and molecular mechanisms	86395
glial scarring and progressive cavitation	86432
glial scarring	86432
progressive cavitation	86451
in vivo and in vitro analysis	86475
vivo	86478
inflammation-induced secondary injury after CNS trauma	86508
inflammation-induced secondary injury	86508
CNS trauma	86552
J Neurosci 1999 , 19 -LRB- 19 -RRB- : 8182 -- 8198 .	86564
J Neurosci 1999 , 19 -LRB- 19 -RRB-	86564
J Neurosci 1999 , 19	86564
19	86584
8182 -- 8198	86588
101	86599
McKeon RJ , Schreiber RC , Rudge JS , Silver J : Reduction	86604
McKeon RJ	86604
Schreiber RC	86615
Rudge JS	86629
Silver J	86639
Reduction	86649
neurite outgrowth	86662
a model of glial scarring	86683
a model	86683
glial scarring	86694
CNS injury	86719
the expression of inhibitory molecules	86749
the expression	86749
inhibitory molecules	86767
reactive astrocytes	86791
J Neurosci 1991 , 11 -LRB- 11 -RRB- : 3398 -- 3411 .	86812
J Neurosci 1991 , 11 -LRB- 11 -RRB-	86812
J Neurosci 1991 , 11	86812
11	86832
3398 -- 3411	86836
102	86847
Alilain WJ , Horn KP , Hu H , Dick TE , Silver J	86852
Alilain WJ	86852
Horn KP	86864
Hu H	86873
Dick TE	86879
Silver J	86888
Functional regeneration of respiratory pathways after spinal cord injury	86898
Functional regeneration	86898
respiratory pathways after spinal cord injury	86925
respiratory pathways	86925
spinal cord injury	86952
Nature 2011 , 475 -LRB- 7355 -RRB- : 196 -- 200 .	86972
Nature 2011 , 475 -LRB- 7355 -RRB-	86972
Nature 2011 , 475	86972
7355	86989
196 -- 200	86995
103	87004
Bradbury EJ	87009
Moon LD	87022
Popat RJ	87031
King VR	87041
Bennett GS	87050
Patel PN	87062
Fawcett JW	87072
McMahon SB	87084
Chondroitinase ABC	87096
functional recovery	87124
spinal cord injury	87150
Nature 2002 , 416 -LRB- 6881 -RRB- : 636 -- 640 .	87170
Nature 2002 , 416 -LRB- 6881 -RRB-	87170
Nature 2002 , 416	87170
6881	87187
636 -- 640	87193
104	87202
Zufferey R , Dull T , Mandel RJ , Bukovsky A , Quiroz D , Naldini L , Trono D	87207
Zufferey R	87207
Dull T	87219
Mandel RJ	87227
Bukovsky A	87238
Quiroz D	87250
Naldini L	87260
Trono D	87271
Selfinactivating lentivirus vector for safe and efficient in vivo gene delivery	87280
Selfinactivating lentivirus vector	87280
vivo gene delivery	87341
vivo	87341
gene delivery	87346
J Virol 1998 , 72 -LRB- 12 -RRB- : 9873 -- 9880 .	87361
J Virol 1998 , 72 -LRB- 12 -RRB-	87361
J Virol 1998 , 72	87361
12	87378
9873 -- 9880	87382
105	87393
Gruner JA : A monitored contusion model of spinal cord injury in the rat .	87398
Gruner JA	87398
A	87409
contusion model of spinal cord injury	87421
contusion model	87421
spinal cord injury	87440
the rat	87462
J Neurotrauma 1992 , 9 -LRB- 2 -RRB- : 123 -- 126 .	87471
J Neurotrauma 1992 , 9 -LRB- 2 -RRB-	87471
J Neurotrauma 1992 , 9	87471
2	87493
123 -- 126	87496
discussion 126 -- 128 .	87505
discussion 126	87505
128	87520
106	87525
Metz GA , Whishaw IQ : Cortical and subcortical lesions	87530
Metz GA	87530
Whishaw IQ : Cortical and subcortical lesions	87539
Whishaw IQ	87539
Cortical and subcortical lesions	87551
skilled walking	87591
the ladder rung walking test	87610
the ladder	87610
test	87634
a new task to evaluate foreand hindlimb stepping placing	87640
foreand hindlimb stepping placing	87663
foreand hindlimb	87663
co-ordination	87701
J Neurosci Meths 2002 , 115 -LRB- 2 -RRB- : 169 -- 179 .	87716
J Neurosci Meths 2002 , 115 -LRB- 2 -RRB-	87716
J Neurosci	87716
Meths 2002 , 115 -LRB- 2 -RRB-	87727
Meths 2002 , 115	87727
2	87743
169 -- 179	87746
169	87746
179	87750
107	87755
Bates KA , Fonte J , Robertson TA , Martins RN , Harvey AR	87760
Bates KA	87760
Fonte J	87770
Robertson TA	87779
Martins RN	87793
Harvey AR	87805
Chronic gliosis	87816
Alzheimer 's disease-like processing of amyloid precursor protein	87841
Alzheimer 's disease-like processing	87841
Alzheimer 's	87841
amyloid precursor protein	87880
Neuroscience 2002 , 113 -LRB- 4 -RRB- : 785 -- 796 .	87907
Neuroscience 2002 , 113 -LRB- 4 -RRB-	87907
Neuroscience 2002 , 113	87907
4	87930
785 -- 796	87933
108	87942
Oudega M , Vargas CG , Weber AB , Kleitman N , Bunge MB	87947
Oudega M	87947
Vargas CG	87957
Weber AB	87968
Kleitman N	87978
Bunge MB	87990
Long-term effects	88000
methylprednisolone following transection of adult rat spinal cord	88021
methylprednisolone following transection	88021
adult rat spinal cord	88065
Eur J Neurosci 1999 , 11 -LRB- 7 -RRB-	88088
Eur J	88088
Neurosci 1999 , 11 -LRB- 7 -RRB-	88094
Neurosci 1999 , 11	88094
7	88112
2453 -- 2464	88115
2453	88115
2464	88120
109	88126
West MJ , Slomianka L , Gundersen HJ	88131
West MJ	88131
Slomianka L	88140
Gundersen HJ	88153
Unbiased stereological estimation	88167
the total number	88204
neurons in thesubdivisions of the rat hippocampus using the optical fractionator	88224
neurons	88224
thesubdivisions of the rat hippocampus using the optical fractionator	88235
thesubdivisions	88235
the rat hippocampus using the optical fractionator	88254
the rat hippocampus	88254
the optical fractionator	88280
Anat Rec 1991 , 231 -LRB- 4 -RRB- : 482 -- 497 .	88306
Anat Rec 1991 , 231 -LRB- 4 -RRB-	88306
Anat Rec 1991 , 231	88306
4	88325
482 -- 497	88328
